
<html lang="en"     class="pb-page"  data-request-id="cddee69c-4bee-4bf0-ac84-3e00931e35d4"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm900400w;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2009.52.issue-15;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Cyclic Minigastrin Analogues for Gastrin Receptor Scintigraphy with Technetium-99m: Preclinical Evaluation" /></meta><meta name="dc.Creator" content="Elisabeth  von Guggenberg" /></meta><meta name="dc.Creator" content="Werner  Sallegger" /></meta><meta name="dc.Creator" content="Anna  Helbok" /></meta><meta name="dc.Creator" content="Meltem  Ocak" /></meta><meta name="dc.Creator" content="Robert  King" /></meta><meta name="dc.Creator" content="Stephen J.  Mather" /></meta><meta name="dc.Creator" content="Clemens  Decristoforo" /></meta><meta name="dc.Description" content="Two cyclized minigastrin analogues for gastrin receptor scintigraphy were synthesized and derivatized with HYNIC at the N-terminus for labeling with 99mTc. Radiolabeling efficiency, stability, cell..." /></meta><meta name="Description" content="Two cyclized minigastrin analogues for gastrin receptor scintigraphy were synthesized and derivatized with HYNIC at the N-terminus for labeling with 99mTc. Radiolabeling efficiency, stability, cell..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 10, 2009" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm900400w" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2009 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm900400w" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm900400w" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm900400w" /></link>
        
    
    

<title>Cyclic Minigastrin Analogues for Gastrin Receptor Scintigraphy with Technetium-99m: Preclinical Evaluation | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm900400w" /></meta><meta property="og:title" content="Cyclic Minigastrin Analogues for Gastrin Receptor Scintigraphy with Technetium-99m: Preclinical Evaluation" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900400w/production/images/large/jm-2009-00400w_0008.jpeg" /></meta><meta property="og:description" content="Two cyclized minigastrin analogues for gastrin receptor scintigraphy were synthesized and derivatized with HYNIC at the N-terminus for labeling with 99mTc. Radiolabeling efficiency, stability, cell internalization, and receptor binding on CCK-2 receptor expressing AR42J cells were studied and the biodistribution evaluated in tumor bearing nude mice, including NanoSPECT/CT imaging. Metabolites in urine, liver, and kidneys were analyzed by radio-HPLC. Radiolabeled cyclic MG showed high stability in vitro and receptor mediated uptake in AR42J cells. In the animal tumor model, fast renal clearance and low nonspecific uptake in most organs were observed. A tumor uptake &gt;3% was calculated ex vivo 1 h p.i. for both 99mTc-EDDA-HYNIC-cyclo-MG1 and 99mTc-EDDA-HYNIC-cyclo-MG2. In an imaging study with 99mTc-EDDA-HYNIC-cyclo-MG1, the tumor was clearly visualized. The metabolite analysis indicated rapid enzymatic degradation in vivo." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm900400w"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm900400w">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm900400w&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm900400w&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm900400w&amp;href=/doi/10.1021/jm900400w" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2009</span><span class="cit-fg-volume">, 52</span><span class="cit-fg-issue">, 15</span><span class="cit-fg-pageRange">, 4786-4793</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/52/15" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm900371z" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm900357y" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Cyclic Minigastrin Analogues for Gastrin Receptor Scintigraphy with Technetium-99m: Preclinical Evaluation</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elisabeth++von+Guggenberg">Elisabeth von Guggenberg</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Werner++Sallegger">Werner Sallegger</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anna++Helbok">Anna Helbok</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Meltem++Ocak">Meltem Ocak</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert++King">Robert King</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen+J.++Mather">Stephen J. Mather</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Clemens++Decristoforo">Clemens Decristoforo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Nuclear Medicine, Innsbruck Medical University, Anichstrasse 35, A-6020 Innsbruck, Austria</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">piCHEM Research and Development GmbH, Kahngasse 20, A-8045 Graz, Austria</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Centre for Molecular Oncology and Imaging, Barts and the London School of Medicine, London, EC1M 6BQ, United Kingdom</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: +43-512-504-80960. E-fax: +43-512-504-6780960. E-mail: <a href="/cdn-cgi/l/email-protection#492c25203a282b2c3d21673f26272e3c2e2e2c272b2c3b2e093c222067283d"><span class="__cf_email__" data-cfemail="086d64617b696a6d7c60267e67666f7d6f6f6d666a6d7a6f487d636126697c">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm900400w&amp;href=/doi/10.1021%2Fjm900400w" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2009</span></span><span class="cit-volume">, 52</span><span class="cit-issue">, 15</span><span class="cit-pageRange">, 4786–4793</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 10, 2009</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>30 March 2009</li><li><span class="item_label"><b>Published</b> online</span>10 July 2009</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 August 2009</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm900400w" title="DOI URL">https://doi.org/10.1021/jm900400w</a></div><div class="article_header-article-copyright"><strong>Copyright © 2009 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4786%26pageCount%3D8%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DElisabeth%2Bvon%2BGuggenberg%252C%2BWerner%2BSallegger%252C%2BAnna%2BHelbok%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D52%26issueNum%3D15%26contentID%3Djm900400w%26title%3DCyclic%2BMinigastrin%2BAnalogues%2Bfor%2BGastrin%2BReceptor%2BScintigraphy%2Bwith%2BTechnetium-99m%253A%2BPreclinical%2BEvaluation%26numPages%3D8%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4793%26publicationDate%3DAugust%2B2009">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm900400w"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">841</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">32</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm900400w" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Cyclic Minigastrin Analogues for Gastrin Receptor Scintigraphy with Technetium-99m: Preclinical Evaluation&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Elisabeth&quot;,&quot;last_name&quot;:&quot;von Guggenberg&quot;},{&quot;first_name&quot;:&quot;Werner&quot;,&quot;last_name&quot;:&quot;Sallegger&quot;},{&quot;first_name&quot;:&quot;Anna&quot;,&quot;last_name&quot;:&quot;Helbok&quot;},{&quot;first_name&quot;:&quot;Meltem&quot;,&quot;last_name&quot;:&quot;Ocak&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;King&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;J. Mather&quot;},{&quot;first_name&quot;:&quot;Clemens&quot;,&quot;last_name&quot;:&quot;Decristoforo&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2009&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;10&quot;,&quot;issue&quot;:&quot;15&quot;,&quot;volume&quot;:&quot;52&quot;,&quot;pages&quot;:&quot;4786-4793&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm900400w&quot;},&quot;abstract&quot;:&quot;Two cyclized minigastrin analogues for gastrin receptor scintigraphy were synthesized and derivatized with HYNIC at the N-terminus for labeling with 99mTc. Radiolabeling efficiency, stability, cell internalization, and receptor binding on CCK-2 receptor expressing AR42J cells were studied and the biodistribution evaluated in tumor bearing nude mice, including NanoSPECT/CT imaging. Metabolites in urine, liver, and kidneys were analyzed by radio-HPLC. Radiolabeled cyclic MG showed high stability in vitro and receptor mediated uptake in AR42J cells. In the animal tumor model, fast renal clearance and low nonspecific uptake in most organs were observed. A tumor uptake &gt;3% was calculated ex vivo 1 h p.i. for both 99mTc-EDDA-HYNIC-cyclo-MG1 and 99mTc-EDDA-HYNIC-cyclo-MG2. In an imaging study with 99mTc-EDDA-HYNIC-cyclo-MG1, the tumor was clearly visualized. The metabolite analysis indicated rapid enzymatic degradation in vivo.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm900400w&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900400w" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm900400w&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900400w" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm900400w&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900400w" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm900400w&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm900400w&amp;href=/doi/10.1021/jm900400w" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm900400w" /></input><a href="/doi/pdf/10.1021/jm900400w" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm900400w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm900400w%26sid%3Dliteratum%253Aachs%26pmid%3D19591486%26genre%3Darticle%26aulast%3Dvon%2BGuggenberg%26date%3D2009%26atitle%3DCyclic%2BMinigastrin%2BAnalogues%2Bfor%2BGastrin%2BReceptor%2BScintigraphy%2Bwith%2BTechnetium-99m%253A%2BPreclinical%2BEvaluation%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D52%26issue%3D15%26spage%3D4786%26epage%3D4793%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292143" title="Metabolism">Metabolism</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/52/15" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900400w/production/images/medium/jm-2009-00400w_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900400w/production/images/large/jm-2009-00400w_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900400w&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Two cyclized minigastrin analogues for gastrin receptor scintigraphy were synthesized and derivatized with HYNIC at the N-terminus for labeling with <sup>99m</sup>Tc. Radiolabeling efficiency, stability, cell internalization, and receptor binding on CCK-2 receptor expressing AR42J cells were studied and the biodistribution evaluated in tumor bearing nude mice, including NanoSPECT/CT imaging. Metabolites in urine, liver, and kidneys were analyzed by radio-HPLC. Radiolabeled cyclic MG showed high stability in vitro and receptor mediated uptake in AR42J cells. In the animal tumor model, fast renal clearance and low nonspecific uptake in most organs were observed. A tumor uptake >3% was calculated ex vivo 1 h p.i. for both <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1 and <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG2. In an imaging study with <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1, the tumor was clearly visualized. The metabolite analysis indicated rapid enzymatic degradation in vivo.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18262" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18262" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Cholecystokinin (CCK<a class="ref internalNav" href="#fn7" aria-label="a">a</a><div class="NLM_fn" id="fn7">a<p class="last">Abbreviations: CCK, cholecystokinin; GRS, gastrin receptor scintigraphy; MG, minigastrin; MTC, medullary thyroid carcinoma; SRS, somatostatin receptor scintigraphy; PRRT, peptide receptor radiotherapy.</p></div>) receptors are overexpressed in numerous neuroendocrine tumors.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Gastrin analogues show a superior selectivity and affinity for CCK-2 receptors and have been extensively investigated for possible applications in nuclear medicine.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> For CCK analogues, it still remains to be clarified whether sulfated CCK8 analogues which bind to both CCK-1 and CCK-2 receptors<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> or nonsulfated CCK8 analogues which display a higher selectivity for CCK-2<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> are more favorable for CCK-2 receptor targeting.</div><div class="NLM_p">Gastrin receptor scintigraphy (GRS) has been proven to be clinically useful for the detection of metastatic medullary thyroid carcinoma (MTC) with a higher tumor detection rate compared to somatostatin receptor scintigraphy (SRS) and 2-[<sup>18</sup>F]fluoro-2-deoxy-<span class="smallcaps smallerCapital">d</span>-glucose positron emission tomography.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> GRS can also provide additional information in the detection of neuroendocrine tumors, especially if SRS is negative, and may possibly also allow the detection of small cell lung cancer.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The recent finding that minigastrin and CCK analogues also bind to a splice variant of the CCK-2 receptor, CCK-2i4svR, overexpressed in colorectal and pancreatic cancer, opens new perspectives for GRS and peptide receptor radiotherapy (PRRT).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><div class="NLM_p"><sup>111</sup>In-DTPA-<span class="smallcaps smallerCapital">d</span>-Glu<sup>1</sup>-minigastrin (<sup>111</sup>In-DTPA-MG0) based on native minigastrin (LEEEEEAYGWMDF-NH2, MG) was used in these human studies<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> and has also been radio-labeled with yttrium-90 for therapeutic applications.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Our group has been involved in the development of a technetium-99m labeled MG analogue based on 6-hydrazinonicotinamide (HYNIC) as a <sup>99m</sup>Tc-binding moiety.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> A <sup>99m</sup>Tc-labeled radioligand would allow on-demand availability of GRS to select patients considered for PRRT in specialized centers.</div><div class="NLM_p">Radioligands based on MG0 display a very high kidney uptake in vivo,<a onclick="showRef(event, 'ref9 ref10 ref12'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref12">(9, 10, 12)</a> and severe nephrotoxic side effects have been reported in first therapeutic applications in humans.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Recent research efforts are therefore trying to understand and overcome this limitation. Kidney uptake has been related to the five glutamic acid residues in the peptide sequence and could be reduced by up to 90% by coinjection of polyglutamic acids,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> indicating that MG uptake in the kidneys is related to these negatively charged amino acids. Also, a gelatin based plasma expander causing low-molecular-weight proteinuria has been shown to reduce kidney uptake, albeit by a lesser extent.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Other studies have confirmed a relationship between kidney reabsorption of different radiopeptides and the number of charged amino acids in the peptide sequence involving the transport molecule megalin and possibly also cubulin<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and other transporter families such as organic anion and cation transporters.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><div class="NLM_p">A second generation of MG analogues (MG11), missing these five glutamic acid residues in position 2−6, has been developed and various radiolabeling strategies have been pursued with this new analogues.<a onclick="showRef(event, 'ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19">(17-19)</a> Besides clearly reduced kidney uptake and retained tumor uptake, these radioligands displayed a reduced stability in vitro and rapid enzymatic degradation in vivo, possibly leading to impaired imaging characteristics in first clinical trials.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Thus decreasing the number of glutamic acid residues, besides increasing tumor-to-kidney ratio, has been shown to progressively decrease enzymatic stability of the peptide conjugate.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> In addition, a deleterious partial oxidation of the Met residue in the C-terminal receptor specific tetrapeptide sequence has been shown to occur, especially during heating steps involved in the radiolabeling process, resulting in a decreased CCK-2 receptor affinity<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and lower cell internalization in vitro and tumor uptake in vivo.<a onclick="showRef(event, 'ref11 ref23'); return false;" href="javascript:void(0);" class="ref ref11 ref23">(11, 23)</a> Although oxidation can be reduced by optimizing the reaction conditions,<a onclick="showRef(event, 'ref22 ref24'); return false;" href="javascript:void(0);" class="ref ref22 ref24">(22, 24)</a> these stability issues demand additional improvements.</div><div class="NLM_p last">Linear CCK8 and gastrin analogues exist under various folded conformations in solution.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> A cyclic CCK8 analogue mimicking this conformation has shown to retain the full biological properties of the linear CCK8 analogue.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Cyclization has already been successfully pursued to improve the in vivo profile of other peptides such as RGD analogues that have been radiolabeled for imaging angiogenesis.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> We have therefore designed a cyclic MG analogue based on MG11, containing unnatural amino acids in the peptide chain and a cyclic constraint introduced through an internal amide bond, cyclo<sup>1,9</sup>[γ-<span class="smallcaps smallerCapital">d</span>-Glu<sup>1</sup>,desGlu<sup>2−6</sup>,<span class="smallcaps smallerCapital">d</span>-Lys<sup>9</sup>]MG (cyclo-MG1). The Met residue in position 11 of MG was additionally replaced with Nle to produce cyclo<sup>1,9</sup>[γ-<span class="smallcaps smallerCapital">d</span>-Glu<sup>1</sup>,desGlu<sup>2−6</sup>,<span class="smallcaps smallerCapital">d</span>-Lys<sup>9</sup>,Nle<sup>11</sup>]MG (cyclo-MG2), even if the effect of this modification on receptor binding is controversial.<a onclick="showRef(event, 'ref21 ref13'); return false;" href="javascript:void(0);" class="ref ref21 ref13">(21, 13)</a> For comparative studies also the linear peptide analogue, [γ-<span class="smallcaps smallerCapital">d</span>-Glu<sup>1</sup>,desGlu<sup>2−6</sup>,<span class="smallcaps smallerCapital">d</span>-Lys<sup>9</sup>]MG (linear-MG1) was synthesized. Labeling with <sup>99m</sup>Tc was accomplished by derivatization with HYNIC at the N-terminus and using ethylenediamine-<i>N</i>,<i>N</i>′-diacetic acid (EDDA) as coligand. In this report, we describe the impact of cyclization of MG on the pharmacokinetics and tumor targeting properties of <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1 and <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG2.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76502" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76502" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Peptide Synthesis</h3><div class="NLM_p">HYNIC-cyclo-MG1, HYNIC-cyclo-MG2, and HYNIC-linear-MG1 were synthesized on a solid support with HYNIC as <sup>99m</sup>Tc binding moiety at the N-terminus. In Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, the amino acid sequence of the new cyclic MG analogues and the linear peptide sequence used for comparative studies are shown in comparison with native MG and previously developed MG analogues. The structural formulas of HYNIC-cyclo-MG1 and HYNIC-cyclo-MG2 are shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Purification of the peptides was performed by reversed-phase high-performance liquid chromatography (RP-HPLC). All compounds were obtained in good yield and ≥95% purity as assessed by RP-HPLC analysis after purification and were characterized by MALDI-TOF mass spectrometry (MS). After freeze-drying, the HYNIC−peptide conjugates were obtained in 20−25% yield. Analytical data comprising RP-HPLC and MALDI-TOF MS results are presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900400w/production/images/medium/jm-2009-00400w_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900400w/production/images/large/jm-2009-00400w_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Structural Formulas of HYNIC-cyclo-MG1 and HYNIC-cyclo-MG2</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900400w/production/images/large/jm-2009-00400w_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900400w&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Amino Acid Sequences of the Cyclic MG Analogues in Comparison with Native MG and Previously Developed MG Analogues</div></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top"><td><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900400w/production/images/medium/jm-2009-00400w_0001.gif" alt="" id="_i6" /></img></td></tr></tbody></table></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Analytical Data for HYNIC-cyclo-MG1, HYNIC-cyclo-MG2, and HYNIC-linear-MG1</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top"><th align="center">peptide conjugate</th><th align="center">% yield</th><th align="center">% purity</th><th align="center"><i>R</i><sub>t</sub>, min<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th align="center"><i>M</i><sub>w</sub><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> calcd, <i>m</i>/<i>z</i></th><th align="center"><i>M</i><sub>w</sub><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> found, <i>m</i>/<i>z</i></th></tr></thead><tbody><tr valign="top"><td align="left">HYNIC-cyclo-MG1</td><td align="center">20</td><td align="center">≥95</td><td align="center">6.9</td><td align="left">1205.6 [M + H] <sup>+</sup></td><td align="left">1205.3 [M + H] <sup>+</sup></td></tr><tr valign="top"><td align="left">HYNIC-cyclo-MG2</td><td align="center">20</td><td align="center">≥96</td><td align="center">7.9</td><td align="left">1187.6 [M + H] <sup>+</sup></td><td align="left">1188.2 [M + H] <sup>+</sup></td></tr><tr valign="top"><td align="left">HYNIC-linear-MG1</td><td align="center">25</td><td align="center">≥95</td><td align="center">6.3</td><td align="left">1223.5 [M + H] <sup>+</sup></td><td align="left">1223.4 [M + H] <sup>+</sup></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">HPLC method 2.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Average mass.</p></div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Radiolabeling</h3><div class="NLM_p last"><sup>99m</sup>Tc-labeling of HYNIC-cyclo-MG1, HYNIC-cyclo-MG2, and HYNIC-linear-MG1 was achieved at specific activities in the range of 20−60 GBq/μmol and with radiochemical purity (RCP) >90%. Radiolabeling resulted in a major product corresponding to the radiolabeled peptide analogue and minor additional species related to hydrophilic impurities and other peptide related impurities in proximity to the main peak. In the radio-HPLC profiles retention times (<i>R</i><sub>t</sub>) in the order of <sup>99m</sup>Tc-EDDA-HYNIC-linear-MG1 (14.8 min) < <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1 (19.5 min) < <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG2 (21.1 min) were found. The formation of side products including oxidized species did not exceed 10% of the total activity.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Characterization in Vitro and Stability Studies</h3><div class="NLM_p">A summary of the in vitro characteristics of <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1 and <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG2 is shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. Both radioligands showed a high stability in aqueous solution and in human plasma with 88.6−97.6% intact peptide after 24 h incubation in the different solutions tested. Protein binding 4 h after incubation was somewhat higher for <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG2 with 17.9% in comparison to 13.4% found for <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1. log P Values of −3.01 ± 0.12 and −3.04 ± 0.16 (<i>n</i> = 6) were obtained for <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1 and for <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG2, respectively.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Vitro Characteristics of <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1 and <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG2</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top"><th align="center">performed assay</th><th align="center">incubation time</th><th align="center"><sup>99m</sup>Tc-EDDA- HYNIC-cyclo-MG1</th><th align="center"><sup>99m</sup>Tc-EDDA- HYNIC-cyclo-MG2</th></tr></thead><tbody><tr valign="top"><td align="left">phosphate</td><td align="center">4 h</td><td align="center">99.4</td><td align="center">95.2</td></tr><tr valign="top"><td align="left"> </td><td align="center">24 h</td><td align="center">98.0</td><td align="center">88.6</td></tr><tr valign="top"><td colspan="4" align="left"> </td></tr><tr valign="top"><td align="left">cysteine</td><td align="center">4 h</td><td align="center">99.1</td><td align="center">95.9</td></tr><tr valign="top"><td align="left"> </td><td align="center">24 h</td><td align="center">97.5</td><td align="center">91.1</td></tr><tr valign="top"><td colspan="4" align="left"> </td></tr><tr valign="top"><td align="left">plasma</td><td align="center">4 h</td><td align="center">97.7</td><td align="center">99.2</td></tr><tr valign="top"><td align="left"> </td><td align="center">24 h</td><td align="center">94.4</td><td align="center">97.6</td></tr><tr valign="top"><td colspan="4" align="left"> </td></tr><tr valign="top"><td align="left">protein binding</td><td align="center">1 h</td><td align="center">12.4<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td><td align="center">11.9<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td></tr><tr valign="top"><td align="left"> </td><td align="center">4 h</td><td align="center">13.4<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td><td align="center">17.9<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td></tr><tr valign="top"><td colspan="4" align="left"> </td></tr><tr valign="top"><td align="left">log P</td><td align="center">15 min</td><td align="char" char="±">−3.01 ± 0.12<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td><td align="char" char="±">−3.04 ± 0.16<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Protein binding (<i>n</i> = 2), log P (<i>n</i> = 6).</p></div></div></div><div class="NLM_p last">The metabolic stability studied in rat tissue homogenates showed complete degradation of both radioligands 2 h after incubation. For <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1, this degradation resulted in one single metabolite with <i>R</i><sub>t</sub> ∼15 min and was somewhat slower in liver homogenate due to the formation of an intermediate metabolite with <i>R</i><sub>t</sub> ∼17 min. For <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG2, the formation of two initial metabolites with <i>R</i><sub>t</sub> ∼15 and ∼17 min resulted in one final metabolite with <i>R</i><sub>t</sub> ∼15 min in kidney homogenate, whereas in liver homogenate, both metabolites were still present 2 h after incubation.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Receptor Binding and Internalization</h3><div class="NLM_p">In saturation assays performed on AR42J cells, <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1 showed an apparent dissociation constant (<i>K</i><sub>d</sub>)<sub></sub> of 19.1 nM (see Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), indicating a somewhat lower binding affinity in comparison with the radioligands previously studied, where an apparent <i>K</i><sub>d</sub> value of 3.97 nM was found for <sup>99m</sup>Tc-EDDA-HYNIC-MG11<sup>11</sup> and of 10.3 nM for <sup>99m</sup>Tc-EDDA-HYNIC-MG0<sup>10</sup>. For <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG2, a similar value of 21.2 nM was found. Cell uptake studies summarized in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> showed, however, results comparable to previous data obtained with <sup>99m</sup>Tc-EDDA-HYNIC-MG11<sup>11</sup>. A rapid internalization of the cell associated activity was observed. Uptake values 2 h after incubation, expressed as percentage of the cell associated activity, were 93.5 ± 1.1% for <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1 and 94.4 ± 1.2% for <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG2 (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). <sup>99m</sup>Tc-EDDA-HYNIC-linear-MG1 showed a lower uptake, reaching a value of only >77% 2 h after incubation (data not shown).</div><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900400w/production/images/medium/jm-2009-00400w_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900400w/production/images/large/jm-2009-00400w_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Receptor binding of <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1 on AR42J cells: saturation curve showing total binding, nonspecific binding, and specific binding, with a calculated apparent <i>K</i><sub>d</sub> of 19.1 nM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900400w/production/images/large/jm-2009-00400w_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900400w&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900400w/production/images/medium/jm-2009-00400w_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900400w/production/images/large/jm-2009-00400w_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Time dependent cell-uptake in AR42J cells of the different <sup>99m</sup>Tc-HYNIC-peptides studied in comparison with <sup>99m</sup>Tc-EDDA-HYNIC-MG11.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900400w/production/images/large/jm-2009-00400w_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900400w&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Biodistribution and Tumor Uptake</h3><div class="NLM_p">The biodistribution and tumor targeting results obtained in nude mice bearing AR42J tumor xenografts 1 and 4 h p.i. are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. Both radioligands were rapidly cleared from the body, mainly through the kidneys. Tissue retention was more pronounced for <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG2 than for <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1. Tumor uptake was similar, with values of 3.61 and 3.17% ID/g 1 h p.i. for <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1 and <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG2, respectively. Tumor uptake of <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1 was reduced by 60% in animals coinjected with an excess of MG, whereas for <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG2, this reduction was only 25%. <sup>99m</sup>Tc-EDDA-HYNIC-linear-MG1 showed a very fast washout from the body and tumor uptake of only 0.28% ID/g.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Biodistribution in AR42J Tumor-Bearing Nude Mice of <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1 and <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG2 in Comparison with <sup>99m</sup>Tc-EDDA-HYNIC-linear-MG1 at 1 and 4 h after Injection (Tumor Uptake was Blocked 1 h after Injection by Co-injection of 50 μg Human MG)<a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top"><th align="center"> </th><th colspan="3" align="center" char="±"><sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1</th><th colspan="3" align="center" char="±"><sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG2</th><th colspan="3" align="center" char="±"><sup>99m</sup>Tc-EDDA-HYNIC-linear-MG1</th></tr><tr valign="top"><th align="left">time p.i.</th><th align="center" char="±">1 h</th><th align="center" char="±">1 h blocked</th><th align="center" char="±">4 h</th><th align="center" char="±">1 h</th><th align="center" char="±">1 h blocked</th><th align="center" char="±">4 h</th><th align="center" char="±">1 h</th><th align="center" char="±">1 h blocked</th><th align="center" char="±">4 h</th></tr></thead><tbody><tr valign="top"><td align="left">blood</td><td align="char" char="±">0.24 ± 0.05</td><td align="char" char="±">0.24 ± 0.01</td><td align="char" char="±">0.18 ± 0.15</td><td align="char" char="±">1.02 ± 0.45</td><td align="char" char="±">1.14 ± 0.11</td><td align="char" char="±">0.57 ± 0.10</td><td align="char" char="±">0.18 ± 0.01</td><td align="char" char="±">0.04 ± 0.01</td><td align="char" char="±">0.13 ± 0.03</td></tr><tr valign="top"><td align="left">lung</td><td align="char" char="±">0.38 ± 0.16</td><td align="char" char="±">0.30 ± 0.01</td><td align="char" char="±">0.21 ± 0.13</td><td align="char" char="±">0.98 ± 0.41</td><td align="char" char="±">1.24 ± 0.15</td><td align="char" char="±">0.47 ± 0.04</td><td align="char" char="±">0.24 ± 0.02</td><td align="char" char="±">0.06 ± 0.00</td><td align="char" char="±">0.16 ± 0.03</td></tr><tr valign="top"><td align="left">heart</td><td align="char" char="±">0.36 ± 0.24</td><td align="char" char="±">0.45 ± 0.21</td><td align="char" char="±">0.23 ± 0.22</td><td align="char" char="±">0.45 ± 0.16</td><td align="char" char="±">0.47 ± 0.06</td><td align="char" char="±">0.26 ± 0.02</td><td align="char" char="±">0.10 ± 0.02</td><td align="char" char="±">0.04 ± 0.02</td><td align="char" char="±">0.07 ± 0.01</td></tr><tr valign="top"><td align="left">muscle</td><td align="char" char="±">0.10 ± 0.03</td><td align="char" char="±">0.08 ± 0.02</td><td align="char" char="±">0.30 ± 0.42</td><td align="char" char="±">0.31 ± 0.19</td><td align="char" char="±">0.16 ± 0.02</td><td align="char" char="±">0.12 ± 0.04</td><td align="char" char="±">0.06 ± 0.01</td><td align="char" char="±">0.05 ± 0.05</td><td align="char" char="±">0.06 ± 0.04</td></tr><tr valign="top"><td align="left">spleen</td><td align="char" char="±">0.16 ± 0.07</td><td align="char" char="±">0.15 ± 0.01</td><td align="char" char="±">0.19 ± 0.13</td><td align="char" char="±">0.39 ± 0.15</td><td align="char" char="±">0.54 ± 0.00</td><td align="char" char="±">0.30 ± 0.01</td><td align="char" char="±">0.10 ± 0.01</td><td align="char" char="±">0.07 ± 0.00</td><td align="char" char="±">0.07 ± 0.01</td></tr><tr valign="top"><td align="left">Intestine</td><td align="char" char="±">1.79 ± 0.36</td><td align="char" char="±">1.37 ± 0.09</td><td align="char" char="±">1.39 ± 1.37</td><td align="char" char="±">2.35 ± 0.43</td><td align="char" char="±">1.78 ± 0.14</td><td align="char" char="±">2.73 ± 0.69</td><td align="char" char="±">0.23 ± 0.07</td><td align="char" char="±">0.40 ± 0.21</td><td align="char" char="±">0.21 ± 0.02</td></tr><tr valign="top"><td align="left">liver</td><td align="char" char="±">0.23 ± 0.06</td><td align="char" char="±">0.38 ± 0.51</td><td align="char" char="±">0.46 ± 0.51</td><td align="char" char="±">1.86 ± 0.57</td><td align="char" char="±">1.94 ± 0.12</td><td align="char" char="±">1.50 ± 0.04</td><td align="char" char="±">0.16 ± 0.00</td><td align="char" char="±">0.11 ± 0.03</td><td align="char" char="±">0.13 ± 0.01</td></tr><tr valign="top"><td align="left">kidney</td><td align="char" char="±">1.92 ± 0.46</td><td align="char" char="±">1.80 ± 0.02</td><td align="char" char="±">1.95 ± 0.43</td><td align="char" char="±">2.11 ± 0.44</td><td align="char" char="±">3.97 ± 0.24</td><td align="char" char="±">1.67 ± 0.06</td><td align="char" char="±">2.02 ± 0.13</td><td align="char" char="±">1.72 ± 0.49</td><td align="char" char="±">1.66 ± 0.10</td></tr><tr valign="top"><td align="left">stomach</td><td align="char" char="±">1.15 ± 0.39</td><td align="char" char="±">0.86 ± 0.32</td><td align="char" char="±">1.14 ± 0.33</td><td align="char" char="±">3.06 ± 1.07</td><td align="char" char="±">2.83 ± 0.52</td><td align="char" char="±">2.66 ± 0.82</td><td align="char" char="±">0.38 ± 0.07</td><td align="char" char="±">0.64 ± 0.94</td><td align="char" char="±">0.22 ± 0.06</td></tr><tr valign="top"><td align="left">pancreas</td><td align="char" char="±">0.26 ± 0.07</td><td align="char" char="±">0.30 ± 0.03</td><td align="char" char="±">0.25 ± 0.16</td><td align="char" char="±">1.05 ± 0.48</td><td align="char" char="±">0.78 ± 0.09</td><td align="char" char="±">0.66 ± 0.07</td><td align="char" char="±">0.10 ± 0.02</td><td align="char" char="±">0.05 ± 0.00</td><td align="char" char="±">0.06 ± 0.01</td></tr><tr valign="top"><td align="left">tumor</td><td align="char" char="±">3.61 ± 0.40</td><td align="char" char="±">1.46 ± 0.71</td><td align="char" char="±">3.40 ± 0.69</td><td align="char" char="±">3.17 ± 0.40</td><td align="char" char="±">2.39 ± 0.29</td><td align="char" char="±">3.25 ± 0.71</td><td align="char" char="±">0.28 ± 0.08</td><td align="char" char="±">0.20 ± 0.06</td><td align="char" char="±">0.16 ± 0.04</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last">Values are expressed as % ID/g (mean ± SD, <i>n</i> = 3).</p></div></div></div><div class="NLM_p">A summary of the biodistribution of <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1 in comparison with previously studied <sup>99m</sup>Tc-EDDA-HYNIC-MG11<sup>11</sup> is shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, and tumor to organ ratios for blood, muscle, and kidney of the various radioligands are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. In the imaging study performed with <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1, besides visualization of abdominal and renal activity, the tumor was clearly delineated (see Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900400w/production/images/medium/jm-2009-00400w_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900400w/production/images/large/jm-2009-00400w_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Biodistribution in AR42J tumor-bearing nude mice of <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1 in comparison with <sup>99m</sup>Tc-EDDA-HYNIC-MG11 at 1 and 4 h after injection. Values are expressed as % ID/g (mean ± SD, <i>n</i> = 3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900400w/production/images/large/jm-2009-00400w_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900400w&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900400w/production/images/medium/jm-2009-00400w_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900400w/production/images/large/jm-2009-00400w_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Fused SPECT/CT image of <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1 in AR42J tumor-bearing nude mouse 1 h after injection (coronal, sagittal, and transversal slices). Besides abdominal and renal activity, the tumor is clearly visualized (arrow).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900400w/production/images/large/jm-2009-00400w_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900400w&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Tissue Ratios Obtained from Biodistribution Studies in AR42J Tumor-Bearing Nude Mice of <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1 and <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG2 in Comparison with <sup>99m</sup>Tc-EDDA-HYNIC-MG11 at 1 and 4 h after Injection</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top"><th align="left"> </th><th colspan="2" align="center"><sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1</th><th colspan="2" align="center"><sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG2</th><th colspan="2" align="center"><sup>99m</sup>Tc-EDDA-HYNIC- MG11</th></tr><tr valign="top"><th align="left" valign="top"> </th><th align="center" valign="top">time p.i. 1 h</th><th align="center" valign="top">time p.i. 4 h</th><th align="center" valign="top">time p.i. 1 h</th><th align="center" valign="top">time p.i. 4 h</th><th align="center" valign="top">time p.i. 1 h</th><th align="center" valign="top">time p.i. 4 h</th></tr></thead><tbody><tr valign="top"><td align="left">tumor/blood</td><td align="center">15.04</td><td align="center">18.89</td><td align="center">3.11</td><td align="center">5.70</td><td align="center">11.93</td><td align="center">64.64</td></tr><tr valign="top"><td align="left">tumor/muscle</td><td align="center">36.10</td><td align="center">11.33</td><td align="center">10.23</td><td align="center">27.08</td><td align="center">11.93</td><td align="center">355.50</td></tr><tr valign="top"><td align="left">tumor/kidney</td><td align="center">1.88</td><td align="center">1.74</td><td align="center">1.50</td><td align="center">1.95</td><td align="center">1.95</td><td align="center">3.63</td></tr></tbody></table></div></div><div class="NLM_p">The metabolites found in vivo did not correspond to those obtained from in vitro studies in tissue homogenates. <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1 and <sup>99m</sup>Tc-EDDA-HYNIC-linear-MG1 1 h p.i. were both digested to metabolites with <i>R</i><sub>t</sub> < 14 min in kidney and liver. In the urine of the mouse injected with <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1, a metabolite with the same <i>R</i><sub>t</sub> as <sup>99m</sup>Tc-EDDA-HYNIC-linear-MG1 was found. The radiochromatograms of the intact radioligands and the metabolites in urine, liver, and kidney are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900400w/production/images/medium/jm-2009-00400w_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900400w/production/images/large/jm-2009-00400w_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Intact radioligand and metabolites in urine, liver, and kidney in nude mice 1 h after injection of <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1 in comparison with <sup>99m</sup>Tc-EDDA-HYNIC-linear-MG1, showing a metabolite with the same <i>R</i><sub>t</sub> as found for <sup>99m</sup>Tc-EDDA-HYNIC-linear-MG1 (arrow).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900400w/production/images/large/jm-2009-00400w_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900400w&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32153" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32153" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Among a variety of peptide analogues studied to broaden the applications for peptide receptor scintigraphy and radiotherapy, gastrin and CCK analogues have shown promising results in preclinical and preliminary clinical studies.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> However, suboptimal pharmacokinetic profiles including rapid metabolism and unfavorable excretion pathways are often a major reason why new peptide based radiopharmaceuticals can not be introduced for clinical applications. The first generation of radiolabeled MG analogues based on MG0 in particular were characterized by a very high kidney uptake, presenting a major limitation especially for therapeutic applications.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The mechanism behind this phenomenon is still not fully understood but is related to the pentaglutamic chain in the peptide sequence.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> In fact, MG analogues missing this sequence showed lower retention in the kidneys and a higher cumulative urinary excretion in rats.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Although this change in the peptide structure did not greatly affect receptor binding in vitro and tumor uptake in vivo, a considerable effect on the stability of the radioligands in vivo was observed. Additional stabilization of the peptide analogue is therefore needed to retain good tumor targeting characteristics for clinical application.</div><div class="NLM_p">The classical strategies to improve the stability of peptides are <span class="smallcaps smallerCapital">d</span>-amino acid substitutions, modification of N- and C-terminus (N-acetylation and C-amidation), replacement of labile amino acids, and cyclization. On the basis of data available in the literature showing that cyclization of CCK analogues retains receptor binding, we decided to study the impact of this modification using MG11 as lead sequence. Two additional modifications in the peptide chain were required to allow cyclization of MG according to Charpentier et al.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Besides substitution of Leu by <span class="smallcaps smallerCapital">d</span>-Glu in position 1 and deletion of the five glutamic acid residues in position 2−6, <span class="smallcaps smallerCapital">d</span>-Glu in position 1 was incorporated into the peptide sequence through the γ carboxylic group and Gly was replaced by <span class="smallcaps smallerCapital">d</span>-Lys in position 9. This modification allowed cyclization by introduction of a lactam bridge between the side chain amino group of <span class="smallcaps smallerCapital">d</span>-Lys<sup>9</sup><sup></sup> and the α-carboxylic group of <span class="smallcaps smallerCapital">d</span>-Glu<sup>1</sup>. To avoid the formation of oxidative side products in the radiolabeling process, substitution of Met by Nle in position 11 was also investigated and the linear peptide sequence was synthesized for comparative studies.</div><div class="NLM_p">Labeling with <sup>99m</sup>Tc was accomplished by derivatization with HYNIC at the N-terminus and using EDDA as coligand. Radiolabeling of the cyclic analogues was achieved with high RCP, and cyclization and substitution with Nle resulted in higher <i>R</i><sub>t</sub> on HPLC. On the basis of the radio-HPLC profiles, a lipophilicity in the order of <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG2 > <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1 > <sup>99m</sup>Tc-EDDA-HYNIC-MG11<sup>11</sup> > <sup>99m</sup>Tc-EDDA-HYNIC-linear-MG1 was found. For <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1, only a minor formation of the methionine sulfoxide was observed in the labeling process and no addition of antioxidants was required to optimize the reaction. Similar results have been described also for other radiolabeled MG analogues.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><div class="NLM_p">Overall in vitro characteristics were favorable with low log P values and a high stability in solution and against possible ligand exchange. Protein binding was moderate and somewhat higher for <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG2 as compared to <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1, in line with its increased lipophilicity. In view of the exclusive presence of some proteolytic enzymes in liver and kidney, the stability in rat tissue homogenates was investigated. Similarly, as previously described for <sup>99m</sup>Tc-EDDA-HYNIC-MG11,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> rapid and complete enzymatic degradation was found in these tissue homogenates. However, in contrast to previous studies with <sup>99m</sup>Tc-EDDA-HYNIC-MG11, metabolites with higher <i>R</i><sub>t</sub> were found in the radio-HPLC profiles, indicating a partial stabilization by the introduced modifications. Despite these results, a higher stability in vivo could be expected, considering the cytosolic restriction of many enzymes found in tissue homogenates.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><div class="NLM_p">Receptor binding was somewhat impaired by cyclization possibly related to the reduced flexibility of the peptide backbone. Recently, also for cyclic CCK8 analogues with a cyclic constraint at the C-terminus, a lower binding affinity was found as compared to a linear CCK analogue.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> However, internalization of <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1 and <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG2 into AR42J cells was similar to <sup>99m</sup>Tc-EDDA-HYNIC-MG11<sup>11</sup>, whereas <sup>99m</sup>Tc-EDDA-HYNIC-linear-MG1 showed a much lower receptor mediated cell uptake.</div><div class="NLM_p">In the animal model, tumor targeting >3% ID/g 1 h p.i. was observed for both <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1 and <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG2. This tumor uptake was lower than that of <sup>99m</sup>Tc-EDDA-HYNIC-MG11<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> but still higher than that observed for other radiolabeled MG11 based analogues studied in the same tumor model where a tumor uptake of <2% ID/g was reported.<a onclick="showRef(event, 'ref19 ref24'); return false;" href="javascript:void(0);" class="ref ref19 ref24">(19, 24)</a> Tumor uptake of <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1 was more completely reduced by coinjection of an excess of MG (30 nmol) than <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG2. This can be explained by the higher blood values and higher nonspecific tissue uptake observed with <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG2, possibly as a result of higher lipophilicity and consequential increased protein binding. Overall target to nontarget ratios were higher for <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1 than <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG2. In agreement with the low receptor mediated internalization in vitro, <sup>99m</sup>Tc-EDDA-HYNIC-linear-MG1 showed a very low in vivo tumor uptake of <0.3% ID/g. Cyclization is therefore clearly important to maximize tumor uptake of this specific peptide sequence, although it remains uncertain whether this is due to an increase in binding affinity or to a higher stability of the cyclic analogues in vivo enhancing the interaction with the receptor.</div><div class="NLM_p">The presence in the urine of a mouse injected with <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1 of a metabolite with the same <i>R</i><sub>t</sub> as <sup>99m</sup>Tc-EDDA-HYNIC-linear-MG1 suggests that initial cleavage of the cyclic radioligands by the opening of the lactam bridge prior to further degradation may occur. Overall biodistribution of <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1 was very similar to <sup>99m</sup>Tc-EDDA-HYNIC-MG11, with target to nontarget ratios in favor of <sup>99m</sup>Tc-EDDA-HYNIC-MG11, especially at late time points (4 h p.i.).</div><div class="NLM_p last">The partial stabilization introduced by cyclization was thus not sufficient to improve the pharmacokinetic profile and requires further optimization. Considering the promising results obtained with <sup>99m</sup>Tc-demogastrin 2, a <sup>99m</sup>Tc-labeled MG0 based radioligand, in patients with evidence of recurrence or metastases of MTC after thyroidectomy,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> a <sup>99m</sup>Tc-based radioligand still seems to be a powerful tool for diagnostic applications. The high kidney uptake of MG0 analogues, however, demands further improvements, especially if therapeutic applications are to be realized. This could possibly be achieved also by dimerization approaches based on MG11, which have been shown to be effective in increasing tumor uptake while maintaining low kidney retention.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76460" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76460" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Two novel MG based peptide analogues for radiolabeling with <sup>99m</sup>Tc were developed. <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1 and <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG2 both showed rapid internalization in receptor expressing cells and high tumor uptake in an animal model. Cyclization of MG had, however, only a limited effect on the overall stability. The biodistribution profile of <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1 was similar to the previously studied linear analogue <sup>99m</sup>Tc-EDDA-HYNIC-MG11. Considering the low kidney retention and potential further stabilization strategies based on the characterization of the metabolites formed during degradation, this new class of peptide analogues targeting CCK-2 receptors holds promise for the development of efficient and safe radiopharmaceuticals for GRS and PRRT.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23140" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23140" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> General</h3><div class="NLM_p">All chemicals obtained commercially were of analytic grade and used without further purification unless otherwise stated.</div><div class="NLM_p">Technetium-99m was eluted as Na<sup>99m</sup>TcO<sub>4</sub> from a commercial <sup>99</sup>Mo/<sup>99m</sup>Tc generator (Ultratechnekow, Mallinckrodt, Petten, The Netherlands).</div><div class="NLM_p">Peptide conjugates were synthesized in an automated synthesizer (PSSM 8, Shimadzu). Purification was performed by RP-HPLC on a Waters chromatography system with a variable UV detector. The system was equipped with an AKZO Nobel Kromasil Semi/Prep C18 column (250 mm × 20 mm) using a linear gradient of solvent A (water containing 0.1% TFA) and solvent B (ACN containing 0.1% TFA) from 10% to 50% B in 70 min with flow rate 12 mL/min (method 1). The peptide conjugates were analyzed by RP-HPLC on a Agilent system equipped with a Nucleosil-100 C18 column (150 mm × 4 mm) and UV detection at 215 nm, using a linear gradient of solvent A and solvent B from 10% to 90% B in 15 min with flow rate 1 mL/min (method 2) to confirm a purity ≥95%. The compounds were characterized by MALDI-TOF MS (Kompact Kratos Axima Analytical, Shimadzu, Manchester, UK).</div><div class="NLM_p">Radiochemical analysis of the radiolabeled peptide conjugates was performed by RP-HPLC on a Dionex P680 chromatography system with a variable UV detector and Bioscan radiometric detection, data were processed using Chromeleon software (Dionex, Vienna, Austria). The system was equipped with a Macherey and Nagl Nucleosil-120−5 C18 column (250 mm × 4.6 mm) using a gradient system starting from 100% solvent A and increasing concentrations of solvent B with flow rate 1 mL/min: 0−3 min 0% B, 3−5 min 0−25% B, 5−20 min 25−40% B, 20−25 min 40−60% B, 25−28 min 60−0% B, 28−33 min 0% B (method 3).</div><div class="NLM_p">For in vitro characterization, the radiolabeled peptides were purified by solid phase extraction. For this purpose, the radiolabeling mixture was passed through a C18 SepPak Light cartridge (Waters, Milford, MA) and pretreated with 5 mL of ethanol and 5 mL of saline. The cartridge was washed with 5 mL saline and the radiolabeled peptide was eluted with 50% ethanol and diluted with saline or 0.1 M phosphate buffered saline pH 7.4 (PBS). This method efficiently removed all hydrophilic, nonpeptide related impurities.</div><div class="NLM_p">The AR42J rat pancreatic tumor cell line was obtained from ECACC (Salisbury, UK). Cells were cultured in RPMI 1640 medium supplemented with 10% fetal bovine serum and 5 mL of a 100× penicillin−streptomycin−glutamine mixture at 37 °C in a humidified 95% air, 5% CO<sub>2</sub> atmosphere. Media and supplements were purchased from Invitrogen Corporation (Lofer, Austria).</div><div class="NLM_p last">All animal experiments were conducted in compliance with the Austrian animal protection laws and with approval of the Austrian Ministry of Science.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Peptide Synthesis and Characterization</h3><div class="NLM_p">Solid phase synthesis of two cyclic and one linear MG analogues was performed using 9-fluorenylmethoxycarbonyl (Fmoc) chemistry on an automated synthesizer. The peptides, cyclo<sup>1,9</sup>[γ-<span class="smallcaps smallerCapital">d</span>-Glu<sup>1</sup>,desGlu<sup>2−6</sup>,<span class="smallcaps smallerCapital">d</span>-Lys<sup>9</sup>]MG (cyclo-MG1), cyclo<sup>1,9</sup>[γ-<span class="smallcaps smallerCapital">d</span>-Glu<sup>1</sup>,desGlu<sup>2−6</sup>,<span class="smallcaps smallerCapital">d</span>-Lys<sup>9</sup>,Nle<sup>11</sup>]MG (cyclo-MG2), and [γ-<span class="smallcaps smallerCapital">d</span>-Glu<sup>1</sup>,desGlu<sup>2−6</sup>,<span class="smallcaps smallerCapital">d</span>-Lys<sup>9</sup>]MG (linear-MG1) were assembled on a TentaGel S RAM resin (capacity: 0.25 mequiv/g resin) purchased from Rapp Polymere GmbH (Tuebingen, Germany). All coupling reactions were performed with a 10-fold excess of Fmoc amino acid, 1-hydroxybenzotriazole (HOBt), <i>N</i>,<i>N</i>′-diisopropylcarbodiimide (DIC), and diisopropylethylamine (DIPEA) in a mixture of <i>N</i>,<i>N</i>-dimethylformamide (DMF) and dichloromethane (DCM) 90:10 v/v. Side chain protection groups were <i>tert</i>-butyl ester for Asp, <i>tert</i>-butyl ether for Tyr, and <i>tert</i>-butyloxycarbonyl (Boc) and <i>N</i>-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl (Dde) in case of the two cyclic MG analogues for <span class="smallcaps smallerCapital">d</span>-Lys. The α-carboxylic group of <span class="smallcaps smallerCapital">d</span>-Glu was protected with α-4-{<i>N</i>-[1-(4,4-dimethyl-2,6-dioxocyclohexylidene)-3-methylbutyl]amino}benzylester (Dmab) for the synthesis of cyclo-MG1 and cyclo-MG2. For preparation of linear-MG1, the α-carboxylic function of <span class="smallcaps smallerCapital">d</span>-Glu was protected with <i>tert</i>-butyl ester.</div><div class="NLM_p">After assembling the desired amino acid sequence, coupling of Boc protected 6-hydrazinonicotinic acid (Boc-Hynic) (3-fold molar excess) was performed with (benzotriazol-1-yloxy)-tripyrrolidinophosphonium hexafluorophosphate (PyBOP) (3-fold molar excess) and DIPEA (6-fold molar excess) in 5 mL of DMF on 200 mg protected peptide-resin. The protecting groups Dde and Dmab were removed with 2% hydrazine in 5 mL of DMF subsequently to enable side-chain-to-end cyclization between the α-carboxylic function of <span class="smallcaps smallerCapital">d</span>-Glu and the side chain amine of <span class="smallcaps smallerCapital">d</span>-Lys. Cyclization was carried out with 0.25 mmol PyBOP and 0.25 mmol <i>N</i>-methyl morpholine (NMM) in 5 mL of DMF as solvent.</div><div class="NLM_p last">Cleavage of the peptides from the resin was achieved by treatment with a mixture of trifluoro acetic acid (TFA), 1,2-ethandithiole (EDT), thioanisole, and water in a ratio 90:4:4:2 v/v/v/v. Purification was carried out by HPLC method 1. Eluted peptides were lyophilized, analyzed by HPLC method 2, and characterized by MALDI-TOF MS.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Radiolabeling and Radiochemical Analysis</h3><div class="NLM_p last">Radiolabeling with <sup>99m</sup>Tc was performed according to our previously described tricine/EDDA exchange labeling strategy.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> In a rubber sealed vial, 10−20 μg of HYNIC-peptide were incubated with a EDDA/tricine solution (10 mg/mL tricine, 5 mg/mL EDDA in water), 400 MBq of Na<sup>99m</sup>TcO<sub>4</sub> solution, and 20 μL of tin(II)-solution (10 mg of SnCl<sub>2</sub>·2H<sub>2</sub>O in 10 mL 0.1 N HCl), pH adjusted to pH 6 with 0.2 N Na<sub>2</sub>HPO<sub>4</sub>·2H<sub>2</sub>O in a total volume of 1 mL at 100 °C for 30 min. Radiochemical purity was assessed by HPLC method 3.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Characterization of the Radioligands in Vitro</h3><div class="NLM_p">The stability of the radiolabeled peptides in solution was analyzed by incubation at a concentration of 500−1000 pmol peptide/mL at 37 °C for up to 24 h in PBS. In parallel, the stability in fresh human plasma and the stability toward cysteine challenge (PBS containing a 10000-fold molar excess of cysteine over the peptide) was evaluated. Degradation of the <sup>99m</sup>Tc-complexes was assessed by HPLC method 3; plasma samples were precipitated with ACN and centrifuged at 2000<i>g</i> for 2 min.</div><div class="NLM_p">For the determination of the octanol/water partition coefficient, the radiolabeled peptides in 500 μL PBS (pH 7.4) were added to 500 μL of octanol in an Eppendorf microcentrifuge tube in six replicates. The mixture was vigorously vortexed over a period of 15 min at room temperature (RT). After centrifugation at 9000<i>g</i> for 2 min (centrifuge 5424, Eppendorf AG, Germany) 50 μL aliquots of both layers were measured in a γ counter (LKB/Wallac, Compugamma 1282, Finland) and the log P value was calculated.</div><div class="NLM_p">For protein binding assessment, the radioligands were incubated in duplicates at a concentration of 500−1000 pmol/mL in fresh human plasma at 37 °C and analyzed for up to 4 h by Sepahdex G-50 size-exclusion chromatography (MicroSpin, GE-Healthcare Life Sciences, Vienna, Austria). Protein binding of the <sup>99m</sup>Tc-complex was determined by measuring the column and the eluate in the γ counter.</div><div class="NLM_p last">The stability of the radiolabeled peptides toward enzymatic degradation was assessed by incubation in liver and kidney homogenates. Liver or kidneys freshly excised from rat were rapidly rinsed and homogenized in 20 mM HEPES buffer pH 7.3 with an Ultra-Turrax T25 homogenator for 1 min at RT. The radiolabeled peptides were incubated with fresh 30% homogenates at a concentration of 500−1000 pmol peptide/mL at 37 °C up to 2 h. Samples were precipitated with ACN, centrifuged at 2000<i>g</i> for 2 min and analyzed by HPLC method 3.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Cell Uptake and Receptor Binding Studies</h3><div class="NLM_p">For internalization experiments, CCK-2 receptor expressing AR42J cells<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> were seeded at a density of 1 × 10<sup>6</sup> cells per well in 6-well plates (Greiner Labortechnik, Kremsmuenster, Austria) and grown to confluency for 48 h. On the day of the experiment, cells were incubated in triplicates with the radiolabeled peptides (∼200 fmol total peptide) at 37 °C for each time point of 30 min and 1 and 2 h incubation time. Nonspecific binding was determined by a parallel series containing 0.5 μM human minigastrin I (MGh). The cells were treated as described previously,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and the collected fractions were counted in the γ counter. The specifically internalized fraction was expressed in relation to the cell associated activity, i.e., internalized plus membrane bound fraction (% of cell bound activity).</div><div class="NLM_p last">To evaluate the binding affinity of the radiolabeled peptides to the CCK-2 receptor, a saturation assay was performed. For this purpose similarly as described above, AR42J cells were seeded at a density of 1 × 10<sup>6</sup> cells per well in 6-well plates and grown to confluency for 48 h. On the day of the experiment, the cells were incubated in triplicate with radiolabeled peptide conjugate of increasing concentrations (0.4−100 nM) at RT for 1 h and treated as previously described.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Nonspecific binding was determined by a parallel series containing 0.5 μM MGh. The dissociation constant (<i>K</i><sub>d</sub>) was calculated by following nonlinear regression with Origin software (Microcal Origin 5.0, Northampton, MA). Receptor binding studies were performed on nonpurified radiolabeling mixtures, containing small amounts of radioactive impurities and an excess of the unlabeled peptide conjugate. Incubation was performed at RT under which conditions a limited extent of internalization (<1.3%) may affect the binding equilibrium. We therefore describe the binding affinity measurements obtained from these studies as “apparent <i>K</i><sub>d</sub>” rather than <i>K</i><sub>d</sub>.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Evaluation of Biodistribution and Tumor Targeting in Vivo</h3><div class="NLM_p">Biodistribution studies were performed in athymic BALB/c female nude mice (Charles River, Sulzfeld, Germany). For the induction of tumor xenografts, AR42J cells were injected subcutaneously in the right tight at a concentration of approximately 10 × 10<sup>6</sup> in 300 μL. After 10−15 days, when tumors had reached a size of approximately 0.5 mL, mice were randomly divided into groups of three mice each. The mice were injected intravenously via a lateral tail vein with <1 MBq of the radiolabeled peptide (<0.2 μg peptide, corresponding to <0.17 nmol). In addition to <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1 and <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG2, the radiolabeled linear peptide sequence (<sup>99m</sup>Tc-EDDA-HYNIC-linear-MG1) was also studied. Three groups of mice were coinjected also with 50 μg of MGh (corresponding to 30 nmol) to determine whether AR42J uptake was receptor specific. The groups of animals were sacrificed by cervical dislocation 1 or 4 h post injection (p.i.). Tumors and other tissues (blood, lung, heart, stomach, spleen, liver, pancreas, kidneys, muscle, intestine) were removed, weighed, and measured in the γ counter. Results were expressed as percentage injected dose per gram tissue (% ID/g).</div><div class="NLM_p">With one AR42J tumor bearing nude mouse, an imaging study for <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1 was performed. For the imaging study a somewhat higher radioactivity of 10 MBq and 1 μg peptide (corresponding to 0.83 nmol) was injected and 4 h post injection images were acquired using a NanoSPECT/CT animal scanner (Bioscan, Washington, DC) under inhaled anesthesia. SPECT images were obtained in 16 projections using a four-headed scanner with 4 × 9 (1.4 mm) pinhole collimators in helical scanning mode and CT images with a 45 kVp X-ray source in 180 projections over 6 min. Images were reconstructed using propriety HiSPECT iterative reconstruction and fused with CT images.</div><div class="NLM_p last">With two animals, additional metabolic studies of <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1 in comparison with <sup>99m</sup>Tc-EDDA-HYNIC-linear-MG1 were performed. To allow monitoring of the metabolites by radio-HPLC, mice were injected with higher levels of radioactivity (100 MBq) and <3 μg peptide (corresponding to <2.5 nmol) intravenously through a lateral tail vein and euthanized 1 h p.i. The urine was collected at the time of sacrifice. A venous blood sample obtained from the vena cava was immediately centrifuged for 5 min at 1000<i>g</i>, and the serum was separated. Liver and kidneys were dissected and processed as described for in vitro studies with rat tissue homogenates. Before radio-HPLC analysis to study the metabolites all samples (except urine) were precipitated with ACN and centrifuged (2000<i>g</i>, 2 min).</div></div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46115" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46115" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elisabeth von Guggenberg</span> - <span class="hlFld-Affiliation affiliation">Department of Nuclear Medicine, Innsbruck Medical University, Anichstrasse 35, A-6020 Innsbruck, Austria</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#d6b3babfa5b7b4b3a2bef8a0b9b8b1a3b1b1b3b8b4b3a4b196a3bdbff8b7a2"><span class="__cf_email__" data-cfemail="ddb8b1b4aebcbfb8a9b5f3abb2b3baa8babab8b3bfb8afba9da8b6b4f3bca9">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Werner Sallegger</span> - <span class="hlFld-Affiliation affiliation">piCHEM Research and Development GmbH, Kahngasse 20, A-8045 Graz, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anna Helbok</span> - <span class="hlFld-Affiliation affiliation">Department of Nuclear Medicine, Innsbruck Medical University, Anichstrasse 35, A-6020 Innsbruck, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Meltem Ocak</span> - <span class="hlFld-Affiliation affiliation">Department of Nuclear Medicine, Innsbruck Medical University, Anichstrasse 35, A-6020 Innsbruck, Austria</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert King</span> - <span class="hlFld-Affiliation affiliation">Centre for Molecular Oncology and Imaging, Barts and the London School of Medicine, London, EC1M 6BQ, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen J. Mather</span> - <span class="hlFld-Affiliation affiliation">Centre for Molecular Oncology and Imaging, Barts and the London School of Medicine, London, EC1M 6BQ, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Clemens Decristoforo</span> - <span class="hlFld-Affiliation affiliation">Department of Nuclear Medicine, Innsbruck Medical University, Anichstrasse 35, A-6020 Innsbruck, Austria</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm900400w" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38766" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38766" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank the radiopharmacy and radiochemistry staff at the Clinical Department of Nuclear Medicine of the Medical University in Innsbruck, especially Christine Rangger and Svetlana Sirakanyan, for assistance in cell work and animal experiments. Collaboration within the COST Action BM0607 “Targeted Radionuclide Therapy (TRNT)” is greatly acknowledged. This work was supported by grants from the Austrian Nano Initiative (Project Nano-Nuc 0208) and the Tiroler Wissenschaftsfonds (Project UNI-0404/417) and was partly performed within the Ph.D. program Image Guided Diagnosis and Therapy (IGDT) of the Medical University Innsbruck, Austria.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70674" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70674" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 36 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Reubi, J. C.</span><span> </span><span class="NLM_article-title">Targeting CCK receptors in human cancers</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1239</span><span class="NLM_x">–</span> <span class="NLM_lpage">1242</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm900400w&amp;key=10.2174%2F156802607780960546" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm900400w&amp;key=17584145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm900400w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptFKgur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=1239-1242&author=J.+C.+Reubi&title=Targeting+CCK+receptors+in+human+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting CCK receptors in human cancers</span></div><div class="casAuthors">Reubi, Jean Claude</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1239-1242</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Gut hormone receptors can be over-expressed in several human cancers and represent the basis for receptor-targeted tumor imaging and therapy.  A promising receptor for such clin. applications is the cholecystokinin receptor.  Cholecystokinin receptors are expressed in numerous neuroendocrine tumors, in particular medullary thyroid carcinomas and neuroendocrine gut tumors, as well as in stromal tumors.  Moreover, several radiolabeled CCK or gastrin analogs have been developed allowing to detect these tumors and their metastases in patients using in vivo cholecystokinin receptor scintigraphy, proving the feasibility of targeting CCK receptors in human tumors in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriZ7QK7kytv7Vg90H21EOLACvtfcHk0ljsBx0xgNmSyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptFKgur8%253D&md5=50319bb1e7e37ce12996c6d3dc1c5c8f</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2174%2F156802607780960546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802607780960546%26sid%3Dliteratum%253Aachs%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26atitle%3DTargeting%2520CCK%2520receptors%2520in%2520human%2520cancers%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D1239%26epage%3D1242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Behr, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenner, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radetzky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Béhe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gratz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yücekent, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raue, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, W.</span><span> </span><span class="NLM_article-title">Targeting of cholecystokinin-B/gastrin receptors in vivo: preclinical and initial clinical evaluation of the diagnostic and therapeutic potential of radiolabelled gastrin</span> <span class="citation_source-journal">Eur. J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">424</span><span class="NLM_x">–</span> <span class="NLM_lpage">430</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm900400w&amp;key=10.1007%2Fs002590050241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm900400w&amp;key=9553173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm900400w&amp;key=1%3ACAS%3A528%3ADyaK1cXit1akt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1998&pages=424-430&author=T.+M.+Behrauthor=N.+Jennerauthor=S.+Radetzkyauthor=M.+B%C3%A9heauthor=S.+Gratzauthor=S.+Y%C3%BCcekentauthor=F.+Raueauthor=W.+Becker&title=Targeting+of+cholecystokinin-B%2Fgastrin+receptors+in+vivo%3A+preclinical+and+initial+clinical+evaluation+of+the+diagnostic+and+therapeutic+potential+of+radiolabelled+gastrin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting of cholecystokinin-B/gastrin receptors in vivo: preclinical and initial clinical evaluation of the diagnostic and therapeutic potential of radiolabeled gastrin</span></div><div class="casAuthors">Behr, Thomas M.; Jenner, Niels; Radetzky, Sven; Behe, Martin; Gratz, Stefan; Yucekent, Selcuk; Raue, Friedhelm; Becker, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">424-430</span>CODEN:
                <span class="NLM_cas:coden">EJNMD9</span>;
        ISSN:<span class="NLM_cas:issn">0340-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">The outstanding sensitivity of pentagastrin in detecting the presence of primary, recurrent or metastatic medullary thyroid cancer (MTC) suggests widespread expression of the corresponding receptor type in human MTC.  Indeed, recent autoradiog. studies have demonstrated the presence of cholecystokinin (CCK)-B (= gastrin) receptors not only in more than 90% of MTCs but also in a high percentage of small cell lung cancers, stromal ovarian cancers, astrocytomas and several other tumor types.  The aim of this study was to evaluate whether radiolabeled gastrin may be suitable for targeting CCK-B receptor-expressing tumors in vivo.  For this purpose, the biodistribution of the radioiodinated human heptadecapeptide gastrin-I was studied in nude mice bearing s.c. xenografts of the human MTC cell line, TT.  Initial therapy expts. were undertaken.  Finally, the biodistribution of [131I-Tyr12]gastrin-I was studied in a patient with metastatic MTC.  At a peptide amt. of approx. 1 μg, max. tumor uptake (8.9%ID/g) was obsd. in animals at 1 h postinjection, with tumor-to-blood ratios as high as 6.3.  Physiol. CCK-B receptors in the stomach, gallbladder and pancreas of the mice were targeted as well.  The major route of excretion was renal, but strong evidence for a biliary excretion pathway also exists.  Pilot therapy studies with 131I-labeled gastrin showed significant antitumor efficacy as compared with untreated controls.  In accordance with the preclin. data, good receptor targeting was obsd. in the tumor sites, stomach, gallbladder and pancreas of a patient with metastatic MTC.  These data suggest that gastrin and its analogs may represent a useful new class of receptor binding peptides for diagnosis and therapy of a variety of tumor types, including MTC and small cell lung cancer.  Future preclin. and clin. studies will address in more detail the mol. features that render CCK-B receptor binding agents potentially useful candidates for in vivo scintigraphy and radionuclide therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwu7Os_fWvNLVg90H21EOLACvtfcHk0lgkmxNRo0zx-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXit1akt70%253D&md5=cea8ff07c245045fb7948fd9f895bda3</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs002590050241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002590050241%26sid%3Dliteratum%253Aachs%26aulast%3DBehr%26aufirst%3DT.%2BM.%26aulast%3DJenner%26aufirst%3DN.%26aulast%3DRadetzky%26aufirst%3DS.%26aulast%3DB%25C3%25A9he%26aufirst%3DM.%26aulast%3DGratz%26aufirst%3DS.%26aulast%3DY%25C3%25BCcekent%26aufirst%3DS.%26aulast%3DRaue%26aufirst%3DF.%26aulast%3DBecker%26aufirst%3DW.%26atitle%3DTargeting%2520of%2520cholecystokinin-B%252Fgastrin%2520receptors%2520in%2520vivo%253A%2520preclinical%2520and%2520initial%2520clinical%2520evaluation%2520of%2520the%2520diagnostic%2520and%2520therapeutic%2520potential%2520of%2520radiolabelled%2520gastrin%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%26date%3D1998%26volume%3D25%26spage%3D424%26epage%3D430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Laverman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Béhé, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyen, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willems, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corstens, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behr, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boerman, O. C.</span><span> </span><span class="NLM_article-title">Two technetium-99m-labeled cholecystokinin-8 (CCK8) peptides for scintigraphic imaging of CCK receptors</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">568</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc034208w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm900400w&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivFemsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2004&pages=561-568&author=P.+Lavermanauthor=M.+B%C3%A9h%C3%A9author=W.+J.+Oyenauthor=P.+H.+Willemsauthor=F.+H.+Corstensauthor=T.+M.+Behrauthor=O.+C.+Boerman&title=Two+technetium-99m-labeled+cholecystokinin-8+%28CCK8%29+peptides+for+scintigraphic+imaging+of+CCK+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Two Technetium-99m-Labeled Cholecystokinin-8 (CCK8) Peptides for Scintigraphic Imaging of CCK Receptors</span></div><div class="casAuthors">Laverman, Peter; Behe, Martin; Oyen, Wim J. G.; Willems, Peter H. G. M.; Corstens, Frans H. M.; Behr, Thomas M.; Boerman, Otto C.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">561-568</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A broad spectrum of radiolabeled peptides with high affinity for receptors expressed on tumor cells is currently under preclin. and clin. investigation for scintigraphic imaging and radionuclide therapy.  The present paper evaluates two 99mTc-labeled forms of the C-terminal octapeptide of cholecystokinin (CCK8): sulfated (s)CCK8, with high affinity for CCK1 and CCK2 receptors, and nonsulfated (ns)CCK8, with high affinity for CCK2 receptors but low affinity for CCK1 receptors.  Peptides were conjugated with the bifunctional chelator N-hydroxysuccinimidyl hydrazino nicotinate (s-HYNIC). 99mTc-labeling, performed in the presence of nicotinic acid and tricine, was highly efficient (∼95%) and yielded products with a high specific activity (∼700 Ci/mmol) and good stability (∼5% release of radiolabel during 16 h incubation in phosphate buffered saline at 37 °C).  Chinese hamster ovary cells stably expressing the CCK1 receptor (CHO-CCK1 cells) internalized ∼3% of added 99mTc-sCCK8 per confluent well during 2 h at 37 °C.  Internalization was effectively blocked by excess unlabeled sCCK8.  CHO-CCK1 cells did not internalize 99mTc-nsCCK8.  Displacement of 99mTc-sCCK8 and -nsCCK8 by unlabeled CCK-8 (performed at 0 °C to prevent internalization) revealed 50% inhibitory concns. (IC50) of 8 nM and >1 μM, resp.  CHO-CCK2 cells internalized ∼25% and ∼5% of added 99mTc-sCCK8 and -nsCCK8, resp.  In both cases internalization was blocked by excess unlabeled peptide. IC50 values for the displacement of 99mTc-sCCK8 and -nsCCK8 were 3 nM and 10 nM, resp.  CHO-CCK1 cell-derived tumors present in one flank of athymic mice accumulated 2.0% of injected 99mTc-sCCK8 per g tissue at 1 h postinjection.  This value decreased to 0.6% following coinjection with excess unlabeled peptide.  Uptake of 99mTc-nsCCK8 was low (0.2%) and not did change by excess unlabeled peptide (0.3%).  Accumulation of 99mTc-sCCK8 and -nsCCK8 by CHO-CCK2 cell-derived tumors (present in the other flank) amounted to 4.2% and 0.6%, resp.  In both cases uptake was significantly reduced by excess unlabeled peptide to 1.0% and 0.4% for sCCK8 and nsCCK8, resp.  Accumulation of 99mTc-sCCK8 was also high in pancreas (11.7%), stomach (2.0%), and kidney (2.1%), whereas uptake of 99mTc-nsCCK8 was high in stomach (0.7%) and kidney (1.4%).  Both radiolabeled peptides showed a rapid blood clearance.  In conclusion, these data show that CCK8 analogs can be efficiently labeled with 99mTc using s-HYNIC as chelator and nicotinic acid/tricine as coligand system without compromising receptor binding.  Furthermore, the present study demonstrates that CCK1 tumors hardly accumulate 99mTc-nsCCK8, CCK2 tumors accumulate 2 times more 99mTc-sCCK8 than CCK1 tumors, and CCK2 tumors accumulate 15 times more 99mTc-sCCK8 than 99mTc-nsCCK8.  Although accumulation in some nontarget organs was also higher with 99mTc-sCCK8, this may not reflect the human situation due to a different receptor expression pattern in humans as compared to mice.  Therefore, further studies are warranted to investigate the possible use of 99mTc-sCCK8 for scintigraphic imaging of CCK receptor-pos. tumors in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0F0dJJhzd5rVg90H21EOLACvtfcHk0lgkmxNRo0zx-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivFemsLY%253D&md5=204aaab821d5525737845431cb51f362</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fbc034208w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc034208w%26sid%3Dliteratum%253Aachs%26aulast%3DLaverman%26aufirst%3DP.%26aulast%3DB%25C3%25A9h%25C3%25A9%26aufirst%3DM.%26aulast%3DOyen%26aufirst%3DW.%2BJ.%26aulast%3DWillems%26aufirst%3DP.%2BH.%26aulast%3DCorstens%26aufirst%3DF.%2BH.%26aulast%3DBehr%26aufirst%3DT.%2BM.%26aulast%3DBoerman%26aufirst%3DO.%2BC.%26atitle%3DTwo%2520technetium-99m-labeled%2520cholecystokinin-8%2520%2528CCK8%2529%2520peptides%2520for%2520scintigraphic%2520imaging%2520of%2520CCK%2520receptors%26jtitle%3DBioconjugate%2520Chem.%26date%3D2004%26volume%3D15%26spage%3D561%26epage%3D568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Aloj, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caracò, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panico, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zannetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Vecchio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tesauro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Luca, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedone, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvatore, M.</span><span> </span><span class="NLM_article-title">In vitro and in vivo evaluation of <sup>111</sup>In-DTPAGlu-G-CCK8 for cholecystokinin-B receptor imaging</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">485</span><span class="NLM_x">–</span> <span class="NLM_lpage">494</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm900400w&amp;key=15001692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm900400w&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivVCju7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2004&pages=485-494&author=L.+Alojauthor=C.+Carac%C3%B2author=M.+Panicoauthor=A.+Zannettiauthor=S.+Del+Vecchioauthor=D.+Tesauroauthor=S.+De+Lucaauthor=C.+Arraauthor=C.+Pedoneauthor=G.+Morelliauthor=M.+Salvatore&title=In+vitro+and+in+vivo+evaluation+of+111In-DTPAGlu-G-CCK8+for+cholecystokinin-B+receptor+imaging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo evaluation of 111In-DTPAGlu-G-CCK8 for cholecystokinin-B receptor imaging</span></div><div class="casAuthors">Aloj, Luigi; Caraco, Corradina; Panico, Mariarosaria; Zannetti, Antonella; del Vecchio, Silvana; Tesauro, Diego; de Luca, Stefania; Arra, Claudio; Pedone, Carlo; Morelli, Giancarlo; Salvatore, Marco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">485-494</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine</span>)
        </div><div class="casAbstract">Regulatory peptides and their analogs are being extensively investigated as radiopharmaceuticals for cancer imaging and therapy.  Receptors of the cholecystokinin family have been shown to be overexpressed in different types of neuroendocrine tumors.  The purposes of this study were to evaluate the cholecystokinin octapeptide amide (CCK8) peptide tagged with a diethylenetriaminepentaacetic acid deriv. (DTPAGlu) and to test whether a 111In-labeled conjugate (111In-DTPAGlu-G-CCK8, a deriv. contg. the chelating agent DTPAGlu bound through a glycine linker at the N-terminal end of the bioactive peptide CCK8) is suitable for cholecystokinin-B receptor (CCKBR) imaging.  Methods: CCK8 was synthesized by solid-phase techniques and covalently coupled to DTPAGlu through a glycine linker at its amino terminus.  The compd. was labeled with 111In.  The radiochem. purity and stability of the compd. were assessed by chromatog. methods.  NIH-3T3 and A431 cells overexpressing CCKBR were used to characterize the in vitro properties of the compd.  Nude mice bearing control and CCKBR-overexpressing A431 xenografts were used as an in vivo model.  Results: DTPAGlu-G-CCK8 showed rapid and efficient labeling with 111In.  The radiolabeled conjugate showed specific binding to both cell lines overexpressing CCKBR.  Binding was saturable, with a dissocn. const. of ∼20 nmol/L in both cell systems.  Both cell lines showed internalization of the ligand after interaction with the receptor.  Biodistribution studies showed rapid localization of 111In-DTPAGluG-CCK8 on CCKBR-overexpressing A431 xenografts that was several-fold higher than that on control tumors at all time points tested.  Unbound activity showed rapid clearance of over 80% through the kidneys by 30 min after injection.  The labeled peptide conjugate was very stable in serum but showed a rapid breakdown after injection.  Incubation with kidney homogenates suggested that most breakdown occurred in the kidneys, favoring the clearance of unbound activity.  Conclusion: Our findings indicate that the in vitro and in vivo characteristics of 111In-DTPAGlu-G-CCK8 are favorable for CCKBR imaging, as the peptide shows high-affinity binding to the receptor, is internalized in CCKBR-expressing cells, and shows avid uptake in CCKBR-overexpressing xenografts, with rapid clearance of unbound radioactivity through the kidneys.  Furthermore, the ease of synthesis, high labeling efficiency, and chem. stability of DTPAGlu make this chelating moiety an ideal candidate for widespread use in peptide radiolabeling for nuclear medicine applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr4AeumsT_kLVg90H21EOLACvtfcHk0lhXWH3oqdxrSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivVCju7g%253D&md5=09bf289f7c3f073993d0943b63fdf4db</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAloj%26aufirst%3DL.%26aulast%3DCarac%25C3%25B2%26aufirst%3DC.%26aulast%3DPanico%26aufirst%3DM.%26aulast%3DZannetti%26aufirst%3DA.%26aulast%3DDel%2BVecchio%26aufirst%3DS.%26aulast%3DTesauro%26aufirst%3DD.%26aulast%3DDe%2BLuca%26aufirst%3DS.%26aulast%3DArra%26aufirst%3DC.%26aulast%3DPedone%26aufirst%3DC.%26aulast%3DMorelli%26aufirst%3DG.%26aulast%3DSalvatore%26aufirst%3DM.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520evaluation%2520of%2520111In-DTPAGlu-G-CCK8%2520for%2520cholecystokinin-B%2520receptor%2520imaging%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2004%26volume%3D45%26spage%3D485%26epage%3D494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Agostani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolzati, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Didonè, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavazza-Ceccato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Refosco, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aloj, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aurilio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tornesello, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tesauro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morelli, G.</span><span> </span><span class="NLM_article-title">The [Tc(N)(PNP)]2+ metal fragment labeled cholecystokinin-8 (CCK8) peptide for CCK-2 receptors imaging: in vitro and in vivo studies</span> <span class="citation_source-journal">J. Pept. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">219</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm900400w&amp;key=10.1002%2Fpsc.834" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm900400w&amp;key=17269133" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=211-219&author=S.+Agostaniauthor=C.+Bolzatiauthor=E.+Didon%C3%A8author=M.+Cavazza-Ceccatoauthor=F.+Refoscoauthor=L.+Alojauthor=C.+Arraauthor=M.+Aurilioauthor=A.+L.+Torneselloauthor=D.+Tesauroauthor=G.+Morelli&title=The+%5BTc%28N%29%28PNP%29%5D2%2B+metal+fragment+labeled+cholecystokinin-8+%28CCK8%29+peptide+for+CCK-2+receptors+imaging%3A+in+vitro+and+in+vivo+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fpsc.834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpsc.834%26sid%3Dliteratum%253Aachs%26aulast%3DAgostani%26aufirst%3DS.%26aulast%3DBolzati%26aufirst%3DC.%26aulast%3DDidon%25C3%25A8%26aufirst%3DE.%26aulast%3DCavazza-Ceccato%26aufirst%3DM.%26aulast%3DRefosco%26aufirst%3DF.%26aulast%3DAloj%26aufirst%3DL.%26aulast%3DArra%26aufirst%3DC.%26aulast%3DAurilio%26aufirst%3DM.%26aulast%3DTornesello%26aufirst%3DA.%2BL.%26aulast%3DTesauro%26aufirst%3DD.%26aulast%3DMorelli%26aufirst%3DG.%26atitle%3DThe%2520%255BTc%2528N%2529%2528PNP%2529%255D2%252B%2520metal%2520fragment%2520labeled%2520cholecystokinin-8%2520%2528CCK8%2529%2520peptide%2520for%2520CCK-2%2520receptors%2520imaging%253A%2520in%2520vitro%2520and%2520in%2520vivo%2520studies%26jtitle%3DJ.%2520Pept.%2520Sci.%26date%3D2007%26volume%3D13%26spage%3D211%26epage%3D219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Gotthardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Béhé, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beuter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauhofer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schurrat, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schipper, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollum, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyen, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behr, T.M..</span><span> </span><span class="NLM_article-title">Improved tumour detection by gastrin receptor scintigraphy in patients with metastasised medullary thyroid carcinoma</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1273</span><span class="NLM_x">–</span> <span class="NLM_lpage">1279</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm900400w&amp;key=10.1007%2Fs00259-006-0157-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm900400w&amp;key=16832634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm900400w&amp;key=1%3ACAS%3A280%3ADC%252BD28nis1eqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2006&pages=1273-1279&author=M.+Gotthardtauthor=M.+P.+B%C3%A9h%C3%A9author=D.+Beuterauthor=A.+Battmannauthor=A.+Bauhoferauthor=T.+Schurratauthor=M.+Schipperauthor=H.+Pollumauthor=W.+J.+Oyenauthor=T.M..+Behr&title=Improved+tumour+detection+by+gastrin+receptor+scintigraphy+in+patients+with+metastasised+medullary+thyroid+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Improved tumour detection by gastrin receptor scintigraphy in patients with metastasised medullary thyroid carcinoma</span></div><div class="casAuthors">Gotthardt Martin; Behe Martin P; Beuter Daniela; Battmann Anke; Bauhofer Artur; Schurrat Tino; Schipper Meike; Pollum Halina; Oyen Wim J G; Behr Thomas M</div><div class="citationInfo"><span class="NLM_cas:title">European journal of nuclear medicine and molecular imaging</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1273-9</span>
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    </div><div class="casAbstract">PURPOSE:  Radiopeptide imaging is a valuable imaging method in the management of patients with neuroendocrine tumours (NET).  To determine the clinical performance of gastrin receptor scintigraphy (GRS), it was compared with somatostatin receptor scintigraphy (SRS), computed tomography (CT) and (18)F-FDG positron emission tomography (PET) in patients with metastasised/recurrent medullary thyroid carcinoma (MTC).  METHODS:  Twenty-seven consecutive patients underwent imaging with GRS, SRS (19 patients), CT and PET (26 patients).  GRS and SRS were compared with respect to tumour detection and uptake.  CT, PET, magnetic resonance imaging (MRI), ultrasound (US) and follow-up were used for verification of findings.  In addition, GRS, CT and PET were directly compared with each other to determine which method performs best.  RESULTS:  Nineteen patients underwent both GRS and SRS.  Among these, GRS showed a tumour detection rate of 94.2% as compared to 40.7% for SRS [mean number of tumour sites (+/-SD) and 95% confidence intervals (CI): GRS 4.3+/-3.1/2.8-5.7, SRS 1.8+/-1.6/1.1-2.6].  In 26 patients, GRS, CT and PET were compared.  Here, GRS showed a tumour detection rate of 87.3% (CT 76.1%, PET 67.2%; mean number of tumour sites and 95% CI: GRS 4.5+/-4.0/2.9-6.1, CT 3.9+/-3.5/2.5-5.3, PET 3.5+/-3.3/2.1-4.8).  If GRS and CT were combined, they were able to detect 96.7% of areas of tumour involvement.  CONCLUSION:  GRS had a higher tumour detection rate than SRS and PET in our study.  GRS in combination with CT was most effective in the detection of metastatic MTC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTae7aIuo6FeVf1XRtfYM0dfW6udTcc2eb761-N8h17rrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28nis1eqtw%253D%253D&md5=b52d7fcc0ceeeef87beb3c24225bf156</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2Fs00259-006-0157-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-006-0157-8%26sid%3Dliteratum%253Aachs%26aulast%3DGotthardt%26aufirst%3DM.%26aulast%3DB%25C3%25A9h%25C3%25A9%26aufirst%3DM.%2BP.%26aulast%3DBeuter%26aufirst%3DD.%26aulast%3DBattmann%26aufirst%3DA.%26aulast%3DBauhofer%26aufirst%3DA.%26aulast%3DSchurrat%26aufirst%3DT.%26aulast%3DSchipper%26aufirst%3DM.%26aulast%3DPollum%26aufirst%3DH.%26aulast%3DOyen%26aufirst%3DW.%2BJ.%26aulast%3DBehr%26aufirst%3DT.M..%26atitle%3DImproved%2520tumour%2520detection%2520by%2520gastrin%2520receptor%2520scintigraphy%2520in%2520patients%2520with%2520metastasised%2520medullary%2520thyroid%2520carcinoma%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2006%26volume%3D33%26spage%3D1273%26epage%3D1279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Gotthardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Béhé, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grass, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauhofer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rinke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schipper, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalinowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyen, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behr, T. M.</span><span> </span><span class="NLM_article-title">Added value of gastrin receptor scintigraphy in comparison to somatostatin receptor scintigraphy in patients with carcinoids and other neuroendocrine tumours</span> <span class="citation_source-journal">Endocr.-Relat. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1203</span><span class="NLM_x">–</span> <span class="NLM_lpage">1211</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=1203-1211&author=M.+Gotthardtauthor=M.+P.+B%C3%A9h%C3%A9author=J.+Grassauthor=A.+Bauhoferauthor=A.+Rinkeauthor=M.+L.+Schipperauthor=M.+Kalinowskiauthor=R.+Arnoldauthor=W.+J.+Oyenauthor=T.+M.+Behr&title=Added+value+of+gastrin+receptor+scintigraphy+in+comparison+to+somatostatin+receptor+scintigraphy+in+patients+with+carcinoids+and+other+neuroendocrine+tumours"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGotthardt%26aufirst%3DM.%26aulast%3DB%25C3%25A9h%25C3%25A9%26aufirst%3DM.%2BP.%26aulast%3DGrass%26aufirst%3DJ.%26aulast%3DBauhofer%26aufirst%3DA.%26aulast%3DRinke%26aufirst%3DA.%26aulast%3DSchipper%26aufirst%3DM.%2BL.%26aulast%3DKalinowski%26aufirst%3DM.%26aulast%3DArnold%26aufirst%3DR.%26aulast%3DOyen%26aufirst%3DW.%2BJ.%26aulast%3DBehr%26aufirst%3DT.%2BM.%26atitle%3DAdded%2520value%2520of%2520gastrin%2520receptor%2520scintigraphy%2520in%2520comparison%2520to%2520somatostatin%2520receptor%2520scintigraphy%2520in%2520patients%2520with%2520carcinoids%2520and%2520other%2520neuroendocrine%2520tumours%26jtitle%3DEndocr.-Relat.%2520Cancer%26date%3D2006%26volume%3D13%26spage%3D1203%26epage%3D1211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Laverman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roosenburg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotthardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyen, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellmich, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutjes, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Delft, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boerman, O. C.</span><span> </span><span class="NLM_article-title">Targeting of a CCK<sub>2</sub> receptor splice variant with <sup>111</sup>In-labelled cholecystokinin-8 (CCK8) and <sup>111</sup>In-labelled minigastrin</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">386</span><span class="NLM_x">–</span> <span class="NLM_lpage">392</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm900400w&amp;key=10.1007%2Fs00259-007-0604-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm900400w&amp;key=17934729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm900400w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXosVeitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2008&pages=386-392&author=P.+Lavermanauthor=S.+Roosenburgauthor=M.+Gotthardtauthor=J.+Parkauthor=W.+J.+Oyenauthor=M.+de+Jongauthor=M.+R.+Hellmichauthor=F.+P.+Rutjesauthor=F.+L.+van+Delftauthor=O.+C.+Boerman&title=Targeting+of+a+CCK2+receptor+splice+variant+with+111In-labelled+cholecystokinin-8+%28CCK8%29+and+111In-labelled+minigastrin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting of a CCK2 receptor splice variant with 111In-labelled cholecystokinin-8 (CCK8) and 111In-labelled minigastrin</span></div><div class="casAuthors">Laverman, Peter; Roosenburg, Susan; Gotthardt, Martin; Park, Jeseong; Oyen, Wim J. G.; de Jong, Marion; Hellmich, Mark R.; Rutjes, Floris P. J. T.; Delft, Floris L.; Boerman, Otto C.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">386-392</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Radiolabeled cholecystokinin (CCK) and gastrin-derived peptides potentially can be used for peptide receptor radionuclide therapy (PRRT).  Recently, a splice variant version of the CCK2R has been identified, designated CCK2i4svR.  Constitutive expression of this receptor has been demonstrated in human colorectal cancer and in pancreatic cancer, but not in normal tissue.  So far, it has never been shown whether radiolabeled peptides can target the CCK2i4svR in vivo.  In this paper, we investigated the potential of sulfated 111In-labeled DOTA-CCK8 (sCCK8), a pan-CCKR-binding peptide, and [111In]DOTA-minigastrin (MG0), a CCK2R selective peptide, for the targeting of the CCK2i4svR.  The receptor binding affinity of [111In]DOTA-sCCK8 and [111In]DOTA-MG0 for the CCK2R and CCK2i4svR was detd. using stably transfected HEK293 cell lines, expressing either CCK2R or CCK2i4svR.  Tumor targeting was studied in HEK293-CCK2i4svR tumor-bearing athymic mice.  [111In]DOTA-sCCK8 as well as [111In]DOTA-MG0 specifically bound both CCK2R and CCK2i4svR with affinities in the low nanomolar range.  In vivo expts. revealed that accumulation of both peptides in CCK2i4svR-pos. tumors was similar (3.21 ± 0.77 and 3.01 ± 0.67%ID/g, sCCK8 and MG0, resp., 24 h p.i.).  Kidney retention of [111In]DOTA-MG0 (32.4 ± 7.5%ID/g, 24 h p.i.) was markedly higher than that of [111In]DOTA-sCCK8 (2.75 ± 0.31%ID/g, 24 h p.i.).  We demonstrated that the CCK2i4svR is a potential target for PRRT using a radiolabeled sulfated CCK8 peptide.  As this receptor is expressed on colorectal and pancreatic tumors, but not in normal tissue, these tumors are potentially new targets for PRRT with CCK8 and gastrin analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDnoTLeE1a5LVg90H21EOLACvtfcHk0lgLfAjn76JkBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXosVeitw%253D%253D&md5=22e30a8b38b76708bb32247322513c24</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2Fs00259-007-0604-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-007-0604-1%26sid%3Dliteratum%253Aachs%26aulast%3DLaverman%26aufirst%3DP.%26aulast%3DRoosenburg%26aufirst%3DS.%26aulast%3DGotthardt%26aufirst%3DM.%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DOyen%26aufirst%3DW.%2BJ.%26aulast%3Dde%2BJong%26aufirst%3DM.%26aulast%3DHellmich%26aufirst%3DM.%2BR.%26aulast%3DRutjes%26aufirst%3DF.%2BP.%26aulast%3Dvan%2BDelft%26aufirst%3DF.%2BL.%26aulast%3DBoerman%26aufirst%3DO.%2BC.%26atitle%3DTargeting%2520of%2520a%2520CCK2%2520receptor%2520splice%2520variant%2520with%2520111In-labelled%2520cholecystokinin-8%2520%2528CCK8%2529%2520and%2520111In-labelled%2520minigastrin%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2008%26volume%3D35%26spage%3D386%26epage%3D392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Béhé, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotthardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angerstein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behr, T. M.</span><span> </span><span class="NLM_article-title">Improved kinetic stability of DTPA-dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivatives</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1140</span><span class="NLM_x">–</span> <span class="NLM_lpage">1146</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm900400w&amp;key=10.1007%2Fs00259-003-1178-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm900400w&amp;key=12768330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm900400w&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlslGrt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2003&pages=1140-1146&author=M.+B%C3%A9h%C3%A9author=W.+Beckerauthor=M.+Gotthardtauthor=C.+Angersteinauthor=T.+M.+Behr&title=Improved+kinetic+stability+of+DTPA-dGlu+as+compared+with+conventional+monofunctional+DTPA+in+chelating+indium+and+yttrium%3A+preclinical+and+initial+clinical+evaluation+of+radiometal+labelled+minigastrin+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Improved kinetic stability of DTPA-dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivatives</span></div><div class="casAuthors">Behe, Martin; Becker, Wolfgang; Gotthardt, Martin; Angerstein, Christa; Behr, Thomas M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1140-1146</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">The development of monofunctional DTPA derivs. has been a major breakthrough in the labeling of proteins or peptides with a variety of radiometals.  Although this methodol. is simple and useful for indium-111 labeling, the stability of these conjugates is too low for most therapeutic nuclides.  Cyclic chelators, such as DOTA, have shown excellent kinetic stability with a variety of radiometals, but the labeling procedure is more difficult, requiring ultra-pure reagents and a heating step that sometimes endangers the biomol.'s integrity.  The aim of this work was twofold: (a) to develop a novel, open chain chelator which can be easily labeled with various radiometals, displaying higher kinetic stability than monofunctional DTPA, and (b) to evaluate this chelator in vitro and in vivo when conjugated to a CCK-B receptor ligand as a detection modality for receptor-(over-)expressing tumors.  DTPA derivs. of Leu1- and dGlu1-minigastrin were synthesized.  All conjugates could be labeled with 111In or 88/90Y at high specific activities (8.5-44.4 GBq/μmol) and with high radiochem. purity.  Serum stability testing was performed, and the labeled conjugates were compared concerning their stability against DTPA challenge.  The biodistribution of the radiolabeled Leu1- and dGlu1-minigastrin derivs. was studied in tumor-bearing nude mice, in one healthy human volunteer and in three patients with metastatic medullary thyroid carcinoma.  The transchelation of all tested radiometals to serum proteins was significantly slower with the DTPA-Glu conjugates as compared with their Leu analogs (e.g. transchelationt1/2 of DTPA-dGlu1-minigastrin vs its Leu1 analog at 37°C in human serum for 111In: 239 h vs 91 h; for 90Y: 130 h vs 53 h).  In animals, all labeled CCK-B receptor ligands showed fast and specific uptake in CCK-B-receptor-pos. tissues, such as the stomach and tumor, as well as a fast renal clearance pattern.  However, DTPA-Leu1-minigastrin showed higher background activity in the whole body and those organs known to accumulate the resp. free radiometal (e.g. 88Y-DTPA-Leu1-minigastrin had bone uptake of 22%ID/g as compared to only 1.2%ID/g with its dGlu1 analog).  In humans, fast tumor and stomach uptake was obsd. for both 111In-labeled compds., but DTPA-dGlu1-minigastrin lacked the liver, spleen and bone marrow uptake obsd. with its Leu1 analog.  In conclusion, anionic amino acid derivs. of DTPA may display improved metabolic stability as compared with monofunctional DTPA conjugates.  DTPA-dGlu1-minigastrin is preferred to "monofunctional" DTPA-Leu1-minigastrin for diagnostic application with 111In for the in vivo detection of CCK-B receptor-expressing tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGbx9i1AEh_rVg90H21EOLACvtfcHk0lgLfAjn76JkBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlslGrt7o%253D&md5=06dd9a8e73fe6a98ab5e27067d1ff2e3</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2Fs00259-003-1178-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-003-1178-1%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25A9h%25C3%25A9%26aufirst%3DM.%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DGotthardt%26aufirst%3DM.%26aulast%3DAngerstein%26aufirst%3DC.%26aulast%3DBehr%26aufirst%3DT.%2BM.%26atitle%3DImproved%2520kinetic%2520stability%2520of%2520DTPA-dGlu%2520as%2520compared%2520with%2520conventional%2520monofunctional%2520DTPA%2520in%2520chelating%2520indium%2520and%2520yttrium%253A%2520preclinical%2520and%2520initial%2520clinical%2520evaluation%2520of%2520radiometal%2520labelled%2520minigastrin%2520derivatives%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2003%26volume%3D30%26spage%3D1140%26epage%3D1146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">von Guggenberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behr, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saurer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seppi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decristoforo, C.</span><span> </span><span class="NLM_article-title"><sup>99m</sup>Tc-labelling and in vitro and in vivo evaluation of HYNIC- and (<i>N</i><sub>α</sub>-His)acetic acid-modified [<span class="smallcaps smallerCapital">d</span>-Glu1]-minigastrin</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">864</span><span class="NLM_x">–</span> <span class="NLM_lpage">871</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc0300807" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm900400w&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlt1yht7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2004&pages=864-871&author=E.+von+Guggenbergauthor=M.+Beheauthor=T.+M.+Behrauthor=M.+Saurerauthor=T.+Seppiauthor=C.+Decristoforo&title=99mTc-labelling+and+in+vitro+and+in+vivo+evaluation+of+HYNIC-+and+%28N%CE%B1-His%29acetic+acid-modified+%5Bd-Glu1%5D-minigastrin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">99mTc-Labeling and in Vitro and in Vivo Evaluation of HYNIC- and (Nα-His)Acetic Acid-Modified [D-Glu1]-Minigastrin</span></div><div class="casAuthors">Von Guggenberg, E.; Behe, M.; Behr, T. M.; Saurer, M.; Seppi, T.; Decristoforo, C.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">864-871</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Gastrin/CCK-2 receptors are overexpressed in a no. of tumors such as medullary thyroid cancer (MTC) and small cell lung cancer (SCLC).  Recently [D-Glu1]-minigastrin (MG) has been radiolabeled with 131I, 111In, and 90Y and evaluated in patients.  This study describes the labeling and evaluation of MG with technetium-99m using two different labeling approaches: HYNIC as bifunctional coupling agent and (Nα-His)Ac as tridentate ligand for 99mTc(CO3) labeling.  Labeling was performed at high specific activities using Tricine and EDDA as coligands for HYNIC-MG and [99mTc(OH2)3(CO)3]+ for (Nα-His)Ac-MG.  Stability expts. were carried out by reversed phase HPLC anal. in PBS, serum, histidine, and cysteine solns., as well as rat liver and kidney homogenates.  Receptor binding and internalization expts. were performed using CCK-2 receptor pos. AR42J rat pancreatic tumor cells.  Biodistribution expts. were carried out in nude mice carrying AR42J tumors by injection of 99mTc-labeled peptide with or without coinjection of 50 μg of minigastrin I human (MGh).  HYNIC-MG and (Nα-His)Ac-MG could be radiolabeled at high specific activities (>1 Ci/μmol).  For HYNIC-MG, high labeling yields (>95%) were achieved using Tricine and EDDA as coligands.  Stability expts. of all 99mTc-labeled conjugates revealed a high stability of the label in PBS and serum as well as toward challenge with histidine and cysteine.  Incubation in kidney homogenates resulted in a rapid degrdn. of all conjugates with <10% intact peptide after 60 min at 37 °C, with no considerable differences between the radiolabeled conjugates; a somewhat lower degrdn. rate was seen in liver homogenates.  Protein binding varied considerably with lowest levels for 99mTc-EDDA/HYNIC-MG.  Competition expts. of unlabeled conjugates on AR42J membranes vs. [125I-Tyr12]-gastrin I showed high CCK-2 receptor affinity for all conjugates under study.  Internalization behavior was very rapid for all radiolabeled conjugates in the order of 99mTc-(Nα-His)Ac-MG > 99mTc-EDDA/HYNIC-MG > 99mTc-Tricine/HYNIC-MG.  In tumor-bearing nude mice the highest tumor-uptake was obsd. with 99mTc-EDDA/HYNIC-MG (8.1%ID/g) followed by 99mTc-Tricine/HYNIC-MG (2.2%ID/g) and 99mTc-(Nα-His)Ac-MG (1.2%ID/g) which correlated with kidney uptake (101.0%ID/g, 53.8%ID/g, 1.8%ID/g resp.).  In this series of compds. 99mTc-EDDA/HYNIC-MG with its very high tumor/organ ratios except for kidneys seems to be the most promising agent to target CCK-2 receptors.  Despite promising properties concerning receptor binding, internalization, and in vitro stability, 99mTc-(Nα-His)Ac-MG showed low tumor uptake in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra9vjVOxJBO7Vg90H21EOLACvtfcHk0lgTeFtXhW6MkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlt1yht7k%253D&md5=f9999e3db7f499385adce8ef1d934521</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fbc0300807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc0300807%26sid%3Dliteratum%253Aachs%26aulast%3Dvon%2BGuggenberg%26aufirst%3DE.%26aulast%3DBehe%26aufirst%3DM.%26aulast%3DBehr%26aufirst%3DT.%2BM.%26aulast%3DSaurer%26aufirst%3DM.%26aulast%3DSeppi%26aufirst%3DT.%26aulast%3DDecristoforo%26aufirst%3DC.%26atitle%3D99mTc-labelling%2520and%2520in%2520vitro%2520and%2520in%2520vivo%2520evaluation%2520of%2520HYNIC-%2520and%2520%2528N%25CE%25B1-His%2529acetic%2520acid-modified%2520%255Bd-Glu1%255D-minigastrin%26jtitle%3DBioconjugate%2520Chem.%26date%3D2004%26volume%3D15%26spage%3D864%26epage%3D871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">von Guggenberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietrich, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skvortsova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Virgolini, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decristoforo, C.</span><span> </span><span class="NLM_article-title"><sup>99m</sup>Tc-labelled HYNIC-minigastrin with reduced kidney uptake for targeting of CCK-2 receptor-positive tumours</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1209</span><span class="NLM_x">–</span> <span class="NLM_lpage">1218</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm900400w&amp;key=10.1007%2Fs00259-006-0348-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm900400w&amp;key=17308920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm900400w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsFaku7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2007&pages=1209-1218&author=E.+von+Guggenbergauthor=H.+Dietrichauthor=I.+Skvortsovaauthor=M.+Gabrielauthor=I.+J.+Virgoliniauthor=C.+Decristoforo&title=99mTc-labelled+HYNIC-minigastrin+with+reduced+kidney+uptake+for+targeting+of+CCK-2+receptor-positive+tumours"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">99mTc-labelled HYNIC-minigastrin with reduced kidney uptake for targeting of CCK-2 receptor-positive tumors</span></div><div class="casAuthors">von Guggenberg, E.; Dietrich, H.; Skvortsova, I.; Gabriel, M.; Virgolini, I. J.; Decristoforo, C.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1209-1218</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Different attempts have been made to develop a suitable radioligand for targeting CCK-2 receptors in vivo, for staging of medullary thyroid carcinoma (MTC) and other receptor-expressing tumors.  After initial successful clin. studies with [DTPA0,DGlu1]minigastrin (DTPA-MG0) radiolabeled with 111In and 90Y, our group developed a 99mTc-labeled radioligand, based on HYNIC-MG0.  A major drawback obsd. with these derivs. is their high uptake by the kidneys.  In this study we describe the preclin. evaluation of the optimized shortened peptide analog, [HYNIC0,DGlu1,desGlu2-6]minigastrin (HYNIC-MG11).  Methods: 99mTc labeling of HYNIC-MG11 was performed using tricine and EDDA as coligands.  Stability expts. were carried out by reversed phase HPLC anal. in PBS, PBS/cysteine and plasma as well as rat liver and kidney homogenates.  Receptor binding and cell uptake expts. were performed using AR4-2J rat pancreatic tumor cells.  Animal biodistribution was studied in AR4-2J tumor-bearing nude mice.  Results: Radiolabelling was performed at high specific activities and radiochem. purity was >90%.  99mTc-EDDA-HYNIC-MG11 showed high affinity for the CCK-2 receptor and cell internalization comparable to that of 99mTc-EDDA-HYNIC-MG0.  Despite high stability in soln., a low metabolic stability in rat tissue homogenates was found.  In a nude mouse tumor model, very low unspecific retention in most organs, rapid renal excretion with reduced renal retention and high tumor uptake were obsd.  Conclusion: 99mTc-EDDA-HYNIC-MG11 shows advantages over 99mTc-EDDA-HYNIC-MG0 in terms of lower kidney retention with unchanged uptake in tumors and CCK-2 receptor-pos. tissue.  However, the lower metabolic stability and impurities formed in the labeling process still leave room for further improvement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNIpTMls4blLVg90H21EOLACvtfcHk0lgTeFtXhW6MkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsFaku7k%253D&md5=b66c2b74d13fcb180af9eb5db73212d6</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs00259-006-0348-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-006-0348-3%26sid%3Dliteratum%253Aachs%26aulast%3Dvon%2BGuggenberg%26aufirst%3DE.%26aulast%3DDietrich%26aufirst%3DH.%26aulast%3DSkvortsova%26aufirst%3DI.%26aulast%3DGabriel%26aufirst%3DM.%26aulast%3DVirgolini%26aufirst%3DI.%2BJ.%26aulast%3DDecristoforo%26aufirst%3DC.%26atitle%3D99mTc-labelled%2520HYNIC-minigastrin%2520with%2520reduced%2520kidney%2520uptake%2520for%2520targeting%2520of%2520CCK-2%2520receptor-positive%2520tumours%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2007%26volume%3D34%26spage%3D1209%26epage%3D1218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Nock, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maina, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Béhé, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolopoulou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotthardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behr, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mäcke, H. R.</span><span> </span><span class="NLM_article-title">CCK-2/gastrin receptor-targeted tumor imaging with <sup>99m</sup>Tc-labeled minigastrin analogs</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1727</span><span class="NLM_x">–</span> <span class="NLM_lpage">1736</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm900400w&amp;key=16204724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm900400w&amp;key=1%3ACAS%3A528%3ADC%252BD28XitVGlt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=1727-1736&author=B.+A.+Nockauthor=T.+Mainaauthor=M.+B%C3%A9h%C3%A9author=A.+Nikolopoulouauthor=M.+Gotthardtauthor=J.+S.+Schmittauthor=T.+M.+Behrauthor=H.+R.+M%C3%A4cke&title=CCK-2%2Fgastrin+receptor-targeted+tumor+imaging+with+99mTc-labeled+minigastrin+analogs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">CCK-2/gastrin receptor-targeted tumor imaging with 99mTc-labeled minigastrin analogs</span></div><div class="casAuthors">Nock, Berthold A.; Maina, Theodosia; Behe, Martin; Nikolopoulou, Anastasia; Gotthardt, Martin; Schmitt, Jorg S.; Behr, Thomas M.; Macke, Helmut R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1727-1736</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine</span>)
        </div><div class="casAbstract">The aim of this study was to evaluate 3 new 99mTc-labeled minigastrin analogs modified with open chain tetraamines at the N-terminus for their suitability in the CCK-2/gastrin-R-targeted imaging of tumors (CCK-2/gastrin-R = cholecystokinin subtype 2/gastrin receptor).  Methods: The [(D)Glu1]minigastrin sequence was assembled on the solid support and the resp. tetraamine precursors coupled at the N-terminus.  Purified peptide conjugates were labeled with 99mTc under alk. conditions.  Satn. binding expts. were performed for (radio)metalated peptides [99mTc/99gTc]Demogastrin 1-3 in rat acinar pancreatic AR4-2J cell membranes.  Internalization was studied in AR4-2J cells at 37°C.  Radiopeptide stability was tested in murine plasma, urine, and kidney homogenates.  Tissue distribution of the peptides was compared in healthy mice and athymic mice bearing AR4-2J tumors.  Results: Peptide conjugates were obtained in 10%-30% overall yields by solid-phase techniques.  Radiolabeling afforded >98% pure [99mTc] Demogastrin 1-3 species in specific activities of ∼37 GBq/μmol.  Radiopeptides retained a high affinity for the CCK-2/gastrin-R in vitro (50% inhibitory concn. values of ∼1 nmol/L) and internalized rapidly in CCK-2/gastrin-R-pos. cells.  After injection in mice they displayed rapid, high, and specific localization in the CCK-2/gastrin-R-expressing tissues (stomach and AR4-2J tumor) and were excreted from the body via the kidneys in the form of hydrophilic metabolites.  Conclusion: The promising characteristics of [99mTc]Demogastrin 1-3 both in vitro and in animal models illustrate their suitability for CCK-2/gastrin-R-targeted tumor imaging.  These qualities could be confirmed for [99mTc]Demogastrin 2, which provided excellent delineation of tumor deposits in a first patient with metastatic medullary thyroid cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrITI8FstUYkrVg90H21EOLACvtfcHk0lgTeFtXhW6MkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitVGlt7g%253D&md5=ad16b01168279fc5334ee61d01c9e4ff</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNock%26aufirst%3DB.%2BA.%26aulast%3DMaina%26aufirst%3DT.%26aulast%3DB%25C3%25A9h%25C3%25A9%26aufirst%3DM.%26aulast%3DNikolopoulou%26aufirst%3DA.%26aulast%3DGotthardt%26aufirst%3DM.%26aulast%3DSchmitt%26aufirst%3DJ.%2BS.%26aulast%3DBehr%26aufirst%3DT.%2BM.%26aulast%3DM%25C3%25A4cke%26aufirst%3DH.%2BR.%26atitle%3DCCK-2%252Fgastrin%2520receptor-targeted%2520tumor%2520imaging%2520with%252099mTc-labeled%2520minigastrin%2520analogs%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2005%26volume%3D46%26spage%3D1727%26epage%3D1736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Béhé, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behr, T. M.</span><span> </span><span class="NLM_article-title">Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies</span> <span class="citation_source-journal">Biopolymers.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">418</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2002&pages=399-418&author=M.+B%C3%A9h%C3%A9author=T.+M.+Behr&title=Cholecystokinin-B+%28CCK-B%29%2Fgastrin+receptor+targeting+peptides+for+staging+and+therapy+of+medullary+thyroid+cancer+and+other+CCK-B+receptor+expressing+malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25A9h%25C3%25A9%26aufirst%3DM.%26aulast%3DBehr%26aufirst%3DT.%2BM.%26atitle%3DCholecystokinin-B%2520%2528CCK-B%2529%252Fgastrin%2520receptor%2520targeting%2520peptides%2520for%2520staging%2520and%2520therapy%2520of%2520medullary%2520thyroid%2520cancer%2520and%2520other%2520CCK-B%2520receptor%2520expressing%2520malignancies%26jtitle%3DBiopolymers.%26date%3D2002%26volume%3D66%26spage%3D399%26epage%3D418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Béhé, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kluge, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotthardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behr, T. M.</span><span> </span><span class="NLM_article-title">Use of polyglutamic acids to reduce uptake of radiometal-labeled minigastrin in the kidneys</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1012</span><span class="NLM_x">–</span> <span class="NLM_lpage">1015</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm900400w&amp;key=15937313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm900400w&amp;key=1%3ACAS%3A528%3ADC%252BD28XitFSqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=1012-1015&author=M.+B%C3%A9h%C3%A9author=G.+Klugeauthor=W.+Beckerauthor=M.+Gotthardtauthor=T.+M.+Behr&title=Use+of+polyglutamic+acids+to+reduce+uptake+of+radiometal-labeled+minigastrin+in+the+kidneys"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Use of polyglutamic acids to reduce uptake of radiometal-labeled minigastrin in the kidneys</span></div><div class="casAuthors">Behe, Martin; Kluge, Gerald; Becker, Wolfgang; Gotthardt, Martin; Behr, Thomas M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1012-1015</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine</span>)
        </div><div class="casAbstract">Uptake of radiolabeled peptides in the kidneys may obscure abdominal tumors in radiopeptide scintigraphy.  This problem is much more pronounced in peptide receptor radionuclide therapy (i.e., radiopeptide therapy), possibly leading to renal damage or even failure.  Cationic peptide uptake in the kidneys can be reduced by the application of cationic amino acids, such as lysine or arginine.  The aim of this study was to develop a suitable method to reduce anionic peptide uptake in the kidneys.  111In-Diethylenetriaminepentaacetic acid DGlu1-minigastrin (111In-DTPA-DGlu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2) was chosen as a model compd. with a sequence of 6 neg. charged glutamic acids in a chain and an addnl. aspartic acid.  Methods: TT (human medullary carcinoma cells)-bearing nu/nu mice of the Institute of Cancer Research genotype received i.p. injections of different chain lengths and wts. of glutamic acids, aspartic acids, and derivs. of glutamic acids.  Uptake in tumors and organs was detd. and compared with the values for untreated control mice.  Results: Accretion of 111In-DTPA-DGlu1-minigastrin in the kidneys could be reduced by up to 90%.  The uptake values for all other organs and the tumors were not affected.  These results were obtained with a chain of 5 or more glutamic acids, whereas uptake in kidneys was affected not at all or only slightly with poly-D-glutamic or polyaspartic acids and with Glux (x = 1-4).  Conclusion: These studies indicated a specific blocking of uptake by Glu5 sequences in the kidneys.  Application of polyglutamic acids is a new, successful method of reducing uptake of neg. charged peptides in the kidneys during radiopeptide therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpICp_yYR6rc7Vg90H21EOLACvtfcHk0lgsYpOYumfWUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitFSqtrk%253D&md5=923b95333f02413a45c67474d3e65ffa</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25A9h%25C3%25A9%26aufirst%3DM.%26aulast%3DKluge%26aufirst%3DG.%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DGotthardt%26aufirst%3DM.%26aulast%3DBehr%26aufirst%3DT.%2BM.%26atitle%3DUse%2520of%2520polyglutamic%2520acids%2520to%2520reduce%2520uptake%2520of%2520radiometal-labeled%2520minigastrin%2520in%2520the%2520kidneys%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2005%26volume%3D46%26spage%3D1012%26epage%3D1015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Gotthardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Eerd-Vismale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyen, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolleman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maecke, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Béhé, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boerman, O.</span><span> </span><span class="NLM_article-title">Indication for different mechanisms of kidney uptake of radiolabeled peptides</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">596</span><span class="NLM_x">–</span> <span class="NLM_lpage">601</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm900400w&amp;key=10.2967%2Fjnumed.106.036020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm900400w&amp;key=17401097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm900400w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVert7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=596-601&author=M.+Gotthardtauthor=J.+van+Eerd-Vismaleauthor=W.+J.+Oyenauthor=M.+de+Jongauthor=H.+Zhangauthor=E.+Rollemanauthor=H.+R.+Maeckeauthor=M.+B%C3%A9h%C3%A9author=O.+Boerman&title=Indication+for+different+mechanisms+of+kidney+uptake+of+radiolabeled+peptides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Indication for different mechanisms of kidney uptake of radiolabeled peptides</span></div><div class="casAuthors">Gotthardt, Martin; van Eerd-Vismale, Julliette; Oyen, Wim J. G.; de Jong, Marion; Zhang, Hanwen; Rolleman, Edgar; Maecke, Helmut R.; Behe, Martin; Boerman, Otto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">596-601</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine</span>)
        </div><div class="casAbstract">Nephrotoxicity due to renal reabsorption of radiolabeled peptides limits the tumor dose in peptide receptor radiotherapy (PRRT).  Therefore, we evaluated the ability of several agents to inhibit the renal accumulation of different radiopeptides.  Male Wistar rats (4 per group) were injected i.v. with 1 MBq of 111In-labeled octreotide (OCT), minigastrin (MG), bombesin (BOM), or exendin (EX), together with a potential inhibitor of renal uptake (lysine [Lys], poly-glutamic acid [PGA], and Gelofusine [GF], a gelatin-based plasma expander) or phosphate-buffered saline as a control.  Organ uptake at 20 h after injection was detd. as the percentage of injected activity per g (%IA/g).  Lys, PGA, and GF were also combined to det. whether an additive effect could be obtained.  The localization of the peptides in the kidneys was investigated by autoradiog. using a phosphor imager.  OCT accumulation in the kidney was inhibited by Lys and GF (40.7%-45.1%), whereas PGA was ineffective.  On the other hand, renal uptake of BOM, MG, and EX was inhibited by PGA and GF (15.4%-85.4%), whereas Lys was ineffective.  The combination of GF and Lys showed additive effects in inhibiting OCT uptake, whereas PGA and GF had additive effects for the inhibition of EX uptake.  The amt. of kidney uptake correlated with the no. of charged amino acids.  All radiopeptides were localized in the renal cortex, as indicated by autoradiog.  Inhibition of renal accumulation of the radiopeptides tested could be achieved by either Lys or PGA but not by both at the same time, suggesting 2 different uptake mechanisms.  The differences in renal accumulation of radiopeptides may be related to the no. of charges of a mol.  GF is the only compd. that inhibited renal accumulation of all radiopeptides tested.  Addnl. expts. are needed to further elucidate these findings and to optimize inhibition of renal accumulation of radiopeptides to reduce the kidney dose in PRRT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprCvnHwzbCg7Vg90H21EOLACvtfcHk0lgsYpOYumfWUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVert7nF&md5=4f777a18c1aa7a8e838b788615063cbd</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.106.036020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.106.036020%26sid%3Dliteratum%253Aachs%26aulast%3DGotthardt%26aufirst%3DM.%26aulast%3Dvan%2BEerd-Vismale%26aufirst%3DJ.%26aulast%3DOyen%26aufirst%3DW.%2BJ.%26aulast%3Dde%2BJong%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DRolleman%26aufirst%3DE.%26aulast%3DMaecke%26aufirst%3DH.%2BR.%26aulast%3DB%25C3%25A9h%25C3%25A9%26aufirst%3DM.%26aulast%3DBoerman%26aufirst%3DO.%26atitle%3DIndication%2520for%2520different%2520mechanisms%2520of%2520kidney%2520uptake%2520of%2520radiolabeled%2520peptides%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2007%26volume%3D48%26spage%3D596%26epage%3D601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Melis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krenning, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Visser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolleman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, M.</span><span> </span><span class="NLM_article-title">Renal uptake and retention of radiolabeled somatostatin, bombesin, neurotensin, minigastrin, and CCK analogs: species and gender differences</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">633</span><span class="NLM_x">–</span> <span class="NLM_lpage">641</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm900400w&amp;key=10.1016%2Fj.nucmedbio.2007.05.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm900400w&amp;key=17707803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm900400w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpt1eit70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2007&pages=633-641&author=M.+Melisauthor=E.+P.+Krenningauthor=B.+F.+Bernardauthor=M.+de+Visserauthor=E.+Rollemanauthor=M.+de+Jong&title=Renal+uptake+and+retention+of+radiolabeled+somatostatin%2C+bombesin%2C+neurotensin%2C+minigastrin%2C+and+CCK+analogs%3A+species+and+gender+differences"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Renal uptake and retention of radiolabeled somatostatin, bombesin, neurotensin, minigastrin and CCK analogues: Species and gender differences</span></div><div class="casAuthors">Melis, Marleen; Krenning, Eric P.; Bernard, Bert F.; de Visser, Monique; Rolleman, Edgar; de Jong, Marion</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">633-641</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Introduction: During therapy with radiolabeled peptides, the kidney is most often the crit. organ.  Newly developed peptides are evaluated preclinically in different animal models before their application in humans.  In this study, the renal retention of several radiolabeled peptides was compared in male and female rats and mice.  Methods: After i.v. injection of radiolabeled peptides [somatostatin, cholecystokinin (CCK), minigastrin, bombesin and neurotensin analogs], renal uptake was detd. in both male and female Lewis rats and C57Bl mice.  In addn., ex vivo autoradiog. of renal sections was performed to localize accumulated radioactivity.  Results: An equal distribution pattern of renal radioactivity was found for all peptides: high accumulation in the cortex, lower accumulation in the outer medulla and no radioactivity in the inner medulla of the kidneys.  In both male rats and mice, an increasing renal uptake was found: [111In-DTPA]CCK8 < [111In-DTPA-Pro1,Tyr4]bombesin ≈ [111In-DTPA]neurotensin < [111In-DTPA]octreotide « [111In-DTPA]MG0.  Renal uptake of [111In-DTPA]octreotide in rats showed no gender difference, and renal radioactivity was about const. over time.  In mice, however, renal uptake in females was significantly higher than that in males and decreased rapidly over time in both genders.  Moreover, renal radioactivity in female mice injected with [111In-DTPA]octreotide showed a different localization pattern.  Conclusions: Regarding the renal uptake of different radiolabeled peptides, both species showed the same ranking order.  Similar to findings in patients, rats showed comparable and const. renal retention of radioactivity in both genders, in contrast to mice.  Therefore, rats appear to be the more favorable species for the study of the renal retention of radioactivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRjBZg5zuTV7Vg90H21EOLACvtfcHk0lgsYpOYumfWUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpt1eit70%253D&md5=102f673938df1694e159b3b55c6723f4</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2007.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2007.05.002%26sid%3Dliteratum%253Aachs%26aulast%3DMelis%26aufirst%3DM.%26aulast%3DKrenning%26aufirst%3DE.%2BP.%26aulast%3DBernard%26aufirst%3DB.%2BF.%26aulast%3Dde%2BVisser%26aufirst%3DM.%26aulast%3DRolleman%26aufirst%3DE.%26aulast%3Dde%2BJong%26aufirst%3DM.%26atitle%3DRenal%2520uptake%2520and%2520retention%2520of%2520radiolabeled%2520somatostatin%252C%2520bombesin%252C%2520neurotensin%252C%2520minigastrin%252C%2520and%2520CCK%2520analogs%253A%2520species%2520and%2520gender%2520differences%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2007%26volume%3D34%26spage%3D633%26epage%3D641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Béhé, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reubi, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maecke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breeman, W. A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krenning, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behr, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, M.</span><span> </span><span class="NLM_article-title">Optimisation of In-111 labelled minigastrin related to the kidney uptake</span> <span class="citation_source-journal">Nucl. Med. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">S5</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2005&pages=S5&author=M.+B%C3%A9h%C3%A9author=J.+C.+Reubiauthor=B.+Nockauthor=J.+S.+Schmittauthor=H.+Maeckeauthor=W.+A.+P.+Breemanauthor=E.+Krenningauthor=T.+M.+Behrauthor=M.+de+Jong&title=Optimisation+of+In-111+labelled+minigastrin+related+to+the+kidney+uptake"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25A9h%25C3%25A9%26aufirst%3DM.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DNock%26aufirst%3DB.%26aulast%3DSchmitt%26aufirst%3DJ.%2BS.%26aulast%3DMaecke%26aufirst%3DH.%26aulast%3DBreeman%26aufirst%3DW.%2BA.%2BP.%26aulast%3DKrenning%26aufirst%3DE.%26aulast%3DBehr%26aufirst%3DT.%2BM.%26aulast%3Dde%2BJong%26aufirst%3DM.%26atitle%3DOptimisation%2520of%2520In-111%2520labelled%2520minigastrin%2520related%2520to%2520the%2520kidney%2520uptake%26jtitle%3DNucl.%2520Med.%2520Rev.%26date%3D2005%26volume%3D8%26spage%3DS5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">von Guggenberg, E.; Saurer, M.; Behe, M.; Virgolini, I.; Decristoforo, C.</span><span> </span><span class="NLM_article-title"><sup>99m</sup>Tc-HYNIC-Minigastrin with high tumour uptake and low kidney accumulation: in vitro and in vivo evaluation</span>. In  <span class="citation_source-book">Technetium, Rhenium and Other Materials in Chemistry and Nuclear Medicine</span>, <span class="NLM_edition">7th</span> ed.; <span class="NLM_publisher-name">SGEditoriali</span>: <span class="NLM_publisher-loc">Padova, Italy</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">333</span>− <span class="NLM_lpage">334</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=333-334&author=E.+von+Guggenberg&author=M.+Saurer&author=M.+Behe&author=I.+Virgolini&author=C.+Decristoforo&title=Technetium%2C+Rhenium+and+Other+Materials+in+Chemistry+and+Nuclear+Medicine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3Dvon%2BGuggenberg%26aufirst%3DE.%26atitle%3D99mTc-HYNIC-Minigastrin%2520with%2520high%2520tumour%2520uptake%2520and%2520low%2520kidney%2520accumulation%253A%2520in%2520vitro%2520and%2520in%2520vivo%2520evaluation%26btitle%3DTechnetium%252C%2520Rhenium%2520and%2520Other%2520Materials%2520in%2520Chemistry%2520and%2520Nuclear%2520Medicine%26pub%3DSGEditoriali%26date%3D2006%26spage%3D333%26epage%3D334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Nikolopoulou, A.; Nock, B. A.; Petrou, C.; Ketani, E.; Cordopatis, P.; Maina, T.</span><span> </span><span class="NLM_article-title">In vivo targeting of CCK-2/Gastrin-R and reduction of renal accumulation with truncated [99mTc]Demogastrin 4−6</span>. In  <span class="citation_source-book">Technetium, Rhenium and Other Materials in Chemistry and Nuclear Medicine</span>, <span class="NLM_edition">7th</span> ed.; <span class="NLM_publisher-name">SGEditoriali</span>: <span class="NLM_publisher-loc">Padova, Italy</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">325</span>− <span class="NLM_lpage">326</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=325-326&author=A.+Nikolopoulou&author=B.+A.+Nock&author=C.+Petrou&author=E.+Ketani&author=P.+Cordopatis&author=T.+Maina&title=Technetium%2C+Rhenium+and+Other+Materials+in+Chemistry+and+Nuclear+Medicine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DNikolopoulou%26aufirst%3DA.%26atitle%3DIn%2520vivo%2520targeting%2520of%2520CCK-2%252FGastrin-R%2520and%2520reduction%2520of%2520renal%2520accumulation%2520with%2520truncated%2520%255B99mTc%255DDemogastrin%25204%25E2%2588%25926%26btitle%3DTechnetium%252C%2520Rhenium%2520and%2520Other%2520Materials%2520in%2520Chemistry%2520and%2520Nuclear%2520Medicine%26pub%3DSGEditoriali%26date%3D2006%26spage%3D325%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Kosowicz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikol̷ajczak, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czepczyński, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziemnicka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gryczyńska, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowiński, J.</span><span> </span><span class="NLM_article-title">Two peptide receptor ligands <sup>99m</sup>Tc-EDDA/HYNIC-Tyr<sub>3</sub>-octreotide and <sup>99m</sup>Tc-EDDA/HYNIC-<span class="smallcaps smallerCapital">d</span>Glu-octagastrin for scintigraphy of medullary thyroid carcinoma</span> <span class="citation_source-journal">Cancer Biother. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">613</span><span class="NLM_x">–</span> <span class="NLM_lpage">628</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm900400w&amp;key=10.1089%2Fcbr.2006.368" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm900400w&amp;key=17979564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm900400w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1GrsLvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2007&pages=613-628&author=J.+Kosowiczauthor=R.+Mikol%CC%B7ajczakauthor=R.+Czepczy%C5%84skiauthor=K.+Ziemnickaauthor=M.+Gryczy%C5%84skaauthor=J.+Sowi%C5%84ski&title=Two+peptide+receptor+ligands+99mTc-EDDA%2FHYNIC-Tyr3-octreotide+and+99mTc-EDDA%2FHYNIC-dGlu-octagastrin+for+scintigraphy+of+medullary+thyroid+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Two Peptide Receptor Ligands 99mTc-EDDA/HYNIC-Tyr3-Octreotide and 99mTc-EDDA/HYNIC-DGlu-Octagastrin for Scintigraphy of Medullary Thyroid Carcinoma</span></div><div class="casAuthors">Kosowicz, Jerzy; Mikolajczak, Renata; Czepczynski, Rafal; Ziemnicka, Katarzyna; Gryczynska, Maria; Sowinski, Jerzy</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biotherapy & Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">613-628</span>CODEN:
                <span class="NLM_cas:coden">CBRAFJ</span>;
        ISSN:<span class="NLM_cas:issn">1084-9785</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Somatostatin and gastrin receptors are overexpressed in medullary thyroid carcinoma (MTC) cells; hence, both of them are potential targets for peptide receptor scintigraphy and radiotherapy.  Therefore, the aim of our study was to assess the clin. value of two technetium-99m-labeled peptides, a new gastrin analog, the EDDA/HYNIC-DGlu-octagastrin and a somatostatin analog, EDDA/HYNIC-Tyr3-octreotide (EDDA/HYNIC-TOC) for scintigraphy in patients with MTC to detect recurrences and metastases and select patients for peptide receptor radiotherapy.  Material and Methods: Thirty (30) patients, 20 females and 10 males, 22-83 years of age (mean, 52.7) with the diagnosis of MTC in different stages of the disease (preoperative, postsurgery, remission, recurrence, or metastatic disease) were included in this study.  Before surgery, in all patients serum calcitonin concns. were elevated.  The diagnosis of MTC was confirmed in all cases by histopathol. of the removed tumor and immunohistochem. staining giving pos. reactions for calcitonin and chromogranin A.  Imaging studies using 99mTc-EDDA/HYNIC-TOC and a new minigastrin analog, 99mTc-EDDA/HYNIC-DGlu-octagastrin, were performed in each patient and the results compared with each other and with other imaging methods.  Scans of the whole body, head, neck, and chest were performed 2 and 4 h after injections of the tracer, 500-600 MBq in each case, using a double-head Varicam (Elscint, Israel) gamma camera.  Results: 99mTc-EDDA/HYNIC-TOC detected somatostatin receptor-pos. lesions in 20 patients with MTC, whereas 99mTc-EDDA/HYNIC-DGlu-octagastrin displayed gastrin receptors in 11 patients.  In 9 cases, the scans were pos. in both methods, although in 2 cases different pathol. foci were visualized.  In 12 cases, only 99mTc-EDDA/HYNIC-TOC scintigraphy was pos., whereas in 3 other cases only 99mTc-EDDA/HYNIC-DGlu-octagastrin revealed pathol. lesions.  Conclusions: Scintigraphy using 99mTc-HYNIC-TOC permits the visualization of somatostatin receptor-pos. MTC in the majority of cases.  The new gastrin analog, 99mTc-HYNIC-DGlu-octagastrin, is well tolerated, shows no renal retention, and in some cases of MTC, provides addnl. information on the expression of gastrin receptors.  However, inferior quality of octagastrin scans indicates the need for further improvement of this radiopeptide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0sHZVa3SHsrVg90H21EOLACvtfcHk0ljr5mXOxg3OlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1GrsLvI&md5=8e1c2766ce53bf0500c97f1c868d1ada</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1089%2Fcbr.2006.368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fcbr.2006.368%26sid%3Dliteratum%253Aachs%26aulast%3DKosowicz%26aufirst%3DJ.%26aulast%3DMikol%25CC%25B7ajczak%26aufirst%3DR.%26aulast%3DCzepczy%25C5%2584ski%26aufirst%3DR.%26aulast%3DZiemnicka%26aufirst%3DK.%26aulast%3DGryczy%25C5%2584ska%26aufirst%3DM.%26aulast%3DSowi%25C5%2584ski%26aufirst%3DJ.%26atitle%3DTwo%2520peptide%2520receptor%2520ligands%252099mTc-EDDA%252FHYNIC-Tyr3-octreotide%2520and%252099mTc-EDDA%252FHYNIC-dGlu-octagastrin%2520for%2520scintigraphy%2520of%2520medullary%2520thyroid%2520carcinoma%26jtitle%3DCancer%2520Biother.%2520Radiopharm.%26date%3D2007%26volume%3D22%26spage%3D613%26epage%3D628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Good, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waser, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller-Brand, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Béhé, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reubi, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maecke, H. R.</span><span> </span><span class="NLM_article-title">Macrocyclic chelator-coupled gastrin-based radiopharmaceuticals for targeting of gastrin receptor-expressing tumours</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1868</span><span class="NLM_x">–</span> <span class="NLM_lpage">1877</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm900400w&amp;key=10.1007%2Fs00259-008-0803-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm900400w&amp;key=18509636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm900400w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCjtbzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2008&pages=1868-1877&author=S.+Goodauthor=M.+A.+Walterauthor=B.+Waserauthor=X.+Wangauthor=J.+M%C3%BCller-Brandauthor=M.+P.+B%C3%A9h%C3%A9author=J.+C.+Reubiauthor=H.+R.+Maecke&title=Macrocyclic+chelator-coupled+gastrin-based+radiopharmaceuticals+for+targeting+of+gastrin+receptor-expressing+tumours"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocyclic chelator-coupled gastrin-based radiopharmaceuticals for targeting of gastrin receptor-expressing tumours</span></div><div class="casAuthors">Good, Stephan; Walter, Martin A.; Waser, Beatrice; Wang, Xuejuan; Muller-Brand, Jan; Behe, Martin P.; Reubi, Jean-Claude; Maecke, Helmut R.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1868-1877</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Diethylenetriamine-pentaacetic acid (DTPA)-coupled minigastrins are unsuitable for therapeutic application with the available β-emitting radiometals due to low complex stability.  Low tumor-to-kidney ratio of the known radiopharmaceuticals is further limiting their potency.  Macrocyclic chelators were used for coupling to increase complex stability, the peptide sequence modified to enhance radiolytic stability, and tumor-to-kidney ratio and metabolic stability studied using 111In-labeled derivs.  Gastrin derivs. with decreasing nos. of glutamic acids were synthesized using 111In as surrogate for therapeutic radiometals for in vitro and in vivo studies.  Gastrin receptor affinities of the natIn-metalated compds. were detd. by receptor autoradiog. using 125I-CCK as radioligand.  Internalization was evaluated in AR4-2J cells.  Enzymic stability was detd. by incubating the 111In-labeled peptides in human serum.  Biodistribution was performed in AR4-2J-bearing Lewis rats.  IC50 values of the natIn-metalated gastrin derivs. vary between 1.2 and 4.8 nmol/L for all methionine-contg. derivs.  Replacement of methionine by norleucine, isoleucine, methionine-sulfoxide, or methionine-sulfone resulted in significant decrease of receptor affinity (IC50 between 9.9 and 1195 nmol/L).  All cholecystokinin receptor affinities were >100 nmol/L.  All 111In-labeled radiopeptides showed receptor-specific internalization.  Serum mean-life times varied between 2.0 and 72.6 h, pos. correlating with the no. of Glu residues.  All 111In-labeled macrocyclic chelator conjugates showed higher tumor-to-kidney ratios after 24 h (0.37-0.99) compared to 111In-DTPA-minigastrin 0 (0.05).  Tumor wash out between 4 and 24 h was low.  Imaging studies confirmed receptor-specific blocking of the tumor uptake.  Thus, reducing the no. of glutamates increased tumor-to-kidney ratio but resulted in lower metabolic stability.  The properties of the macrocyclic chelator-bearing derivs. make them potentially suitable for clin. purposes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTFCtj4wIeGLVg90H21EOLACvtfcHk0lh0x0rXxpzbvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCjtbzE&md5=32bd7ff02f3bedfe4bc038575b949da7</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2Fs00259-008-0803-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-008-0803-4%26sid%3Dliteratum%253Aachs%26aulast%3DGood%26aufirst%3DS.%26aulast%3DWalter%26aufirst%3DM.%2BA.%26aulast%3DWaser%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DM%25C3%25BCller-Brand%26aufirst%3DJ.%26aulast%3DB%25C3%25A9h%25C3%25A9%26aufirst%3DM.%2BP.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DMaecke%26aufirst%3DH.%2BR.%26atitle%3DMacrocyclic%2520chelator-coupled%2520gastrin-based%2520radiopharmaceuticals%2520for%2520targeting%2520of%2520gastrin%2520receptor-expressing%2520tumours%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2008%26volume%3D35%26spage%3D1868%26epage%3D1877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Breeman, W. A. P.; de Blois, E.; van Gameren, A.; Melis, M.; Fröberg, A.; de Jong, M.; Mäcke, H.; Krenning, E. P.</span><span> </span><span class="NLM_article-title">Aspects of CCK-2 Receptor-Targeting with <sup>111</sup>In-DOTA-MG</span>. In  <span class="citation_source-book">Technetium, Rhenium and Other Materials in Chemistry and Nuclear Medicine</span>, <span class="NLM_edition">7th</span> ed.; <span class="NLM_publisher-name">SGEditoriali</span>: <span class="NLM_publisher-loc">Padova, Italy</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">231</span>− <span class="NLM_lpage">232</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=231-232&author=W.+A.+P.+Breeman&author=E.+de+Blois&author=A.+van+Gameren&author=M.+Melis&author=A.+Fr%C3%B6berg&author=M.+de+Jong&author=H.+M%C3%A4cke&author=E.+P.+Krenning&title=Technetium%2C+Rhenium+and+Other+Materials+in+Chemistry+and+Nuclear+Medicine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBreeman%26aufirst%3DW.%2BA.%2BP.%26atitle%3DAspects%2520of%2520CCK-2%2520Receptor-Targeting%2520with%2520111In-DOTA-MG%26btitle%3DTechnetium%252C%2520Rhenium%2520and%2520Other%2520Materials%2520in%2520Chemistry%2520and%2520Nuclear%2520Medicine%26pub%3DSGEditoriali%26date%3D2006%26spage%3D231%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Maina, T.; Nikolopoulou, A.; Ketani, E.; Petrou, C.; Cordopatis, P.; Nock, B. A.</span><span> </span><span class="NLM_article-title">Oxidation−Nle<sup>11</sup>/Mox<sup>11</sup> replacement of Met<sup>11</sup> in [99mTc]Demogastrin 2: Effects on CCK-2/Gastrin-R-Interaction</span>. In  <span class="citation_source-book">Technetium, Rhenium and Other Materials in Chemistry and Nuclear Medicine</span>, <span class="NLM_edition">7th</span> ed.; <span class="NLM_publisher-name">SGEditoriali</span>: <span class="NLM_publisher-loc">Padova, Italy</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">, </span>: pp  <span class="NLM_fpage">323</span>− <span class="NLM_lpage">324</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=323-324&author=T.+Maina&author=A.+Nikolopoulou&author=E.+Ketani&author=C.+Petrou&author=P.+Cordopatis&author=B.+A.+Nock&title=Technetium%2C+Rhenium+and+Other+Materials+in+Chemistry+and+Nuclear+Medicine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMaina%26aufirst%3DT.%26atitle%3DOxidation%25E2%2588%2592Nle11%252FMox11%2520replacement%2520of%2520Met11%2520in%2520%255B99mTc%255DDemogastrin%25202%253A%2520Effects%2520on%2520CCK-2%252FGastrin-R-Interaction%26btitle%3DTechnetium%252C%2520Rhenium%2520and%2520Other%2520Materials%2520in%2520Chemistry%2520and%2520Nuclear%2520Medicine%26pub%3DSGEditoriali%26date%3D2006%26spage%3D323%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Mather, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenzie, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sosabowski, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellison, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, S. A.</span><span> </span><span class="NLM_article-title">Selection of radiolabeled gastrin analogs for peptide receptor-targeted radionuclide therapy</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">615</span><span class="NLM_x">–</span> <span class="NLM_lpage">622</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=615-622&author=S.+J.+Matherauthor=A.+J.+McKenzieauthor=J.+K.+Sosabowskiauthor=T.+M.+Morrisauthor=D.+Ellisonauthor=S.+A.+Watson&title=Selection+of+radiolabeled+gastrin+analogs+for+peptide+receptor-targeted+radionuclide+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMather%26aufirst%3DS.%2BJ.%26aulast%3DMcKenzie%26aufirst%3DA.%2BJ.%26aulast%3DSosabowski%26aufirst%3DJ.%2BK.%26aulast%3DMorris%26aufirst%3DT.%2BM.%26aulast%3DEllison%26aufirst%3DD.%26aulast%3DWatson%26aufirst%3DS.%2BA.%26atitle%3DSelection%2520of%2520radiolabeled%2520gastrin%2520analogs%2520for%2520peptide%2520receptor-targeted%2520radionuclide%2520therapy%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2007%26volume%3D48%26spage%3D615%26epage%3D622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Stone, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giragossian, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mierke, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, G. E.</span><span> </span><span class="NLM_article-title">Further evidence for a C-terminal structural motif in CCK2 receptor active peptide hormones</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">2211</span><span class="NLM_x">–</span> <span class="NLM_lpage">2222</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=2211-2222&author=S.+R.+Stoneauthor=C.+Giragossianauthor=D.+F.+Mierkeauthor=G.+E.+Jackson&title=Further+evidence+for+a+C-terminal+structural+motif+in+CCK2+receptor+active+peptide+hormones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStone%26aufirst%3DS.%2BR.%26aulast%3DGiragossian%26aufirst%3DC.%26aulast%3DMierke%26aufirst%3DD.%2BF.%26aulast%3DJackson%26aufirst%3DG.%2BE.%26atitle%3DFurther%2520evidence%2520for%2520a%2520C-terminal%2520structural%2520motif%2520in%2520CCK2%2520receptor%2520active%2520peptide%2520hormones%26jtitle%3DPeptides%26date%3D2007%26volume%3D28%26spage%3D2211%26epage%3D2222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Charpentier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelaprat, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durieux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reibaud, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchard, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roques, B. P.</span><span> </span><span class="NLM_article-title">Cyclic cholecystokinin analogs with high selectivity for central receptors</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">1968</span><span class="NLM_x">–</span> <span class="NLM_lpage">1972</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1988&pages=1968-1972&author=B.+Charpentierauthor=D.+Pelapratauthor=C.+Durieuxauthor=A.+Dorauthor=M.+Reibaudauthor=J.+C.+Blanchardauthor=B.+P.+Roques&title=Cyclic+cholecystokinin+analogs+with+high+selectivity+for+central+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCharpentier%26aufirst%3DB.%26aulast%3DPelaprat%26aufirst%3DD.%26aulast%3DDurieux%26aufirst%3DC.%26aulast%3DDor%26aufirst%3DA.%26aulast%3DReibaud%26aufirst%3DM.%26aulast%3DBlanchard%26aufirst%3DJ.%2BC.%26aulast%3DRoques%26aufirst%3DB.%2BP.%26atitle%3DCyclic%2520cholecystokinin%2520analogs%2520with%2520high%2520selectivity%2520for%2520central%2520receptors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1988%26volume%3D85%26spage%3D1968%26epage%3D1972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Haubner, R.</span><span> </span><span class="NLM_article-title">Alphavbeta3-integrin imaging: a new approach to characterise angiogenesis?</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">S54</span><span class="NLM_x">–</span> <span class="NLM_lpage">S63</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2006&pages=S54-S63&author=R.+Haubner&title=Alphavbeta3-integrin+imaging%3A+a+new+approach+to+characterise+angiogenesis%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHaubner%26aufirst%3DR.%26atitle%3DAlphavbeta3-integrin%2520imaging%253A%2520a%2520new%2520approach%2520to%2520characterise%2520angiogenesis%253F%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2006%26volume%3D33%26spage%3DS54%26epage%3DS63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">de Visser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verwijnen, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, M.</span><span> </span><span class="NLM_article-title">Update: improvement strategies for peptide receptor scintigraphy and radionuclide therapy</span> <span class="citation_source-journal">Cancer Biother. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">157</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm900400w&amp;key=10.1089%2Fcbr.2007.0435" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm900400w&amp;key=18454684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm900400w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlsV2mt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2008&pages=137-157&author=M.+de+Visserauthor=S.+M.+Verwijnenauthor=M.+de+Jong&title=Update%3A+improvement+strategies+for+peptide+receptor+scintigraphy+and+radionuclide+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Update: Improvement Strategies for Peptide Receptor Scintigraphy and Radionuclide Therapy</span></div><div class="casAuthors">de Visser, Monique; Verwijnen, Suzanne M.; de Jong, Marion</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biotherapy & Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">137-157</span>CODEN:
                <span class="NLM_cas:coden">CBRAFJ</span>;
        ISSN:<span class="NLM_cas:issn">1084-9785</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Somatostatin receptor-targeting peptides are widely used for the imaging and therapy of neuroendocrine tumors.  Peptide-receptor radionuclide therapy (PRRT) in neuroendocrine tumor patients with radiolabeled somatostatin analogs has resulted in symptomatic improvement, prolonged survival, and enhanced quality of life.  The side-effects of PRRT are few and mostly mild, certainly when using kidney protective agents.  If a more widespread use of PRRT is possible, such therapy might become the therapy of first choice in patients with metastasized or inoperable neuroendocrine gastroenteropancreatic tumors.  Yet, much profit can be gained from improving the receptor-targeting strategies available and developing new strategies.  This review presents an overview of several options to optimize receptor-targeted imaging and radionuclide therapy.  These include the optimization of peptide analogs, increasing the no. of receptors on the tumor site, and combining PRRT with other treatment strategies.  The development of new peptide analogs with increased receptor-binding affinity and improved stability might lead to a higher accumulation of radioactivity inside tumor cells.  Analogs of somatostatin have been widely studied.  However, much profit can be gained in improving peptide analogs targeting other tumor-related receptors, including gastrin-releasing peptide (GRP) receptors, neurotensin (NT) receptors, cholecystokinin (CCK) receptors, and glucagon-like peptide-1 (GLP-1) receptors.  Several peptide analogs targeting these receptors are well on their way to clin. utilization.  The literature shows that it is possible to increase the receptor d. on tumor cells by using different methods, which results in higher binding and internalization rates and thus a higher contrast during peptide-receptor scintigraphy.  In PRRT treatment, this would enable the administration of higher therapeutic doses to tumors, which might lead to a higher cure rate in patients.  Combinations of radionuclide therapy with other treatment modalities, such as chemotherapy or pretreatment with radiosensitizers, might increase the impact of the treatment.  Further, the administration of higher dosages of radioactivity to the patient, enabled by combinations of PRRT with strategies reducing the radiation dose to healthy organs, will improve the outcome of tumor treatment.  Also, targeting one or several tumor-specific receptors by using combinations of therapeutic agents, as well as by reducing nontarget uptake of radioactivity, will enlarge the therapeutic window of PRRT.  Clin. studies will provide more insight in the effects of combining treatment strategies in cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhR64l5HA65bVg90H21EOLACvtfcHk0li-kEz2oOl23g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlsV2mt78%253D&md5=9edb9300c263f764e945cb9f1dbee0c7</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1089%2Fcbr.2007.0435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fcbr.2007.0435%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BVisser%26aufirst%3DM.%26aulast%3DVerwijnen%26aufirst%3DS.%2BM.%26aulast%3Dde%2BJong%26aufirst%3DM.%26atitle%3DUpdate%253A%2520improvement%2520strategies%2520for%2520peptide%2520receptor%2520scintigraphy%2520and%2520radionuclide%2520therapy%26jtitle%3DCancer%2520Biother.%2520Radiopharm.%26date%3D2008%26volume%3D23%26spage%3D137%26epage%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Trejtnar, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laznicek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laznickova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopecky, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Béhé, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maecke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maina, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nock, B.</span><span> </span><span class="NLM_article-title">Biodistribution and elimination characteristics of two <sup>111</sup>In-labeled CCK-2/gastrin receptor-specific peptides in rats</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">907</span><span class="NLM_x">–</span> <span class="NLM_lpage">912</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm900400w&amp;key=17465219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm900400w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltVKmt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=907-912&author=F.+Trejtnarauthor=M.+Laznicekauthor=A.+Laznickovaauthor=M.+Kopeckyauthor=M.+Petrikauthor=M.+B%C3%A9h%C3%A9author=J.+Schmidtauthor=H.+Maeckeauthor=T.+Mainaauthor=B.+Nock&title=Biodistribution+and+elimination+characteristics+of+two+111In-labeled+CCK-2%2Fgastrin+receptor-specific+peptides+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Biodistribution and elimination characteristics of two 111In-labeled CCK-2/gastrin receptor-specific peptides in rats</span></div><div class="casAuthors">Trejtnar, Franktisek; Laznicek, Milan; Laznickova, Alice; Kopecky, Martin; Petrik, Milos; Behe, Martin; Schmidt, Jorg; Maecke, Helmut; Maina, Theodosia; Nock, Berthold</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">907-912</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Background: Due to their high CCK-2/gastrin receptor selectivity, high affinity, and rapid background clearance, radiolabeled minigastrins (MG) are emerging as promising new tools in the diagnosis and therapy of CCK-2/gastrin receptor-pos. tumors.  In this study, the pharmacokinetic profile, particularly the excretion mode, of two 111In-labeled minigastrins was compared in rats.  The first tracer, 111In-MG-0 is based on (D)Glu1-MG, while the second, 111In-MG-11, is its des-(Glu)5-deriv., expected to be less retained in renal tissue.  Materials and Methods: The fate of 111In-MG-0 and 111In-MG-11 in the body of rats was investigated during biodistribution and bioelimination expts., while the resp. elimination parameters were detd. in perfused rat liver and kidney models.  Results: During biodistribution both compds. were rapidly cleared from the blood and most non-target organs whereas activity levels in the bowel and stomach declined slowly.  The overall contribution of hepatobiliary excretion of 111In-MG-0 and 111In-MG-11 was relatively small.  In the perfused rat liver their elimination into the bile was negligible.  In contrast, renal excretion was the major excretion pathway for both analogs, mainly via glomerular filtration.  However, kidney levels were substantially higher and retention was more prolonged in the case of 111In-MG-0 as compared to 111In-MG-11.  Conclusion: The presence of the (Glu)5-chain in 111In-MG-0 appears to be implicated in the prolonged radioactivity retention in the kidney of rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUmwWI7DqYarVg90H21EOLACvtfcHk0li-kEz2oOl23g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltVKmt7c%253D&md5=f9a7065d2f074358ed795f14e79365e0</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTrejtnar%26aufirst%3DF.%26aulast%3DLaznicek%26aufirst%3DM.%26aulast%3DLaznickova%26aufirst%3DA.%26aulast%3DKopecky%26aufirst%3DM.%26aulast%3DPetrik%26aufirst%3DM.%26aulast%3DB%25C3%25A9h%25C3%25A9%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DJ.%26aulast%3DMaecke%26aufirst%3DH.%26aulast%3DMaina%26aufirst%3DT.%26aulast%3DNock%26aufirst%3DB.%26atitle%3DBiodistribution%2520and%2520elimination%2520characteristics%2520of%2520two%2520111In-labeled%2520CCK-2%252Fgastrin%2520receptor-specific%2520peptides%2520in%2520rats%26jtitle%3DAnticancer%2520Res.%26date%3D2007%26volume%3D27%26spage%3D907%26epage%3D912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Sosabowski, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dekker, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beresford, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagan, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenzie, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mather, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, S. A.</span><span> </span><span class="NLM_article-title">Formulation development and manufacturing of a gastrin/CCK-2 receptor targeting peptide as an intermediate drug product for a clinical imaging study</span> <span class="citation_source-journal">Eur. J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">211</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm900400w&amp;key=10.1016%2Fj.ejps.2007.02.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm900400w&amp;key=17387005" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm900400w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkvFyqu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2007&pages=102-211&author=J.+K.+Sosabowskiauthor=M.+Leeauthor=B.+A.+Dekkerauthor=B.+P.+Simmonsauthor=S.+Singhauthor=H.+Beresfordauthor=S.+A.+Haganauthor=A.+J.+McKenzieauthor=S.+J.+Matherauthor=S.+A.+Watson&title=Formulation+development+and+manufacturing+of+a+gastrin%2FCCK-2+receptor+targeting+peptide+as+an+intermediate+drug+product+for+a+clinical+imaging+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Formulation development and manufacturing of a gastrin/CCK-2 receptor targeting peptide as an intermediate drug product for a clinical imaging study</span></div><div class="casAuthors">Sosabowski, Jane K.; Lee, Myrto; Dekker, Bronwen A.; Simmons, Ben P.; Singh, Surjeet; Beresford, Hayden; Hagan, Susan A.; McKenzie, Andrew J.; Mather, Stephen J.; Watson, Susan A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">102-111</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A DOTA-gastrin analog (APH070) which, when labeled with 111In, has high affinity for the gastrin/CCK-2 receptor (3 nM) and low tumor to kidney ratio in animal models, has been formulated and manufd. for a clin. study.  Oxidn. of the peptide methionine residue greatly reduces receptor affinity, therefore development work focused on producing a stable intermediate drug product (iDP) while ensuring that the formulation, container, closure and manufg. process did not inhibit the extremely sensitive radiolabeling reaction (itself a source of oxidn.).  Stress testing revealed that APH070 was stable at 2-8° at pH 6-9.  Addn. of an antioxidant (monothioglycerol) to the peptide formulation reduced stability when compared to buffer alone.  Use of FluroTec (4023/50) stoppers (rather than FluroTec Plus (4110/40)) increased both the stability and radiolabeling efficiency of APH070.  Long term stability (6 mo) of the final formulation (1 mg/mL APH070 in 0.01 M pH 7.2 phosphate buffer) stored at 5° in type I glass vials with FluroTec (4023/50) stoppers was 98.6±0.2% and 98.4±0.1% for upright and inverted samples, resp.  Clin. scale radiolabeling of the final formulation routinely achieves the specification of >85% 111In-APH070 (unoxidized) stable for up to 2 h after diln. with 0.9% w/v saline soln.  Specific uptake of the radiopharmaceutical in CCK-2R-expressing AR42J tumors in nude mice has been demonstrated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFwp3OJd00hrVg90H21EOLACvtfcHk0li-kEz2oOl23g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkvFyqu74%253D&md5=ad9ccf0a418295e805808edbf56c8589</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2007.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2007.02.007%26sid%3Dliteratum%253Aachs%26aulast%3DSosabowski%26aufirst%3DJ.%2BK.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DDekker%26aufirst%3DB.%2BA.%26aulast%3DSimmons%26aufirst%3DB.%2BP.%26aulast%3DSingh%26aufirst%3DS.%26aulast%3DBeresford%26aufirst%3DH.%26aulast%3DHagan%26aufirst%3DS.%2BA.%26aulast%3DMcKenzie%26aufirst%3DA.%2BJ.%26aulast%3DMather%26aufirst%3DS.%2BJ.%26aulast%3DWatson%26aufirst%3DS.%2BA.%26atitle%3DFormulation%2520development%2520and%2520manufacturing%2520of%2520a%2520gastrin%252FCCK-2%2520receptor%2520targeting%2520peptide%2520as%2520an%2520intermediate%2520drug%2520product%2520for%2520a%2520clinical%2520imaging%2520study%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2007%26volume%3D31%26spage%3D102%26epage%3D211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Werle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernkop-Schnürch, A.</span><span> </span><span class="NLM_article-title">Strategies to improve plasma half life time of peptide and protein drugs</span> <span class="citation_source-journal">Amino Acids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">351</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm900400w&amp;key=10.1007%2Fs00726-005-0289-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm900400w&amp;key=16622600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm900400w&amp;key=1%3ACAS%3A528%3ADC%252BD28Xls1egsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2006&pages=351-367&author=M.+Werleauthor=A.+Bernkop-Schn%C3%BCrch&title=Strategies+to+improve+plasma+half+life+time+of+peptide+and+protein+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies to improve plasma half life time of peptide and protein drugs</span></div><div class="casAuthors">Werle, M.; Bernkop-Schnuerch, A.</div><div class="citationInfo"><span class="NLM_cas:title">Amino Acids</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">351-367</span>CODEN:
                <span class="NLM_cas:coden">AACIE6</span>;
        ISSN:<span class="NLM_cas:issn">0939-4451</span>.
    
            (<span class="NLM_cas:orgname">Springer Wien</span>)
        </div><div class="casAbstract">A review.  Due to the obvious advantages of long-acting peptide and protein drugs, strategies to prolong blood plasma half life time of such compds. are highly on demand.  Short plasma half life times are commonly due to fast renal clearance as well as to enzymic degrdn. occurring during systemic circulation.  Modifications of the peptide/protein can lead to prolonged plasma half life times.  By shortening the overall amino acid amt. of somatostatin and replacing L-analog amino acids with D-amino acids, plasma half life time of the derivate octreotide was 1.5 h in comparison to only few minutes of somatostatin.  A PEG2,40K conjugate of INF-α-2b exhibited a 330-fold prolonged plasma half life time compared to the native protein.  It was the aim of this review to provide an overview of possible strategies to prolong plasma half life time such as modification of N- and C-terminus or PEGylation as well as methods to evaluate the effectiveness of drug modifications.  Furthermore, fundamental data about most important proteolytic enzymes of human blood, liver, and kidney as well as their cleavage specificity and inhibitors for them are provided to predict enzymic cleavage of peptide and protein drugs during systemic circulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovVKc2VODC97Vg90H21EOLACvtfcHk0ljl9np26Owc9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xls1egsrw%253D&md5=2e286c53028f38cfe33deef26bb160d0</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1007%2Fs00726-005-0289-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00726-005-0289-3%26sid%3Dliteratum%253Aachs%26aulast%3DWerle%26aufirst%3DM.%26aulast%3DBernkop-Schn%25C3%25BCrch%26aufirst%3DA.%26atitle%3DStrategies%2520to%2520improve%2520plasma%2520half%2520life%2520time%2520of%2520peptide%2520and%2520protein%2520drugs%26jtitle%3DAmino%2520Acids%26date%3D2006%26volume%3D30%26spage%3D351%26epage%3D367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">De Luca, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Capua, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saviano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Della Moglie, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aloj, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarallo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedone, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morelli, G.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of cyclic and branched peptide analogs as ligands for cholecystokinin type 1 receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">5845</span><span class="NLM_x">–</span> <span class="NLM_lpage">3853</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=5845-3853&author=S.+De+Lucaauthor=A.+De+Capuaauthor=M.+Savianoauthor=R.+Della+Moglieauthor=L.+Alojauthor=L.+Taralloauthor=C.+Pedoneauthor=G.+Morelli&title=Synthesis+and+biological+evaluation+of+cyclic+and+branched+peptide+analogs+as+ligands+for+cholecystokinin+type+1+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BLuca%26aufirst%3DS.%26aulast%3DDe%2BCapua%26aufirst%3DA.%26aulast%3DSaviano%26aufirst%3DM.%26aulast%3DDella%2BMoglie%26aufirst%3DR.%26aulast%3DAloj%26aufirst%3DL.%26aulast%3DTarallo%26aufirst%3DL.%26aulast%3DPedone%26aufirst%3DC.%26aulast%3DMorelli%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520cyclic%2520and%2520branched%2520peptide%2520analogs%2520as%2520ligands%2520for%2520cholecystokinin%2520type%25201%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D5845%26epage%3D3853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Fröberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maina, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Herder, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Wilt, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Lugt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Blois, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdijsseldonck, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mäcke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krenning, E.</span><span> </span><span class="NLM_article-title"><sup>99m</sup>Tc-Demogastrin 2 for CCK 2-receptor scintigraphy in medullary thyroid carcinoma</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">S109</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2006&pages=S109&author=A.+Fr%C3%B6bergauthor=B.+Nockauthor=T.+Mainaauthor=M.+de+Jongauthor=W.+de+Herderauthor=H.+de+Wiltauthor=A.+van+der+Lugtauthor=E.+de+Bloisauthor=M.+Verdijsseldonckauthor=H.+M%C3%A4ckeauthor=E.+Krenning&title=99mTc-Demogastrin+2+for+CCK+2-receptor+scintigraphy+in+medullary+thyroid+carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFr%25C3%25B6berg%26aufirst%3DA.%26aulast%3DNock%26aufirst%3DB.%26aulast%3DMaina%26aufirst%3DT.%26aulast%3Dde%2BJong%26aufirst%3DM.%26aulast%3Dde%2BHerder%26aufirst%3DW.%26aulast%3Dde%2BWilt%26aufirst%3DH.%26aulast%3Dvan%2Bder%2BLugt%26aufirst%3DA.%26aulast%3Dde%2BBlois%26aufirst%3DE.%26aulast%3DVerdijsseldonck%26aufirst%3DM.%26aulast%3DM%25C3%25A4cke%26aufirst%3DH.%26aulast%3DKrenning%26aufirst%3DE.%26atitle%3D99mTc-Demogastrin%25202%2520for%2520CCK%25202-receptor%2520scintigraphy%2520in%2520medullary%2520thyroid%2520carcinoma%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2006%26volume%3D33%26spage%3DS109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Sosabowski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matzow, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mather, S.</span><span> </span><span class="NLM_article-title">Targeting of CCK2 receptor expressing tumours using an <sup>111</sup>In-labelled minigastrin dimer</span> <span class="citation_source-journal">Q. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">S13</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=S13&author=J.+Sosabowskiauthor=T.+Matzowauthor=J.+Fosterauthor=S.+Mather&title=Targeting+of+CCK2+receptor+expressing+tumours+using+an+111In-labelled+minigastrin+dimer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSosabowski%26aufirst%3DJ.%26aulast%3DMatzow%26aufirst%3DT.%26aulast%3DFoster%26aufirst%3DJ.%26aulast%3DMather%26aufirst%3DS.%26atitle%3DTargeting%2520of%2520CCK2%2520receptor%2520expressing%2520tumours%2520using%2520an%2520111In-labelled%2520minigastrin%2520dimer%26jtitle%3DQ.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2008%26volume%3D52%26spage%3DS13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">von Guggenberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melendez Alafort, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mather, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moncayo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decristoforo, C.</span><span> </span><span class="NLM_article-title">Preparation via coligand exchange and characterization of [<sup>99m</sup>Tc-EDDA-HYNIC-D-Phe<sup>1</sup>;Tyr<sup>3</sup>]Octreotide (<sup>99m</sup>Tc-EDDA/HYNIC-TOC)</span> <span class="citation_source-journal">J. Lab. Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">318</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm900400w&amp;key=10.1002%2Fjlcr.672" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm900400w&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjt1Wmsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=307-318&author=E.+von+Guggenbergauthor=B.+Sargauthor=H.+Lindnerauthor=L.+Melendez+Alafortauthor=S.+J.+Matherauthor=R.+Moncayoauthor=C.+Decristoforo&title=Preparation+via+coligand+exchange+and+characterization+of+%5B99mTc-EDDA-HYNIC-D-Phe1%3BTyr3%5DOctreotide+%2899mTc-EDDA%2FHYNIC-TOC%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation via coligand exchange and characterization of [99mTc-EDDA-HYNIC-D-Phe1,Tyr3]octreotide (99mTc-EDDA/HYNIC-TOC)</span></div><div class="casAuthors">von Guggenberg, Elisabeth; Sarg, Bettina; Lindner, Herbert; Alafort, Laura Melendez; Mather, Stephen J.; Moncayo, Roy; Decristoforo, Clemens</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds & Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">307-318</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">[99mTc-EDDA-HYNIC-D-Phe1,Tyr3]octreotide (99mTc-EDDA/HYNIC-TOC) is a promising new agent with the potential to replace [111In-DTPA-D-Phe1]-octreotide in somatostatin receptor scintigraphy.  This hydrazinonicotinic acid derivatized somatostatin complex contains ethylenediamine-N,N'-diacetic acid (EDDA) as a coligand resulting in a high in vitro and in vivo stability.  Since direct 99mTc-labeling of HYNIC-TOC with EDDA results in low labeling yields, the authors describe the prepn. of 99mTc-EDDA/HYNIC-TOC via coligand exchange from Tricine for EDDA.  Exchange of coligands is achieved at elevated temp. and under optimized conditions of pH, EDDA concn. and stannous ion.  High labeling yields (mean 95.9%) were achieved at high specific activities (> 37 GBq/μmol).  Characterization via HPLC, receptor binding and LC-MS of the resulting complex is described.  The formulation developed enables rapid and simple labeling of 99mTc-EDDA/HYNIC-TOC in a manner suitable for a clin. setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlLpzV54vF8LVg90H21EOLACvtfcHk0ljl9np26Owc9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjt1Wmsrk%253D&md5=22ff744e46c93a28cb25088c73aab20a</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.672&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.672%26sid%3Dliteratum%253Aachs%26aulast%3Dvon%2BGuggenberg%26aufirst%3DE.%26aulast%3DSarg%26aufirst%3DB.%26aulast%3DLindner%26aufirst%3DH.%26aulast%3DMelendez%2BAlafort%26aufirst%3DL.%26aulast%3DMather%26aufirst%3DS.%2BJ.%26aulast%3DMoncayo%26aufirst%3DR.%26aulast%3DDecristoforo%26aufirst%3DC.%26atitle%3DPreparation%2520via%2520coligand%2520exchange%2520and%2520characterization%2520of%2520%255B99mTc-EDDA-HYNIC-D-Phe1%253BTyr3%255DOctreotide%2520%252899mTc-EDDA%252FHYNIC-TOC%2529%26jtitle%3DJ.%2520Lab.%2520Compd.%2520Radiopharm.%26date%3D2003%26volume%3D46%26spage%3D307%26epage%3D318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Svoboda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dupuche, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bui, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christophe, J.</span><span> </span><span class="NLM_article-title">Internalization−sequestration and degradation of cholecystokinin (CCK) in tumoral rat pancreatic AR 4-2 J cells</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">1055</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1055&publication_year=1990&pages=207-216&author=M.+Svobodaauthor=M.+H.+Dupucheauthor=M.+Lambertauthor=D.+Buiauthor=J.+Christophe&title=Internalization%E2%88%92sequestration+and+degradation+of+cholecystokinin+%28CCK%29+in+tumoral+rat+pancreatic+AR+4-2+J+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSvoboda%26aufirst%3DM.%26aulast%3DDupuche%26aufirst%3DM.%2BH.%26aulast%3DLambert%26aufirst%3DM.%26aulast%3DBui%26aufirst%3DD.%26aulast%3DChristophe%26aufirst%3DJ.%26atitle%3DInternalization%25E2%2588%2592sequestration%2520and%2520degradation%2520of%2520cholecystokinin%2520%2528CCK%2529%2520in%2520tumoral%2520rat%2520pancreatic%2520AR%25204-2%2520J%2520cells%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1990%26volume%3D1055%26spage%3D207%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 32 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Maximilian Klingler, Anton A. Hörmann, Christine Rangger, Laurence Desrues, Hélène Castel, Pierrick Gandolfo, <span class="NLM_string-name hlFld-ContribAuthor">Elisabeth von Guggenberg</span>. </span><span class="cited-content_cbyCitation_article-title">Stabilization Strategies for Linear Minigastrin Analogues: Further Improvements via the Inclusion of Proline into the Peptide Sequence. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (23)
                                     , 14668-14679. <a href="https://doi.org/10.1021/acs.jmedchem.0c01233" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01233</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01233%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStabilization%252BStrategies%252Bfor%252BLinear%252BMinigastrin%252BAnalogues%25253A%252BFurther%252BImprovements%252Bvia%252Bthe%252BInclusion%252Bof%252BProline%252Binto%252Bthe%252BPeptide%252BSequence%26aulast%3DKlingler%26aufirst%3DMaximilian%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D15072020%26date%3D23112020%26volume%3D63%26issue%3D23%26spage%3D14668%26epage%3D14679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christine  Rangger</span>, <span class="hlFld-ContribAuthor ">Maximilian  Klingler</span>, <span class="hlFld-ContribAuthor ">Lajos  Balogh</span>, <span class="hlFld-ContribAuthor ">Zita  Pöstényi</span>, <span class="hlFld-ContribAuthor ">Andras  Polyak</span>, <span class="hlFld-ContribAuthor ">Dariusz  Pawlak</span>, <span class="hlFld-ContribAuthor ">Renata  Mikołajczak</span>, and <span class="hlFld-ContribAuthor ">Elisabeth  von Guggenberg</span>  . </span><span class="cited-content_cbyCitation_article-title">177Lu Labeled Cyclic Minigastrin Analogues with Therapeutic Activity in CCK2R Expressing Tumors: Preclinical Evaluation of a Kit Formulation. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2017,</strong> <em>14 </em>
                                    (9)
                                     , 3045-3058. <a href="https://doi.org/10.1021/acs.molpharmaceut.7b00241" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.7b00241</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.7b00241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.7b00241%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3D177Lu%252BLabeled%252BCyclic%252BMinigastrin%252BAnalogues%252Bwith%252BTherapeutic%252BActivity%252Bin%252BCCK2R%252BExpressing%252BTumors%25253A%252BPreclinical%252BEvaluation%252Bof%252Ba%252BKit%252BFormulation%26aulast%3DRangger%26aufirst%3DChristine%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D28032017%26date%3D20072017%26date%3D14072017%26date%3D07082017%26date%3D05092017%26date%3D20072017%26volume%3D14%26issue%3D9%26spage%3D3045%26epage%3D3058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Petra  Kolenc-Peitl</span>, <span class="hlFld-ContribAuthor ">Rosalba  Mansi</span>, <span class="hlFld-ContribAuthor ">MariaLuisa  Tamma</span>, <span class="hlFld-ContribAuthor ">Tanja  Gmeiner-Stopar</span>, <span class="hlFld-ContribAuthor ">Marija  Sollner-Dolenc</span>, <span class="hlFld-ContribAuthor ">Beatrice  Waser</span>, <span class="hlFld-ContribAuthor ">Richard P.  Baum</span>, <span class="hlFld-ContribAuthor ">Jean Claude  Reubi</span>, and <span class="hlFld-ContribAuthor ">Helmut R.  Maecke</span>  . </span><span class="cited-content_cbyCitation_article-title">Highly Improved Metabolic Stability and Pharmacokinetics of Indium-111-DOTA-Gastrin Conjugates for Targeting of the Gastrin Receptor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (8)
                                     , 2602-2609. <a href="https://doi.org/10.1021/jm101279a" title="DOI URL">https://doi.org/10.1021/jm101279a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm101279a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm101279a%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHighly%252BImproved%252BMetabolic%252BStability%252Band%252BPharmacokinetics%252Bof%252BIndium-111-DOTA-Gastrin%252BConjugates%252Bfor%252BTargeting%252Bof%252Bthe%252BGastrin%252BReceptor%26aulast%3DKolenc-Peitl%26aufirst%3DPetra%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D05102010%26date%3D01042011%26date%3D28042011%26volume%3D54%26issue%3D8%26spage%3D2602%26epage%3D2609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark D.  Bartholomä</span>, <span class="hlFld-ContribAuthor ">Anika S.  Louie</span>, <span class="hlFld-ContribAuthor ">John F.  Valliant</span> and <span class="hlFld-ContribAuthor ">Jon  Zubieta</span>. </span><span class="cited-content_cbyCitation_article-title">Technetium and Gallium Derived Radiopharmaceuticals: Comparing and Contrasting the Chemistry of Two Important Radiometals for the Molecular Imaging Era. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2010,</strong> <em>110 </em>
                                    (5)
                                     , 2903-2920. <a href="https://doi.org/10.1021/cr1000755" title="DOI URL">https://doi.org/10.1021/cr1000755</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr1000755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr1000755%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DTechnetium%252Band%252BGallium%252BDerived%252BRadiopharmaceuticals%25253A%252BComparing%252Band%252BContrasting%252Bthe%252BChemistry%252Bof%252BTwo%252BImportant%252BRadiometals%252Bfor%252Bthe%252BMolecular%252BImaging%252BEra%26aulast%3DBartholom%25C3%25A4%26aufirst%3DMark%2BD.%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D3%252003%25202010%26date%3D23042010%26date%3D12052010%26volume%3D110%26issue%3D5%26spage%3D2903%26epage%3D2920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dionysia  Papagiannopoulou</span>. </span><span class="cited-content_cbyCitation_article-title">
                99m
                Tc
              
              Radiopharmaceutical Chemistry. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 375-433. <a href="https://doi.org/10.1002/9781119500575.ch12" title="DOI URL">https://doi.org/10.1002/9781119500575.ch12</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781119500575.ch12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781119500575.ch12%26sid%3Dliteratum%253Aachs%26atitle%3D99m%252BTc%252BRadiopharmaceutical%252BChemistry%26aulast%3DPapagiannopoulou%26aufirst%3DDionysia%26date%3D2020%26date%3D2021%26spage%3D375%26epage%3D433%26pub%3DWiley%26atitle%3DHandbook%252Bof%252BRadiopharmaceuticals%26aulast%3DScott%26aufirst%3DPeter%26date%3D2020%26date%3D2021%26volume%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Syed Faheem Askari  Rizvi</span>, <span class="hlFld-ContribAuthor ">Shuai  Mu</span>, <span class="hlFld-ContribAuthor ">Yaya  Wang</span>, <span class="hlFld-ContribAuthor ">Shuangqin  Li</span>, <span class="hlFld-ContribAuthor ">Haixia  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorescent RGD-based pro-apoptotic peptide conjugates as mitochondria-targeting probes for enhanced anticancer activities. </span><span class="cited-content_cbyCitation_journal-name">Biomedicine & Pharmacotherapy</span><span> <strong>2020,</strong> <em>127 </em>, 110179. <a href="https://doi.org/10.1016/j.biopha.2020.110179" title="DOI URL">https://doi.org/10.1016/j.biopha.2020.110179</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopha.2020.110179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopha.2020.110179%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicine%2520%2526%2520Pharmacotherapy%26atitle%3DFluorescent%252BRGD-based%252Bpro-apoptotic%252Bpeptide%252Bconjugates%252Bas%252Bmitochondria-targeting%252Bprobes%252Bfor%252Benhanced%252Banticancer%252Bactivities%26aulast%3DRizvi%26aufirst%3DSyed%2BFaheem%2BAskari%26date%3D2020%26volume%3D127%26spage%3D110179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fariba  Maleki</span>, <span class="hlFld-ContribAuthor ">Arezou Masteri  Farahani</span>, <span class="hlFld-ContribAuthor ">Farzaneh  Rezazedeh</span>, <span class="hlFld-ContribAuthor ">Nourollah  Sadeghzadeh</span>. </span><span class="cited-content_cbyCitation_article-title">Structural modifications of amino acid sequences of radiolabeled peptides for targeted tumor imaging. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>99 </em>, 103802. <a href="https://doi.org/10.1016/j.bioorg.2020.103802" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103802</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103802%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DStructural%252Bmodifications%252Bof%252Bamino%252Bacid%252Bsequences%252Bof%252Bradiolabeled%252Bpeptides%252Bfor%252Btargeted%252Btumor%252Bimaging%26aulast%3DMaleki%26aufirst%3DFariba%26date%3D2020%26volume%3D99%26spage%3D103802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Soghra  Farzipour</span>, <span class="hlFld-ContribAuthor ">Seyed Jalal  Hosseinimehr</span>. </span><span class="cited-content_cbyCitation_article-title">Correlation between in vitro and in vivo Data of Radiolabeled Peptide for Tumor Targeting. </span><span class="cited-content_cbyCitation_journal-name">Mini-Reviews in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (12)
                                     , 950-960. <a href="https://doi.org/10.2174/1389557519666190304120011" title="DOI URL">https://doi.org/10.2174/1389557519666190304120011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1389557519666190304120011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1389557519666190304120011%26sid%3Dliteratum%253Aachs%26jtitle%3DMini-Reviews%2520in%2520Medicinal%2520Chemistry%26atitle%3DCorrelation%252Bbetween%252Bin%252Bvitro%252Band%252Bin%252Bvivo%252BData%252Bof%252BRadiolabeled%252BPeptide%252Bfor%252BTumor%252BTargeting%26aulast%3DFarzipour%26aufirst%3DSoghra%26date%3D2019%26volume%3D19%26issue%3D12%26spage%3D950%26epage%3D960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maximilian  Klingler</span>, <span class="hlFld-ContribAuthor ">Dominik  Summer</span>, <span class="hlFld-ContribAuthor ">Christine  Rangger</span>, <span class="hlFld-ContribAuthor ">Roland  Haubner</span>, <span class="hlFld-ContribAuthor ">Julie  Foster</span>, <span class="hlFld-ContribAuthor ">Jane  Sosabowski</span>, <span class="hlFld-ContribAuthor ">Clemens  Decristoforo</span>, <span class="hlFld-ContribAuthor ">Irene  Virgolini</span>, <span class="hlFld-ContribAuthor ">Elisabeth  von Guggenberg</span>. </span><span class="cited-content_cbyCitation_article-title">DOTA-MGS5, a New Cholecystokinin-2 Receptor-Targeting Peptide Analog with an Optimized Targeting Profile for Theranostic Use. </span><span class="cited-content_cbyCitation_journal-name">Journal of Nuclear Medicine</span><span> <strong>2019,</strong> <em>60 </em>
                                    (7)
                                     , 1010-1016. <a href="https://doi.org/10.2967/jnumed.118.221283" title="DOI URL">https://doi.org/10.2967/jnumed.118.221283</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2967/jnumed.118.221283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2967%2Fjnumed.118.221283%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Nuclear%2520Medicine%26atitle%3DDOTA-MGS5%25252C%252Ba%252BNew%252BCholecystokinin-2%252BReceptor-Targeting%252BPeptide%252BAnalog%252Bwith%252Ban%252BOptimized%252BTargeting%252BProfile%252Bfor%252BTheranostic%252BUse%26aulast%3DKlingler%26aufirst%3DMaximilian%26date%3D2019%26date%3D2018%26volume%3D60%26issue%3D7%26spage%3D1010%26epage%3D1016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Farzaneh  Rezazadeh</span>, <span class="hlFld-ContribAuthor ">Nourollah  Sadeghzadeh</span>. </span><span class="cited-content_cbyCitation_article-title">Tumor targeting with
              99m
              Tc radiolabeled peptides: Clinical application and recent development. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2019,</strong> <em>93 </em>
                                    (3)
                                     , 205-221. <a href="https://doi.org/10.1111/cbdd.13413" title="DOI URL">https://doi.org/10.1111/cbdd.13413</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13413%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DTumor%252Btargeting%252Bwith%252B99m%252BTc%252Bradiolabeled%252Bpeptides%25253A%252BClinical%252Bapplication%252Band%252Brecent%252Bdevelopment%26aulast%3DRezazadeh%26aufirst%3DFarzaneh%26date%3D2019%26date%3D2018%26volume%3D93%26issue%3D3%26spage%3D205%26epage%3D221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maximilian  Klingler</span>, <span class="hlFld-ContribAuthor ">Christine  Rangger</span>, <span class="hlFld-ContribAuthor ">Dominik  Summer</span>, <span class="hlFld-ContribAuthor ">Piriya  Kaeopookum</span>, <span class="hlFld-ContribAuthor ">Clemens  Decristoforo</span>, <span class="hlFld-ContribAuthor ">Elisabeth  von Guggenberg</span>. </span><span class="cited-content_cbyCitation_article-title">Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2019,</strong> <em>12 </em>
                                    (1)
                                     , 13. <a href="https://doi.org/10.3390/ph12010013" title="DOI URL">https://doi.org/10.3390/ph12010013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph12010013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph12010013%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DCholecystokinin-2%252BReceptor%252BTargeting%252Bwith%252BNovel%252BC-terminally%252BStabilized%252BHYNIC-Minigastrin%252BAnalogs%252BRadiolabeled%252Bwith%252BTechnetium-99m%26aulast%3DKlingler%26aufirst%3DMaximilian%26date%3D2019%26date%3D2019%26volume%3D12%26issue%3D1%26spage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Piotr F. J.  Lipiński</span>, <span class="hlFld-ContribAuthor ">Piotr  Garnuszek</span>, <span class="hlFld-ContribAuthor ">Michał  Maurin</span>, <span class="hlFld-ContribAuthor ">Raphael  Stoll</span>, <span class="hlFld-ContribAuthor ">Nils  Metzler-Nolte</span>, <span class="hlFld-ContribAuthor ">Artur  Wodyński</span>, <span class="hlFld-ContribAuthor ">Jan Cz.  Dobrowolski</span>, <span class="hlFld-ContribAuthor ">Marta K.  Dudek</span>, <span class="hlFld-ContribAuthor ">Monika  Orzełowska</span>, <span class="hlFld-ContribAuthor ">Renata  Mikołajczak</span>. </span><span class="cited-content_cbyCitation_article-title">Structural studies on radiopharmaceutical DOTA-minigastrin analogue (CP04) complexes and their interaction with CCK2 receptor. </span><span class="cited-content_cbyCitation_journal-name">EJNMMI Research</span><span> <strong>2018,</strong> <em>8 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13550-018-0387-3" title="DOI URL">https://doi.org/10.1186/s13550-018-0387-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13550-018-0387-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13550-018-0387-3%26sid%3Dliteratum%253Aachs%26jtitle%3DEJNMMI%2520Research%26atitle%3DStructural%252Bstudies%252Bon%252Bradiopharmaceutical%252BDOTA-minigastrin%252Banalogue%252B%252528CP04%252529%252Bcomplexes%252Band%252Btheir%252Binteraction%252Bwith%252BCCK2%252Breceptor%26aulast%3DLipi%25C5%2584ski%26aufirst%3DPiotr%2BF.%2BJ.%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dominik  Summer</span>, <span class="hlFld-ContribAuthor ">Andrea  Kroess</span>, <span class="hlFld-ContribAuthor ">Rudolf  Woerndle</span>, <span class="hlFld-ContribAuthor ">Christine  Rangger</span>, <span class="hlFld-ContribAuthor ">Maximilian  Klingler</span>, <span class="hlFld-ContribAuthor ">Hubertus  Haas</span>, <span class="hlFld-ContribAuthor ">Leopold  Kremser</span>, <span class="hlFld-ContribAuthor ">Herbert H.  Lindner</span>, <span class="hlFld-ContribAuthor ">Elisabeth  von Guggenberg</span>, <span class="hlFld-ContribAuthor ">Clemens  Decristoforo</span>, . </span><span class="cited-content_cbyCitation_article-title">Multimerization results in formation of re-bindable metabolites: A proof of concept study with FSC-based minigastrin imaging probes targeting CCK2R expression. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2018,</strong> <em>13 </em>
                                    (7)
                                     , e0201224. <a href="https://doi.org/10.1371/journal.pone.0201224" title="DOI URL">https://doi.org/10.1371/journal.pone.0201224</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0201224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0201224%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DMultimerization%252Bresults%252Bin%252Bformation%252Bof%252Bre-bindable%252Bmetabolites%25253A%252BA%252Bproof%252Bof%252Bconcept%252Bstudy%252Bwith%252BFSC-based%252Bminigastrin%252Bimaging%252Bprobes%252Btargeting%252BCCK2R%252Bexpression%26aulast%3DSummer%26aufirst%3DDominik%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D7%26spage%3De0201224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Theodosia  Maina</span>, <span class="hlFld-ContribAuthor ">Mark W.  Konijnenberg</span>, <span class="hlFld-ContribAuthor ">Petra  KolencPeitl</span>, <span class="hlFld-ContribAuthor ">Piotr  Garnuszek</span>, <span class="hlFld-ContribAuthor ">Berthold A.  Nock</span>, <span class="hlFld-ContribAuthor ">Aikaterini  Kaloudi</span>, <span class="hlFld-ContribAuthor ">Marko  Kroselj</span>, <span class="hlFld-ContribAuthor ">Katja  Zaletel</span>, <span class="hlFld-ContribAuthor ">Helmut  Maecke</span>, <span class="hlFld-ContribAuthor ">Rosalba  Mansi</span>, <span class="hlFld-ContribAuthor ">Paola  Erba</span>, <span class="hlFld-ContribAuthor ">Elisabeth  von Guggenberg</span>, <span class="hlFld-ContribAuthor ">Alicja  Hubalewska-Dydejczyk</span>, <span class="hlFld-ContribAuthor ">Renata  Mikolajczak</span>, <span class="hlFld-ContribAuthor ">Clemens  Decristoforo</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical pharmacokinetics, biodistribution, radiation dosimetry and toxicity studies required for regulatory approval of a phase I clinical trial with 111In-CP04 in medullary thyroid carcinoma patients. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2016,</strong> <em>91 </em>, 236-242. <a href="https://doi.org/10.1016/j.ejps.2016.05.011" title="DOI URL">https://doi.org/10.1016/j.ejps.2016.05.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2016.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2016.05.011%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DPreclinical%252Bpharmacokinetics%25252C%252Bbiodistribution%25252C%252Bradiation%252Bdosimetry%252Band%252Btoxicity%252Bstudies%252Brequired%252Bfor%252Bregulatory%252Bapproval%252Bof%252Ba%252Bphase%252BI%252Bclinical%252Btrial%252Bwith%252B111In-CP04%252Bin%252Bmedullary%252Bthyroid%252Bcarcinoma%252Bpatients%26aulast%3DMaina%26aufirst%3DTheodosia%26date%3D2016%26volume%3D91%26spage%3D236%26epage%3D242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kristof  Zarschler</span>, <span class="hlFld-ContribAuthor ">Louise  Rocks</span>, <span class="hlFld-ContribAuthor ">Nadia  Licciardello</span>, <span class="hlFld-ContribAuthor ">Luca  Boselli</span>, <span class="hlFld-ContribAuthor ">Ester  Polo</span>, <span class="hlFld-ContribAuthor ">Karina Pombo  Garcia</span>, <span class="hlFld-ContribAuthor ">Luisa  De Cola</span>, <span class="hlFld-ContribAuthor ">Holger  Stephan</span>, <span class="hlFld-ContribAuthor ">Kenneth A.  Dawson</span>. </span><span class="cited-content_cbyCitation_article-title">Ultrasmall inorganic nanoparticles: State-of-the-art and perspectives for biomedical applications. </span><span class="cited-content_cbyCitation_journal-name">Nanomedicine: Nanotechnology, Biology and Medicine</span><span> <strong>2016,</strong> <em>12 </em>
                                    (6)
                                     , 1663-1701. <a href="https://doi.org/10.1016/j.nano.2016.02.019" title="DOI URL">https://doi.org/10.1016/j.nano.2016.02.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nano.2016.02.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nano.2016.02.019%26sid%3Dliteratum%253Aachs%26jtitle%3DNanomedicine%253A%2520Nanotechnology%252C%2520Biology%2520and%2520Medicine%26atitle%3DUltrasmall%252Binorganic%252Bnanoparticles%25253A%252BState-of-the-art%252Band%252Bperspectives%252Bfor%252Bbiomedical%252Bapplications%26aulast%3DZarschler%26aufirst%3DKristof%26date%3D2016%26volume%3D12%26issue%3D6%26spage%3D1663%26epage%3D1701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aikaterini  Kaloudi</span>, <span class="hlFld-ContribAuthor ">Berthold A.  Nock</span>, <span class="hlFld-ContribAuthor ">Emmanouil  Lymperis</span>, <span class="hlFld-ContribAuthor ">Eric P.  Krenning</span>, <span class="hlFld-ContribAuthor ">Marion  de Jong</span>, <span class="hlFld-ContribAuthor ">Theodosia  Maina</span>. </span><span class="cited-content_cbyCitation_article-title">99mTc-labeled gastrins of varying peptide chain length: Distinct impact of NEP/ACE-inhibition on stability and tumor uptake in mice. </span><span class="cited-content_cbyCitation_journal-name">Nuclear Medicine and Biology</span><span> <strong>2016,</strong> <em>43 </em>
                                    (6)
                                     , 347-354. <a href="https://doi.org/10.1016/j.nucmedbio.2016.03.003" title="DOI URL">https://doi.org/10.1016/j.nucmedbio.2016.03.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nucmedbio.2016.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nucmedbio.2016.03.003%26sid%3Dliteratum%253Aachs%26jtitle%3DNuclear%2520Medicine%2520and%2520Biology%26atitle%3D99mTc-labeled%252Bgastrins%252Bof%252Bvarying%252Bpeptide%252Bchain%252Blength%25253A%252BDistinct%252Bimpact%252Bof%252BNEP%25252FACE-inhibition%252Bon%252Bstability%252Band%252Btumor%252Buptake%252Bin%252Bmice%26aulast%3DKaloudi%26aufirst%3DAikaterini%26date%3D2016%26volume%3D43%26issue%3D6%26spage%3D347%26epage%3D354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dariusz  Pawlak</span>, <span class="hlFld-ContribAuthor ">Christine  Rangger</span>, <span class="hlFld-ContribAuthor ">Petra  Kolenc Peitl</span>, <span class="hlFld-ContribAuthor ">Piotr  Garnuszek</span>, <span class="hlFld-ContribAuthor ">Michał  Maurin</span>, <span class="hlFld-ContribAuthor ">Laura  Ihli</span>, <span class="hlFld-ContribAuthor ">Marko  Kroselj</span>, <span class="hlFld-ContribAuthor ">Theodosia  Maina</span>, <span class="hlFld-ContribAuthor ">Helmut  Maecke</span>, <span class="hlFld-ContribAuthor ">Paola  Erba</span>, <span class="hlFld-ContribAuthor ">Leopold  Kremser</span>, <span class="hlFld-ContribAuthor ">Alicja  Hubalewska-Dydejczyk</span>, <span class="hlFld-ContribAuthor ">Renata  Mikołajczak</span>, <span class="hlFld-ContribAuthor ">Clemens  Decristoforo</span>. </span><span class="cited-content_cbyCitation_article-title">From preclinical development to clinical application: Kit formulation for radiolabelling the minigastrin analogue CP04 with In-111 for a first-in-human clinical trial. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2016,</strong> <em>85 </em>, 1-9. <a href="https://doi.org/10.1016/j.ejps.2016.01.023" title="DOI URL">https://doi.org/10.1016/j.ejps.2016.01.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2016.01.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2016.01.023%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DFrom%252Bpreclinical%252Bdevelopment%252Bto%252Bclinical%252Bapplication%25253A%252BKit%252Bformulation%252Bfor%252Bradiolabelling%252Bthe%252Bminigastrin%252Banalogue%252BCP04%252Bwith%252BIn-111%252Bfor%252Ba%252Bfirst-in-human%252Bclinical%252Btrial%26aulast%3DPawlak%26aufirst%3DDariusz%26date%3D2016%26volume%3D85%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C. L.  Charron</span>, <span class="hlFld-ContribAuthor ">J. L.  Hickey</span>, <span class="hlFld-ContribAuthor ">T. K.  Nsiama</span>, <span class="hlFld-ContribAuthor ">D. R.  Cruickshank</span>, <span class="hlFld-ContribAuthor ">W. L.  Turnbull</span>, <span class="hlFld-ContribAuthor ">L. G.  Luyt</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular imaging probes derived from natural peptides. </span><span class="cited-content_cbyCitation_journal-name">Natural Product Reports</span><span> <strong>2016,</strong> <em>33 </em>
                                    (6)
                                     , 761-800. <a href="https://doi.org/10.1039/C5NP00083A" title="DOI URL">https://doi.org/10.1039/C5NP00083A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5NP00083A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5NP00083A%26sid%3Dliteratum%253Aachs%26jtitle%3DNatural%2520Product%2520Reports%26atitle%3DMolecular%252Bimaging%252Bprobes%252Bderived%252Bfrom%252Bnatural%252Bpeptides%26aulast%3DCharron%26aufirst%3DC.%2BL.%26date%3D2016%26date%3D2016%26volume%3D33%26issue%3D6%26spage%3D761%26epage%3D800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joachim  Pfister</span>, <span class="hlFld-ContribAuthor ">Dominik  Summer</span>, <span class="hlFld-ContribAuthor ">Christine  Rangger</span>, <span class="hlFld-ContribAuthor ">Milos  Petrik</span>, <span class="hlFld-ContribAuthor ">Elisabeth  von Guggenberg</span>, <span class="hlFld-ContribAuthor ">Paolo  Minazzi</span>, <span class="hlFld-ContribAuthor ">Giovanni B.  Giovenzana</span>, <span class="hlFld-ContribAuthor ">Luigi  Aloj</span>, <span class="hlFld-ContribAuthor ">Clemens  Decristoforo</span>. </span><span class="cited-content_cbyCitation_article-title">Influence of a novel, versatile bifunctional chelator on theranostic properties of a minigastrin analogue. </span><span class="cited-content_cbyCitation_journal-name">EJNMMI Research</span><span> <strong>2015,</strong> <em>5 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13550-015-0154-7" title="DOI URL">https://doi.org/10.1186/s13550-015-0154-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13550-015-0154-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13550-015-0154-7%26sid%3Dliteratum%253Aachs%26jtitle%3DEJNMMI%2520Research%26atitle%3DInfluence%252Bof%252Ba%252Bnovel%25252C%252Bversatile%252Bbifunctional%252Bchelator%252Bon%252Btheranostic%252Bproperties%252Bof%252Ba%252Bminigastrin%252Banalogue%26aulast%3DPfister%26aufirst%3DJoachim%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aikaterini  Kaloudi</span>, <span class="hlFld-ContribAuthor ">Berthold A.  Nock</span>, <span class="hlFld-ContribAuthor ">Emmanouil  Lymperis</span>, <span class="hlFld-ContribAuthor ">Werner  Sallegger</span>, <span class="hlFld-ContribAuthor ">Eric P.  Krenning</span>, <span class="hlFld-ContribAuthor ">Marion  de Jong</span>, <span class="hlFld-ContribAuthor ">Theodosia  Maina</span>. </span><span class="cited-content_cbyCitation_article-title">In vivo inhibition of neutral endopeptidase enhances the diagnostic potential of truncated gastrin 111In-radioligands. </span><span class="cited-content_cbyCitation_journal-name">Nuclear Medicine and Biology</span><span> <strong>2015,</strong> <em>42 </em>
                                    (11)
                                     , 824-832. <a href="https://doi.org/10.1016/j.nucmedbio.2015.07.009" title="DOI URL">https://doi.org/10.1016/j.nucmedbio.2015.07.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nucmedbio.2015.07.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nucmedbio.2015.07.009%26sid%3Dliteratum%253Aachs%26jtitle%3DNuclear%2520Medicine%2520and%2520Biology%26atitle%3DIn%252Bvivo%252Binhibition%252Bof%252Bneutral%252Bendopeptidase%252Benhances%252Bthe%252Bdiagnostic%252Bpotential%252Bof%252Btruncated%252Bgastrin%252B111In-radioligands%26aulast%3DKaloudi%26aufirst%3DAikaterini%26date%3D2015%26volume%3D42%26issue%3D11%26spage%3D824%26epage%3D832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">R.  Alberto</span>, <span class="hlFld-ContribAuthor ">H.  Braband</span>. </span><span class="cited-content_cbyCitation_article-title">SPECT/PET Imaging with Technetium, Gallium, Copper, and Other Metallic Radionuclides. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 785-817. <a href="https://doi.org/10.1016/B978-0-08-097774-4.00331-4" title="DOI URL">https://doi.org/10.1016/B978-0-08-097774-4.00331-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-097774-4.00331-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-097774-4.00331-4%26sid%3Dliteratum%253Aachs%26atitle%3DSPECT%25252FPET%252BImaging%252Bwith%252BTechnetium%25252C%252BGallium%25252C%252BCopper%25252C%252Band%252BOther%252BMetallic%252BRadionuclides%26aulast%3DAlberto%26aufirst%3DR.%26date%3D2013%26spage%3D785%26epage%3D817%26pub%3DElsevier%26atitle%3DComprehensive%252BInorganic%252BChemistry%252BII%26date%3D2013%26volume%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elisabeth  von Guggenberg</span>, <span class="hlFld-ContribAuthor ">Christine  Rangger</span>, <span class="hlFld-ContribAuthor ">Jane  Sosabowski</span>, <span class="hlFld-ContribAuthor ">Peter  Laverman</span>, <span class="hlFld-ContribAuthor ">Jean-Claude  Reubi</span>, <span class="hlFld-ContribAuthor ">Irene Johanna  Virgolini</span>, <span class="hlFld-ContribAuthor ">Clemens  Decristoforo</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical Evaluation of Radiolabeled DOTA-Derivatized Cyclic Minigastrin Analogs for Targeting Cholecystokinin Receptor Expressing Malignancies. </span><span class="cited-content_cbyCitation_journal-name">Molecular Imaging and Biology</span><span> <strong>2012,</strong> <em>14 </em>
                                    (3)
                                     , 366-375. <a href="https://doi.org/10.1007/s11307-011-0506-2" title="DOI URL">https://doi.org/10.1007/s11307-011-0506-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11307-011-0506-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11307-011-0506-2%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Imaging%2520and%2520Biology%26atitle%3DPreclinical%252BEvaluation%252Bof%252BRadiolabeled%252BDOTA-Derivatized%252BCyclic%252BMinigastrin%252BAnalogs%252Bfor%252BTargeting%252BCholecystokinin%252BReceptor%252BExpressing%252BMalignancies%26aulast%3Dvon%2BGuggenberg%26aufirst%3DElisabeth%26date%3D2012%26date%3D2011%26volume%3D14%26issue%3D3%26spage%3D366%26epage%3D375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frantisek  Trejtnar</span>, <span class="hlFld-ContribAuthor ">Alice  Laznickova</span>, <span class="hlFld-ContribAuthor ">Milan  Laznicek</span>, <span class="hlFld-ContribAuthor ">Zbynek  Novy</span>, <span class="hlFld-ContribAuthor ">Theodosia  Maina</span>, <span class="hlFld-ContribAuthor ">Berthold A.  Nock</span>, <span class="hlFld-ContribAuthor ">Martin  Behe</span>. </span><span class="cited-content_cbyCitation_article-title">Distribution, Elimination, and Renal Handling of
              99m
              Technetium-Demogastrin 1. </span><span class="cited-content_cbyCitation_journal-name">Cancer Biotherapy and Radiopharmaceuticals</span><span> <strong>2012,</strong> <em>27 </em>
                                    (2)
                                     , 169-174. <a href="https://doi.org/10.1089/cbr.2011.1008" title="DOI URL">https://doi.org/10.1089/cbr.2011.1008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1089/cbr.2011.1008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1089%2Fcbr.2011.1008%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Biotherapy%2520and%2520Radiopharmaceuticals%26atitle%3DDistribution%25252C%252BElimination%25252C%252Band%252BRenal%252BHandling%252Bof%252B99m%252BTechnetium-Demogastrin%252B1%26aulast%3DTrejtnar%26aufirst%3DFrantisek%26date%3D2012%26volume%3D27%26issue%3D2%26spage%3D169%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Melpomeni  Fani</span>, <span class="hlFld-ContribAuthor ">Helmut R.  Maecke</span>. </span><span class="cited-content_cbyCitation_article-title">Radiopharmaceutical development of radiolabelled peptides. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Nuclear Medicine and Molecular Imaging</span><span> <strong>2012,</strong> <em>39 </em>
                                    (S1)
                                     , 11-30. <a href="https://doi.org/10.1007/s00259-011-2001-z" title="DOI URL">https://doi.org/10.1007/s00259-011-2001-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00259-011-2001-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00259-011-2001-z%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Nuclear%2520Medicine%2520and%2520Molecular%2520Imaging%26atitle%3DRadiopharmaceutical%252Bdevelopment%252Bof%252Bradiolabelled%252Bpeptides%26aulast%3DFani%26aufirst%3DMelpomeni%26date%3D2012%26date%3D2012%26volume%3D39%26issue%3DS1%26spage%3D11%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter  Laverman</span>, <span class="hlFld-ContribAuthor ">Jane K.  Sosabowski</span>, <span class="hlFld-ContribAuthor ">Otto C.  Boerman</span>, <span class="hlFld-ContribAuthor ">Wim J. G.  Oyen</span>. </span><span class="cited-content_cbyCitation_article-title">Radiolabelled peptides for oncological diagnosis. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Nuclear Medicine and Molecular Imaging</span><span> <strong>2012,</strong> <em>39 </em>
                                    (S1)
                                     , 78-92. <a href="https://doi.org/10.1007/s00259-011-2014-7" title="DOI URL">https://doi.org/10.1007/s00259-011-2014-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00259-011-2014-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00259-011-2014-7%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Nuclear%2520Medicine%2520and%2520Molecular%2520Imaging%26atitle%3DRadiolabelled%252Bpeptides%252Bfor%252Boncological%252Bdiagnosis%26aulast%3DLaverman%26aufirst%3DPeter%26date%3D2012%26date%3D2012%26volume%3D39%26issue%3DS1%26spage%3D78%26epage%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Susan  Roosenburg</span>, <span class="hlFld-ContribAuthor ">Peter  Laverman</span>, <span class="hlFld-ContribAuthor ">Floris L.  van Delft</span>, <span class="hlFld-ContribAuthor ">Otto C.  Boerman</span>. </span><span class="cited-content_cbyCitation_article-title">Radiolabeled CCK/gastrin peptides for imaging and therapy of CCK2 receptor-expressing tumors. </span><span class="cited-content_cbyCitation_journal-name">Amino Acids</span><span> <strong>2011,</strong> <em>41 </em>
                                    (5)
                                     , 1049-1058. <a href="https://doi.org/10.1007/s00726-010-0501-y" title="DOI URL">https://doi.org/10.1007/s00726-010-0501-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00726-010-0501-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00726-010-0501-y%26sid%3Dliteratum%253Aachs%26jtitle%3DAmino%2520Acids%26atitle%3DRadiolabeled%252BCCK%25252Fgastrin%252Bpeptides%252Bfor%252Bimaging%252Band%252Btherapy%252Bof%252BCCK2%252Breceptor-expressing%252Btumors%26aulast%3DRoosenburg%26aufirst%3DSusan%26date%3D2011%26date%3D2010%26volume%3D41%26issue%3D5%26spage%3D1049%26epage%3D1058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter  Laverman</span>, <span class="hlFld-ContribAuthor ">Lieke  Joosten</span>, <span class="hlFld-ContribAuthor ">Annemarie  Eek</span>, <span class="hlFld-ContribAuthor ">Susan  Roosenburg</span>, <span class="hlFld-ContribAuthor ">Petra Kolenc  Peitl</span>, <span class="hlFld-ContribAuthor ">Theodosia  Maina</span>, <span class="hlFld-ContribAuthor ">Helmut  Mäcke</span>, <span class="hlFld-ContribAuthor ">Luigi  Aloj</span>, <span class="hlFld-ContribAuthor ">Elisabeth  von Guggenberg</span>, <span class="hlFld-ContribAuthor ">Jane K.  Sosabowski</span>, <span class="hlFld-ContribAuthor ">Marion  de Jong</span>, <span class="hlFld-ContribAuthor ">Jean-Claude  Reubi</span>, <span class="hlFld-ContribAuthor ">Wim J. G.  Oyen</span>, <span class="hlFld-ContribAuthor ">Otto C.  Boerman</span>. </span><span class="cited-content_cbyCitation_article-title">Comparative biodistribution of 12 111In-labelled gastrin/CCK2 receptor-targeting peptides. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Nuclear Medicine and Molecular Imaging</span><span> <strong>2011,</strong> <em>38 </em>
                                    (8)
                                     , 1410-1416. <a href="https://doi.org/10.1007/s00259-011-1806-0" title="DOI URL">https://doi.org/10.1007/s00259-011-1806-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00259-011-1806-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00259-011-1806-0%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Nuclear%2520Medicine%2520and%2520Molecular%2520Imaging%26atitle%3DComparative%252Bbiodistribution%252Bof%252B12%252B111In-labelled%252Bgastrin%25252FCCK2%252Breceptor-targeting%252Bpeptides%26aulast%3DLaverman%26aufirst%3DPeter%26date%3D2011%26date%3D2011%26volume%3D38%26issue%3D8%26spage%3D1410%26epage%3D1416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luigi  Aloj</span>, <span class="hlFld-ContribAuthor ">Michela  Aurilio</span>, <span class="hlFld-ContribAuthor ">Valentina  Rinaldi</span>, <span class="hlFld-ContribAuthor ">Laura  D’ambrosio</span>, <span class="hlFld-ContribAuthor ">Diego  Tesauro</span>, <span class="hlFld-ContribAuthor ">Petra Kolenc  Peitl</span>, <span class="hlFld-ContribAuthor ">Theodosia  Maina</span>, <span class="hlFld-ContribAuthor ">Rosalba  Mansi</span>, <span class="hlFld-ContribAuthor ">Elisabeth  von Guggenberg</span>, <span class="hlFld-ContribAuthor ">Lieke  Joosten</span>, <span class="hlFld-ContribAuthor ">Jane K.  Sosabowski</span>, <span class="hlFld-ContribAuthor ">Wouter A. P.  Breeman</span>, <span class="hlFld-ContribAuthor ">Erik  De Blois</span>, <span class="hlFld-ContribAuthor ">Stuart  Koelewijn</span>, <span class="hlFld-ContribAuthor ">Marleen  Melis</span>, <span class="hlFld-ContribAuthor ">Beatrice  Waser</span>, <span class="hlFld-ContribAuthor ">Karin  Beetschen</span>, <span class="hlFld-ContribAuthor ">Jean Claude  Reubi</span>, <span class="hlFld-ContribAuthor ">Marion  de Jong</span>. </span><span class="cited-content_cbyCitation_article-title">Comparison of the binding and internalization properties of 12 DOTA-coupled and 111In-labelled CCK2/gastrin receptor binding peptides: a collaborative project under COST Action BM0607. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Nuclear Medicine and Molecular Imaging</span><span> <strong>2011,</strong> <em>38 </em>
                                    (8)
                                     , 1417-1425. <a href="https://doi.org/10.1007/s00259-011-1816-y" title="DOI URL">https://doi.org/10.1007/s00259-011-1816-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00259-011-1816-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00259-011-1816-y%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Nuclear%2520Medicine%2520and%2520Molecular%2520Imaging%26atitle%3DComparison%252Bof%252Bthe%252Bbinding%252Band%252Binternalization%252Bproperties%252Bof%252B12%252BDOTA-coupled%252Band%252B111In-labelled%252BCCK2%25252Fgastrin%252Breceptor%252Bbinding%252Bpeptides%25253A%252Ba%252Bcollaborative%252Bproject%252Bunder%252BCOST%252BAction%252BBM0607%26aulast%3DAloj%26aufirst%3DLuigi%26date%3D2011%26date%3D2011%26volume%3D38%26issue%3D8%26spage%3D1417%26epage%3D1425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meltem  Ocak</span>, <span class="hlFld-ContribAuthor ">Anna  Helbok</span>, <span class="hlFld-ContribAuthor ">Elisabeth  von Guggenberg</span>, <span class="hlFld-ContribAuthor ">Y.  Ozsoy</span>, <span class="hlFld-ContribAuthor ">Levent  Kabasakal</span>, <span class="hlFld-ContribAuthor ">Leopold  Kremser</span>, <span class="hlFld-ContribAuthor ">Clemens  Decristoforo</span>. </span><span class="cited-content_cbyCitation_article-title">Influence of biological assay conditions on stability assessment of radiometal-labelled peptides exemplified using a 177Lu-DOTA-minigastrin derivative. </span><span class="cited-content_cbyCitation_journal-name">Nuclear Medicine and Biology</span><span> <strong>2011,</strong> <em>38 </em>
                                    (2)
                                     , 171-179. <a href="https://doi.org/10.1016/j.nucmedbio.2010.07.009" title="DOI URL">https://doi.org/10.1016/j.nucmedbio.2010.07.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nucmedbio.2010.07.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nucmedbio.2010.07.009%26sid%3Dliteratum%253Aachs%26jtitle%3DNuclear%2520Medicine%2520and%2520Biology%26atitle%3DInfluence%252Bof%252Bbiological%252Bassay%252Bconditions%252Bon%252Bstability%252Bassessment%252Bof%252Bradiometal-labelled%252Bpeptides%252Bexemplified%252Busing%252Ba%252B177Lu-DOTA-minigastrin%252Bderivative%26aulast%3DOcak%26aufirst%3DMeltem%26date%3D2011%26volume%3D38%26issue%3D2%26spage%3D171%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">João D. G.  Correia</span>, <span class="hlFld-ContribAuthor ">António  Paulo</span>, <span class="hlFld-ContribAuthor ">Paula D.  Raposinho</span>, <span class="hlFld-ContribAuthor ">Isabel  Santos</span>. </span><span class="cited-content_cbyCitation_article-title">Radiometallated peptides for molecular imaging and targeted therapy. </span><span class="cited-content_cbyCitation_journal-name">Dalton Transactions</span><span> <strong>2011,</strong> <em>40 </em>
                                    (23)
                                     , 6144. <a href="https://doi.org/10.1039/c0dt01599g" title="DOI URL">https://doi.org/10.1039/c0dt01599g</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c0dt01599g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc0dt01599g%26sid%3Dliteratum%253Aachs%26jtitle%3DDalton%2520Transactions%26atitle%3DRadiometallated%252Bpeptides%252Bfor%252Bmolecular%252Bimaging%252Band%252Btargeted%252Btherapy%26aulast%3DCorreia%26aufirst%3DJo%25C3%25A3o%2BD.%2BG.%26date%3D2011%26volume%3D40%26issue%3D23%26spage%3D6144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefan E.  Pool</span>, <span class="hlFld-ContribAuthor ">Eric P.  Krenning</span>, <span class="hlFld-ContribAuthor ">Gerben A.  Koning</span>, <span class="hlFld-ContribAuthor ">Casper H.J.  van Eijck</span>, <span class="hlFld-ContribAuthor ">Jaap J.M.  Teunissen</span>, <span class="hlFld-ContribAuthor ">Boen  Kam</span>, <span class="hlFld-ContribAuthor ">Roelf  Valkema</span>, <span class="hlFld-ContribAuthor ">Dik J.  Kwekkeboom</span>, <span class="hlFld-ContribAuthor ">Marion  de Jong</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical and Clinical Studies of Peptide Receptor Radionuclide Therapy. </span><span class="cited-content_cbyCitation_journal-name">Seminars in Nuclear Medicine</span><span> <strong>2010,</strong> <em>40 </em>
                                    (3)
                                     , 209-218. <a href="https://doi.org/10.1053/j.semnuclmed.2009.12.001" title="DOI URL">https://doi.org/10.1053/j.semnuclmed.2009.12.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1053/j.semnuclmed.2009.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1053%2Fj.semnuclmed.2009.12.001%26sid%3Dliteratum%253Aachs%26jtitle%3DSeminars%2520in%2520Nuclear%2520Medicine%26atitle%3DPreclinical%252Band%252BClinical%252BStudies%252Bof%252BPeptide%252BReceptor%252BRadionuclide%252BTherapy%26aulast%3DPool%26aufirst%3DStefan%2BE.%26date%3D2010%26volume%3D40%26issue%3D3%26spage%3D209%26epage%3D218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alvin A.  Holder</span>. </span><span class="cited-content_cbyCitation_article-title">Inorganic pharmaceuticals. </span><span class="cited-content_cbyCitation_journal-name">Annual Reports Section "A" (Inorganic Chemistry)</span><span> <strong>2010,</strong> <em>106 </em>, 504. <a href="https://doi.org/10.1039/b918408m" title="DOI URL">https://doi.org/10.1039/b918408m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/b918408m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fb918408m%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnual%2520Reports%2520Section%2520%2522A%2522%2520%2528Inorganic%2520Chemistry%2529%26atitle%3DInorganic%252Bpharmaceuticals%26aulast%3DHolder%26aufirst%3DAlvin%2BA.%26date%3D2010%26volume%3D106%26spage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900400w/production/images/medium/jm-2009-00400w_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900400w/production/images/large/jm-2009-00400w_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900400w&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900400w/production/images/medium/jm-2009-00400w_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900400w/production/images/large/jm-2009-00400w_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Structural Formulas of HYNIC-cyclo-MG1 and HYNIC-cyclo-MG2</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900400w/production/images/large/jm-2009-00400w_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900400w&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900400w/production/images/medium/jm-2009-00400w_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900400w/production/images/large/jm-2009-00400w_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Receptor binding of <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1 on AR42J cells: saturation curve showing total binding, nonspecific binding, and specific binding, with a calculated apparent <i>K</i><sub>d</sub> of 19.1 nM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900400w/production/images/large/jm-2009-00400w_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900400w&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900400w/production/images/medium/jm-2009-00400w_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900400w/production/images/large/jm-2009-00400w_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Time dependent cell-uptake in AR42J cells of the different <sup>99m</sup>Tc-HYNIC-peptides studied in comparison with <sup>99m</sup>Tc-EDDA-HYNIC-MG11.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900400w/production/images/large/jm-2009-00400w_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900400w&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900400w/production/images/medium/jm-2009-00400w_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900400w/production/images/large/jm-2009-00400w_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Biodistribution in AR42J tumor-bearing nude mice of <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1 in comparison with <sup>99m</sup>Tc-EDDA-HYNIC-MG11 at 1 and 4 h after injection. Values are expressed as % ID/g (mean ± SD, <i>n</i> = 3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900400w/production/images/large/jm-2009-00400w_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900400w&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900400w/production/images/medium/jm-2009-00400w_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900400w/production/images/large/jm-2009-00400w_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Fused SPECT/CT image of <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1 in AR42J tumor-bearing nude mouse 1 h after injection (coronal, sagittal, and transversal slices). Besides abdominal and renal activity, the tumor is clearly visualized (arrow).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900400w/production/images/large/jm-2009-00400w_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900400w&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900400w/production/images/medium/jm-2009-00400w_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900400w/production/images/large/jm-2009-00400w_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Intact radioligand and metabolites in urine, liver, and kidney in nude mice 1 h after injection of <sup>99m</sup>Tc-EDDA-HYNIC-cyclo-MG1 in comparison with <sup>99m</sup>Tc-EDDA-HYNIC-linear-MG1, showing a metabolite with the same <i>R</i><sub>t</sub> as found for <sup>99m</sup>Tc-EDDA-HYNIC-linear-MG1 (arrow).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-15/jm900400w/production/images/large/jm-2009-00400w_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm900400w&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i25">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52660" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52660" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 36 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Reubi, J. C.</span><span> </span><span class="NLM_article-title">Targeting CCK receptors in human cancers</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1239</span><span class="NLM_x">–</span> <span class="NLM_lpage">1242</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm900400w&amp;key=10.2174%2F156802607780960546" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm900400w&amp;key=17584145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm900400w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptFKgur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=1239-1242&author=J.+C.+Reubi&title=Targeting+CCK+receptors+in+human+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting CCK receptors in human cancers</span></div><div class="casAuthors">Reubi, Jean Claude</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1239-1242</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Gut hormone receptors can be over-expressed in several human cancers and represent the basis for receptor-targeted tumor imaging and therapy.  A promising receptor for such clin. applications is the cholecystokinin receptor.  Cholecystokinin receptors are expressed in numerous neuroendocrine tumors, in particular medullary thyroid carcinomas and neuroendocrine gut tumors, as well as in stromal tumors.  Moreover, several radiolabeled CCK or gastrin analogs have been developed allowing to detect these tumors and their metastases in patients using in vivo cholecystokinin receptor scintigraphy, proving the feasibility of targeting CCK receptors in human tumors in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriZ7QK7kytv7Vg90H21EOLACvtfcHk0ljPqzbMbl7JXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptFKgur8%253D&md5=50319bb1e7e37ce12996c6d3dc1c5c8f</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2174%2F156802607780960546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802607780960546%26sid%3Dliteratum%253Aachs%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26atitle%3DTargeting%2520CCK%2520receptors%2520in%2520human%2520cancers%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D1239%26epage%3D1242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Behr, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenner, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radetzky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Béhe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gratz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yücekent, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raue, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, W.</span><span> </span><span class="NLM_article-title">Targeting of cholecystokinin-B/gastrin receptors in vivo: preclinical and initial clinical evaluation of the diagnostic and therapeutic potential of radiolabelled gastrin</span> <span class="citation_source-journal">Eur. J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">424</span><span class="NLM_x">–</span> <span class="NLM_lpage">430</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm900400w&amp;key=10.1007%2Fs002590050241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm900400w&amp;key=9553173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm900400w&amp;key=1%3ACAS%3A528%3ADyaK1cXit1akt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1998&pages=424-430&author=T.+M.+Behrauthor=N.+Jennerauthor=S.+Radetzkyauthor=M.+B%C3%A9heauthor=S.+Gratzauthor=S.+Y%C3%BCcekentauthor=F.+Raueauthor=W.+Becker&title=Targeting+of+cholecystokinin-B%2Fgastrin+receptors+in+vivo%3A+preclinical+and+initial+clinical+evaluation+of+the+diagnostic+and+therapeutic+potential+of+radiolabelled+gastrin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting of cholecystokinin-B/gastrin receptors in vivo: preclinical and initial clinical evaluation of the diagnostic and therapeutic potential of radiolabeled gastrin</span></div><div class="casAuthors">Behr, Thomas M.; Jenner, Niels; Radetzky, Sven; Behe, Martin; Gratz, Stefan; Yucekent, Selcuk; Raue, Friedhelm; Becker, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">424-430</span>CODEN:
                <span class="NLM_cas:coden">EJNMD9</span>;
        ISSN:<span class="NLM_cas:issn">0340-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">The outstanding sensitivity of pentagastrin in detecting the presence of primary, recurrent or metastatic medullary thyroid cancer (MTC) suggests widespread expression of the corresponding receptor type in human MTC.  Indeed, recent autoradiog. studies have demonstrated the presence of cholecystokinin (CCK)-B (= gastrin) receptors not only in more than 90% of MTCs but also in a high percentage of small cell lung cancers, stromal ovarian cancers, astrocytomas and several other tumor types.  The aim of this study was to evaluate whether radiolabeled gastrin may be suitable for targeting CCK-B receptor-expressing tumors in vivo.  For this purpose, the biodistribution of the radioiodinated human heptadecapeptide gastrin-I was studied in nude mice bearing s.c. xenografts of the human MTC cell line, TT.  Initial therapy expts. were undertaken.  Finally, the biodistribution of [131I-Tyr12]gastrin-I was studied in a patient with metastatic MTC.  At a peptide amt. of approx. 1 μg, max. tumor uptake (8.9%ID/g) was obsd. in animals at 1 h postinjection, with tumor-to-blood ratios as high as 6.3.  Physiol. CCK-B receptors in the stomach, gallbladder and pancreas of the mice were targeted as well.  The major route of excretion was renal, but strong evidence for a biliary excretion pathway also exists.  Pilot therapy studies with 131I-labeled gastrin showed significant antitumor efficacy as compared with untreated controls.  In accordance with the preclin. data, good receptor targeting was obsd. in the tumor sites, stomach, gallbladder and pancreas of a patient with metastatic MTC.  These data suggest that gastrin and its analogs may represent a useful new class of receptor binding peptides for diagnosis and therapy of a variety of tumor types, including MTC and small cell lung cancer.  Future preclin. and clin. studies will address in more detail the mol. features that render CCK-B receptor binding agents potentially useful candidates for in vivo scintigraphy and radionuclide therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwu7Os_fWvNLVg90H21EOLACvtfcHk0ljPqzbMbl7JXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXit1akt70%253D&md5=cea8ff07c245045fb7948fd9f895bda3</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs002590050241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002590050241%26sid%3Dliteratum%253Aachs%26aulast%3DBehr%26aufirst%3DT.%2BM.%26aulast%3DJenner%26aufirst%3DN.%26aulast%3DRadetzky%26aufirst%3DS.%26aulast%3DB%25C3%25A9he%26aufirst%3DM.%26aulast%3DGratz%26aufirst%3DS.%26aulast%3DY%25C3%25BCcekent%26aufirst%3DS.%26aulast%3DRaue%26aufirst%3DF.%26aulast%3DBecker%26aufirst%3DW.%26atitle%3DTargeting%2520of%2520cholecystokinin-B%252Fgastrin%2520receptors%2520in%2520vivo%253A%2520preclinical%2520and%2520initial%2520clinical%2520evaluation%2520of%2520the%2520diagnostic%2520and%2520therapeutic%2520potential%2520of%2520radiolabelled%2520gastrin%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%26date%3D1998%26volume%3D25%26spage%3D424%26epage%3D430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Laverman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Béhé, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyen, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willems, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corstens, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behr, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boerman, O. C.</span><span> </span><span class="NLM_article-title">Two technetium-99m-labeled cholecystokinin-8 (CCK8) peptides for scintigraphic imaging of CCK receptors</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">568</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc034208w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm900400w&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivFemsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2004&pages=561-568&author=P.+Lavermanauthor=M.+B%C3%A9h%C3%A9author=W.+J.+Oyenauthor=P.+H.+Willemsauthor=F.+H.+Corstensauthor=T.+M.+Behrauthor=O.+C.+Boerman&title=Two+technetium-99m-labeled+cholecystokinin-8+%28CCK8%29+peptides+for+scintigraphic+imaging+of+CCK+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Two Technetium-99m-Labeled Cholecystokinin-8 (CCK8) Peptides for Scintigraphic Imaging of CCK Receptors</span></div><div class="casAuthors">Laverman, Peter; Behe, Martin; Oyen, Wim J. G.; Willems, Peter H. G. M.; Corstens, Frans H. M.; Behr, Thomas M.; Boerman, Otto C.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">561-568</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A broad spectrum of radiolabeled peptides with high affinity for receptors expressed on tumor cells is currently under preclin. and clin. investigation for scintigraphic imaging and radionuclide therapy.  The present paper evaluates two 99mTc-labeled forms of the C-terminal octapeptide of cholecystokinin (CCK8): sulfated (s)CCK8, with high affinity for CCK1 and CCK2 receptors, and nonsulfated (ns)CCK8, with high affinity for CCK2 receptors but low affinity for CCK1 receptors.  Peptides were conjugated with the bifunctional chelator N-hydroxysuccinimidyl hydrazino nicotinate (s-HYNIC). 99mTc-labeling, performed in the presence of nicotinic acid and tricine, was highly efficient (∼95%) and yielded products with a high specific activity (∼700 Ci/mmol) and good stability (∼5% release of radiolabel during 16 h incubation in phosphate buffered saline at 37 °C).  Chinese hamster ovary cells stably expressing the CCK1 receptor (CHO-CCK1 cells) internalized ∼3% of added 99mTc-sCCK8 per confluent well during 2 h at 37 °C.  Internalization was effectively blocked by excess unlabeled sCCK8.  CHO-CCK1 cells did not internalize 99mTc-nsCCK8.  Displacement of 99mTc-sCCK8 and -nsCCK8 by unlabeled CCK-8 (performed at 0 °C to prevent internalization) revealed 50% inhibitory concns. (IC50) of 8 nM and >1 μM, resp.  CHO-CCK2 cells internalized ∼25% and ∼5% of added 99mTc-sCCK8 and -nsCCK8, resp.  In both cases internalization was blocked by excess unlabeled peptide. IC50 values for the displacement of 99mTc-sCCK8 and -nsCCK8 were 3 nM and 10 nM, resp.  CHO-CCK1 cell-derived tumors present in one flank of athymic mice accumulated 2.0% of injected 99mTc-sCCK8 per g tissue at 1 h postinjection.  This value decreased to 0.6% following coinjection with excess unlabeled peptide.  Uptake of 99mTc-nsCCK8 was low (0.2%) and not did change by excess unlabeled peptide (0.3%).  Accumulation of 99mTc-sCCK8 and -nsCCK8 by CHO-CCK2 cell-derived tumors (present in the other flank) amounted to 4.2% and 0.6%, resp.  In both cases uptake was significantly reduced by excess unlabeled peptide to 1.0% and 0.4% for sCCK8 and nsCCK8, resp.  Accumulation of 99mTc-sCCK8 was also high in pancreas (11.7%), stomach (2.0%), and kidney (2.1%), whereas uptake of 99mTc-nsCCK8 was high in stomach (0.7%) and kidney (1.4%).  Both radiolabeled peptides showed a rapid blood clearance.  In conclusion, these data show that CCK8 analogs can be efficiently labeled with 99mTc using s-HYNIC as chelator and nicotinic acid/tricine as coligand system without compromising receptor binding.  Furthermore, the present study demonstrates that CCK1 tumors hardly accumulate 99mTc-nsCCK8, CCK2 tumors accumulate 2 times more 99mTc-sCCK8 than CCK1 tumors, and CCK2 tumors accumulate 15 times more 99mTc-sCCK8 than 99mTc-nsCCK8.  Although accumulation in some nontarget organs was also higher with 99mTc-sCCK8, this may not reflect the human situation due to a different receptor expression pattern in humans as compared to mice.  Therefore, further studies are warranted to investigate the possible use of 99mTc-sCCK8 for scintigraphic imaging of CCK receptor-pos. tumors in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0F0dJJhzd5rVg90H21EOLACvtfcHk0lgP3V174E8iww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivFemsLY%253D&md5=204aaab821d5525737845431cb51f362</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fbc034208w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc034208w%26sid%3Dliteratum%253Aachs%26aulast%3DLaverman%26aufirst%3DP.%26aulast%3DB%25C3%25A9h%25C3%25A9%26aufirst%3DM.%26aulast%3DOyen%26aufirst%3DW.%2BJ.%26aulast%3DWillems%26aufirst%3DP.%2BH.%26aulast%3DCorstens%26aufirst%3DF.%2BH.%26aulast%3DBehr%26aufirst%3DT.%2BM.%26aulast%3DBoerman%26aufirst%3DO.%2BC.%26atitle%3DTwo%2520technetium-99m-labeled%2520cholecystokinin-8%2520%2528CCK8%2529%2520peptides%2520for%2520scintigraphic%2520imaging%2520of%2520CCK%2520receptors%26jtitle%3DBioconjugate%2520Chem.%26date%3D2004%26volume%3D15%26spage%3D561%26epage%3D568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Aloj, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caracò, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panico, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zannetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Vecchio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tesauro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Luca, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedone, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morelli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvatore, M.</span><span> </span><span class="NLM_article-title">In vitro and in vivo evaluation of <sup>111</sup>In-DTPAGlu-G-CCK8 for cholecystokinin-B receptor imaging</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">485</span><span class="NLM_x">–</span> <span class="NLM_lpage">494</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm900400w&amp;key=15001692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm900400w&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivVCju7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2004&pages=485-494&author=L.+Alojauthor=C.+Carac%C3%B2author=M.+Panicoauthor=A.+Zannettiauthor=S.+Del+Vecchioauthor=D.+Tesauroauthor=S.+De+Lucaauthor=C.+Arraauthor=C.+Pedoneauthor=G.+Morelliauthor=M.+Salvatore&title=In+vitro+and+in+vivo+evaluation+of+111In-DTPAGlu-G-CCK8+for+cholecystokinin-B+receptor+imaging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo evaluation of 111In-DTPAGlu-G-CCK8 for cholecystokinin-B receptor imaging</span></div><div class="casAuthors">Aloj, Luigi; Caraco, Corradina; Panico, Mariarosaria; Zannetti, Antonella; del Vecchio, Silvana; Tesauro, Diego; de Luca, Stefania; Arra, Claudio; Pedone, Carlo; Morelli, Giancarlo; Salvatore, Marco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">485-494</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine</span>)
        </div><div class="casAbstract">Regulatory peptides and their analogs are being extensively investigated as radiopharmaceuticals for cancer imaging and therapy.  Receptors of the cholecystokinin family have been shown to be overexpressed in different types of neuroendocrine tumors.  The purposes of this study were to evaluate the cholecystokinin octapeptide amide (CCK8) peptide tagged with a diethylenetriaminepentaacetic acid deriv. (DTPAGlu) and to test whether a 111In-labeled conjugate (111In-DTPAGlu-G-CCK8, a deriv. contg. the chelating agent DTPAGlu bound through a glycine linker at the N-terminal end of the bioactive peptide CCK8) is suitable for cholecystokinin-B receptor (CCKBR) imaging.  Methods: CCK8 was synthesized by solid-phase techniques and covalently coupled to DTPAGlu through a glycine linker at its amino terminus.  The compd. was labeled with 111In.  The radiochem. purity and stability of the compd. were assessed by chromatog. methods.  NIH-3T3 and A431 cells overexpressing CCKBR were used to characterize the in vitro properties of the compd.  Nude mice bearing control and CCKBR-overexpressing A431 xenografts were used as an in vivo model.  Results: DTPAGlu-G-CCK8 showed rapid and efficient labeling with 111In.  The radiolabeled conjugate showed specific binding to both cell lines overexpressing CCKBR.  Binding was saturable, with a dissocn. const. of ∼20 nmol/L in both cell systems.  Both cell lines showed internalization of the ligand after interaction with the receptor.  Biodistribution studies showed rapid localization of 111In-DTPAGluG-CCK8 on CCKBR-overexpressing A431 xenografts that was several-fold higher than that on control tumors at all time points tested.  Unbound activity showed rapid clearance of over 80% through the kidneys by 30 min after injection.  The labeled peptide conjugate was very stable in serum but showed a rapid breakdown after injection.  Incubation with kidney homogenates suggested that most breakdown occurred in the kidneys, favoring the clearance of unbound activity.  Conclusion: Our findings indicate that the in vitro and in vivo characteristics of 111In-DTPAGlu-G-CCK8 are favorable for CCKBR imaging, as the peptide shows high-affinity binding to the receptor, is internalized in CCKBR-expressing cells, and shows avid uptake in CCKBR-overexpressing xenografts, with rapid clearance of unbound radioactivity through the kidneys.  Furthermore, the ease of synthesis, high labeling efficiency, and chem. stability of DTPAGlu make this chelating moiety an ideal candidate for widespread use in peptide radiolabeling for nuclear medicine applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr4AeumsT_kLVg90H21EOLACvtfcHk0lgP3V174E8iww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivVCju7g%253D&md5=09bf289f7c3f073993d0943b63fdf4db</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAloj%26aufirst%3DL.%26aulast%3DCarac%25C3%25B2%26aufirst%3DC.%26aulast%3DPanico%26aufirst%3DM.%26aulast%3DZannetti%26aufirst%3DA.%26aulast%3DDel%2BVecchio%26aufirst%3DS.%26aulast%3DTesauro%26aufirst%3DD.%26aulast%3DDe%2BLuca%26aufirst%3DS.%26aulast%3DArra%26aufirst%3DC.%26aulast%3DPedone%26aufirst%3DC.%26aulast%3DMorelli%26aufirst%3DG.%26aulast%3DSalvatore%26aufirst%3DM.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520evaluation%2520of%2520111In-DTPAGlu-G-CCK8%2520for%2520cholecystokinin-B%2520receptor%2520imaging%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2004%26volume%3D45%26spage%3D485%26epage%3D494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Agostani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolzati, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Didonè, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavazza-Ceccato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Refosco, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aloj, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arra, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aurilio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tornesello, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tesauro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morelli, G.</span><span> </span><span class="NLM_article-title">The [Tc(N)(PNP)]2+ metal fragment labeled cholecystokinin-8 (CCK8) peptide for CCK-2 receptors imaging: in vitro and in vivo studies</span> <span class="citation_source-journal">J. Pept. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">219</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm900400w&amp;key=10.1002%2Fpsc.834" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm900400w&amp;key=17269133" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=211-219&author=S.+Agostaniauthor=C.+Bolzatiauthor=E.+Didon%C3%A8author=M.+Cavazza-Ceccatoauthor=F.+Refoscoauthor=L.+Alojauthor=C.+Arraauthor=M.+Aurilioauthor=A.+L.+Torneselloauthor=D.+Tesauroauthor=G.+Morelli&title=The+%5BTc%28N%29%28PNP%29%5D2%2B+metal+fragment+labeled+cholecystokinin-8+%28CCK8%29+peptide+for+CCK-2+receptors+imaging%3A+in+vitro+and+in+vivo+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fpsc.834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpsc.834%26sid%3Dliteratum%253Aachs%26aulast%3DAgostani%26aufirst%3DS.%26aulast%3DBolzati%26aufirst%3DC.%26aulast%3DDidon%25C3%25A8%26aufirst%3DE.%26aulast%3DCavazza-Ceccato%26aufirst%3DM.%26aulast%3DRefosco%26aufirst%3DF.%26aulast%3DAloj%26aufirst%3DL.%26aulast%3DArra%26aufirst%3DC.%26aulast%3DAurilio%26aufirst%3DM.%26aulast%3DTornesello%26aufirst%3DA.%2BL.%26aulast%3DTesauro%26aufirst%3DD.%26aulast%3DMorelli%26aufirst%3DG.%26atitle%3DThe%2520%255BTc%2528N%2529%2528PNP%2529%255D2%252B%2520metal%2520fragment%2520labeled%2520cholecystokinin-8%2520%2528CCK8%2529%2520peptide%2520for%2520CCK-2%2520receptors%2520imaging%253A%2520in%2520vitro%2520and%2520in%2520vivo%2520studies%26jtitle%3DJ.%2520Pept.%2520Sci.%26date%3D2007%26volume%3D13%26spage%3D211%26epage%3D219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Gotthardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Béhé, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beuter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Battmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauhofer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schurrat, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schipper, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollum, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyen, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behr, T.M..</span><span> </span><span class="NLM_article-title">Improved tumour detection by gastrin receptor scintigraphy in patients with metastasised medullary thyroid carcinoma</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">1273</span><span class="NLM_x">–</span> <span class="NLM_lpage">1279</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm900400w&amp;key=10.1007%2Fs00259-006-0157-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm900400w&amp;key=16832634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm900400w&amp;key=1%3ACAS%3A280%3ADC%252BD28nis1eqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2006&pages=1273-1279&author=M.+Gotthardtauthor=M.+P.+B%C3%A9h%C3%A9author=D.+Beuterauthor=A.+Battmannauthor=A.+Bauhoferauthor=T.+Schurratauthor=M.+Schipperauthor=H.+Pollumauthor=W.+J.+Oyenauthor=T.M..+Behr&title=Improved+tumour+detection+by+gastrin+receptor+scintigraphy+in+patients+with+metastasised+medullary+thyroid+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Improved tumour detection by gastrin receptor scintigraphy in patients with metastasised medullary thyroid carcinoma</span></div><div class="casAuthors">Gotthardt Martin; Behe Martin P; Beuter Daniela; Battmann Anke; Bauhofer Artur; Schurrat Tino; Schipper Meike; Pollum Halina; Oyen Wim J G; Behr Thomas M</div><div class="citationInfo"><span class="NLM_cas:title">European journal of nuclear medicine and molecular imaging</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1273-9</span>
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    </div><div class="casAbstract">PURPOSE:  Radiopeptide imaging is a valuable imaging method in the management of patients with neuroendocrine tumours (NET).  To determine the clinical performance of gastrin receptor scintigraphy (GRS), it was compared with somatostatin receptor scintigraphy (SRS), computed tomography (CT) and (18)F-FDG positron emission tomography (PET) in patients with metastasised/recurrent medullary thyroid carcinoma (MTC).  METHODS:  Twenty-seven consecutive patients underwent imaging with GRS, SRS (19 patients), CT and PET (26 patients).  GRS and SRS were compared with respect to tumour detection and uptake.  CT, PET, magnetic resonance imaging (MRI), ultrasound (US) and follow-up were used for verification of findings.  In addition, GRS, CT and PET were directly compared with each other to determine which method performs best.  RESULTS:  Nineteen patients underwent both GRS and SRS.  Among these, GRS showed a tumour detection rate of 94.2% as compared to 40.7% for SRS [mean number of tumour sites (+/-SD) and 95% confidence intervals (CI): GRS 4.3+/-3.1/2.8-5.7, SRS 1.8+/-1.6/1.1-2.6].  In 26 patients, GRS, CT and PET were compared.  Here, GRS showed a tumour detection rate of 87.3% (CT 76.1%, PET 67.2%; mean number of tumour sites and 95% CI: GRS 4.5+/-4.0/2.9-6.1, CT 3.9+/-3.5/2.5-5.3, PET 3.5+/-3.3/2.1-4.8).  If GRS and CT were combined, they were able to detect 96.7% of areas of tumour involvement.  CONCLUSION:  GRS had a higher tumour detection rate than SRS and PET in our study.  GRS in combination with CT was most effective in the detection of metastatic MTC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTae7aIuo6FeVf1XRtfYM0dfW6udTcc2eZzf1o1oWXF3rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28nis1eqtw%253D%253D&md5=b52d7fcc0ceeeef87beb3c24225bf156</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2Fs00259-006-0157-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-006-0157-8%26sid%3Dliteratum%253Aachs%26aulast%3DGotthardt%26aufirst%3DM.%26aulast%3DB%25C3%25A9h%25C3%25A9%26aufirst%3DM.%2BP.%26aulast%3DBeuter%26aufirst%3DD.%26aulast%3DBattmann%26aufirst%3DA.%26aulast%3DBauhofer%26aufirst%3DA.%26aulast%3DSchurrat%26aufirst%3DT.%26aulast%3DSchipper%26aufirst%3DM.%26aulast%3DPollum%26aufirst%3DH.%26aulast%3DOyen%26aufirst%3DW.%2BJ.%26aulast%3DBehr%26aufirst%3DT.M..%26atitle%3DImproved%2520tumour%2520detection%2520by%2520gastrin%2520receptor%2520scintigraphy%2520in%2520patients%2520with%2520metastasised%2520medullary%2520thyroid%2520carcinoma%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2006%26volume%3D33%26spage%3D1273%26epage%3D1279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Gotthardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Béhé, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grass, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauhofer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rinke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schipper, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalinowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyen, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behr, T. M.</span><span> </span><span class="NLM_article-title">Added value of gastrin receptor scintigraphy in comparison to somatostatin receptor scintigraphy in patients with carcinoids and other neuroendocrine tumours</span> <span class="citation_source-journal">Endocr.-Relat. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1203</span><span class="NLM_x">–</span> <span class="NLM_lpage">1211</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=1203-1211&author=M.+Gotthardtauthor=M.+P.+B%C3%A9h%C3%A9author=J.+Grassauthor=A.+Bauhoferauthor=A.+Rinkeauthor=M.+L.+Schipperauthor=M.+Kalinowskiauthor=R.+Arnoldauthor=W.+J.+Oyenauthor=T.+M.+Behr&title=Added+value+of+gastrin+receptor+scintigraphy+in+comparison+to+somatostatin+receptor+scintigraphy+in+patients+with+carcinoids+and+other+neuroendocrine+tumours"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGotthardt%26aufirst%3DM.%26aulast%3DB%25C3%25A9h%25C3%25A9%26aufirst%3DM.%2BP.%26aulast%3DGrass%26aufirst%3DJ.%26aulast%3DBauhofer%26aufirst%3DA.%26aulast%3DRinke%26aufirst%3DA.%26aulast%3DSchipper%26aufirst%3DM.%2BL.%26aulast%3DKalinowski%26aufirst%3DM.%26aulast%3DArnold%26aufirst%3DR.%26aulast%3DOyen%26aufirst%3DW.%2BJ.%26aulast%3DBehr%26aufirst%3DT.%2BM.%26atitle%3DAdded%2520value%2520of%2520gastrin%2520receptor%2520scintigraphy%2520in%2520comparison%2520to%2520somatostatin%2520receptor%2520scintigraphy%2520in%2520patients%2520with%2520carcinoids%2520and%2520other%2520neuroendocrine%2520tumours%26jtitle%3DEndocr.-Relat.%2520Cancer%26date%3D2006%26volume%3D13%26spage%3D1203%26epage%3D1211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Laverman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roosenburg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotthardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyen, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellmich, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutjes, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Delft, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boerman, O. C.</span><span> </span><span class="NLM_article-title">Targeting of a CCK<sub>2</sub> receptor splice variant with <sup>111</sup>In-labelled cholecystokinin-8 (CCK8) and <sup>111</sup>In-labelled minigastrin</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">386</span><span class="NLM_x">–</span> <span class="NLM_lpage">392</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm900400w&amp;key=10.1007%2Fs00259-007-0604-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm900400w&amp;key=17934729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm900400w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXosVeitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2008&pages=386-392&author=P.+Lavermanauthor=S.+Roosenburgauthor=M.+Gotthardtauthor=J.+Parkauthor=W.+J.+Oyenauthor=M.+de+Jongauthor=M.+R.+Hellmichauthor=F.+P.+Rutjesauthor=F.+L.+van+Delftauthor=O.+C.+Boerman&title=Targeting+of+a+CCK2+receptor+splice+variant+with+111In-labelled+cholecystokinin-8+%28CCK8%29+and+111In-labelled+minigastrin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting of a CCK2 receptor splice variant with 111In-labelled cholecystokinin-8 (CCK8) and 111In-labelled minigastrin</span></div><div class="casAuthors">Laverman, Peter; Roosenburg, Susan; Gotthardt, Martin; Park, Jeseong; Oyen, Wim J. G.; de Jong, Marion; Hellmich, Mark R.; Rutjes, Floris P. J. T.; Delft, Floris L.; Boerman, Otto C.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">386-392</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Radiolabeled cholecystokinin (CCK) and gastrin-derived peptides potentially can be used for peptide receptor radionuclide therapy (PRRT).  Recently, a splice variant version of the CCK2R has been identified, designated CCK2i4svR.  Constitutive expression of this receptor has been demonstrated in human colorectal cancer and in pancreatic cancer, but not in normal tissue.  So far, it has never been shown whether radiolabeled peptides can target the CCK2i4svR in vivo.  In this paper, we investigated the potential of sulfated 111In-labeled DOTA-CCK8 (sCCK8), a pan-CCKR-binding peptide, and [111In]DOTA-minigastrin (MG0), a CCK2R selective peptide, for the targeting of the CCK2i4svR.  The receptor binding affinity of [111In]DOTA-sCCK8 and [111In]DOTA-MG0 for the CCK2R and CCK2i4svR was detd. using stably transfected HEK293 cell lines, expressing either CCK2R or CCK2i4svR.  Tumor targeting was studied in HEK293-CCK2i4svR tumor-bearing athymic mice.  [111In]DOTA-sCCK8 as well as [111In]DOTA-MG0 specifically bound both CCK2R and CCK2i4svR with affinities in the low nanomolar range.  In vivo expts. revealed that accumulation of both peptides in CCK2i4svR-pos. tumors was similar (3.21 ± 0.77 and 3.01 ± 0.67%ID/g, sCCK8 and MG0, resp., 24 h p.i.).  Kidney retention of [111In]DOTA-MG0 (32.4 ± 7.5%ID/g, 24 h p.i.) was markedly higher than that of [111In]DOTA-sCCK8 (2.75 ± 0.31%ID/g, 24 h p.i.).  We demonstrated that the CCK2i4svR is a potential target for PRRT using a radiolabeled sulfated CCK8 peptide.  As this receptor is expressed on colorectal and pancreatic tumors, but not in normal tissue, these tumors are potentially new targets for PRRT with CCK8 and gastrin analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDnoTLeE1a5LVg90H21EOLACvtfcHk0liFJAi8vNAR7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXosVeitw%253D%253D&md5=22e30a8b38b76708bb32247322513c24</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2Fs00259-007-0604-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-007-0604-1%26sid%3Dliteratum%253Aachs%26aulast%3DLaverman%26aufirst%3DP.%26aulast%3DRoosenburg%26aufirst%3DS.%26aulast%3DGotthardt%26aufirst%3DM.%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DOyen%26aufirst%3DW.%2BJ.%26aulast%3Dde%2BJong%26aufirst%3DM.%26aulast%3DHellmich%26aufirst%3DM.%2BR.%26aulast%3DRutjes%26aufirst%3DF.%2BP.%26aulast%3Dvan%2BDelft%26aufirst%3DF.%2BL.%26aulast%3DBoerman%26aufirst%3DO.%2BC.%26atitle%3DTargeting%2520of%2520a%2520CCK2%2520receptor%2520splice%2520variant%2520with%2520111In-labelled%2520cholecystokinin-8%2520%2528CCK8%2529%2520and%2520111In-labelled%2520minigastrin%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2008%26volume%3D35%26spage%3D386%26epage%3D392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Béhé, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotthardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angerstein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behr, T. M.</span><span> </span><span class="NLM_article-title">Improved kinetic stability of DTPA-dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivatives</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1140</span><span class="NLM_x">–</span> <span class="NLM_lpage">1146</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm900400w&amp;key=10.1007%2Fs00259-003-1178-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm900400w&amp;key=12768330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm900400w&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlslGrt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2003&pages=1140-1146&author=M.+B%C3%A9h%C3%A9author=W.+Beckerauthor=M.+Gotthardtauthor=C.+Angersteinauthor=T.+M.+Behr&title=Improved+kinetic+stability+of+DTPA-dGlu+as+compared+with+conventional+monofunctional+DTPA+in+chelating+indium+and+yttrium%3A+preclinical+and+initial+clinical+evaluation+of+radiometal+labelled+minigastrin+derivatives"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Improved kinetic stability of DTPA-dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivatives</span></div><div class="casAuthors">Behe, Martin; Becker, Wolfgang; Gotthardt, Martin; Angerstein, Christa; Behr, Thomas M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1140-1146</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">The development of monofunctional DTPA derivs. has been a major breakthrough in the labeling of proteins or peptides with a variety of radiometals.  Although this methodol. is simple and useful for indium-111 labeling, the stability of these conjugates is too low for most therapeutic nuclides.  Cyclic chelators, such as DOTA, have shown excellent kinetic stability with a variety of radiometals, but the labeling procedure is more difficult, requiring ultra-pure reagents and a heating step that sometimes endangers the biomol.'s integrity.  The aim of this work was twofold: (a) to develop a novel, open chain chelator which can be easily labeled with various radiometals, displaying higher kinetic stability than monofunctional DTPA, and (b) to evaluate this chelator in vitro and in vivo when conjugated to a CCK-B receptor ligand as a detection modality for receptor-(over-)expressing tumors.  DTPA derivs. of Leu1- and dGlu1-minigastrin were synthesized.  All conjugates could be labeled with 111In or 88/90Y at high specific activities (8.5-44.4 GBq/μmol) and with high radiochem. purity.  Serum stability testing was performed, and the labeled conjugates were compared concerning their stability against DTPA challenge.  The biodistribution of the radiolabeled Leu1- and dGlu1-minigastrin derivs. was studied in tumor-bearing nude mice, in one healthy human volunteer and in three patients with metastatic medullary thyroid carcinoma.  The transchelation of all tested radiometals to serum proteins was significantly slower with the DTPA-Glu conjugates as compared with their Leu analogs (e.g. transchelationt1/2 of DTPA-dGlu1-minigastrin vs its Leu1 analog at 37°C in human serum for 111In: 239 h vs 91 h; for 90Y: 130 h vs 53 h).  In animals, all labeled CCK-B receptor ligands showed fast and specific uptake in CCK-B-receptor-pos. tissues, such as the stomach and tumor, as well as a fast renal clearance pattern.  However, DTPA-Leu1-minigastrin showed higher background activity in the whole body and those organs known to accumulate the resp. free radiometal (e.g. 88Y-DTPA-Leu1-minigastrin had bone uptake of 22%ID/g as compared to only 1.2%ID/g with its dGlu1 analog).  In humans, fast tumor and stomach uptake was obsd. for both 111In-labeled compds., but DTPA-dGlu1-minigastrin lacked the liver, spleen and bone marrow uptake obsd. with its Leu1 analog.  In conclusion, anionic amino acid derivs. of DTPA may display improved metabolic stability as compared with monofunctional DTPA conjugates.  DTPA-dGlu1-minigastrin is preferred to "monofunctional" DTPA-Leu1-minigastrin for diagnostic application with 111In for the in vivo detection of CCK-B receptor-expressing tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGbx9i1AEh_rVg90H21EOLACvtfcHk0lhdPhEy6v_kkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlslGrt7o%253D&md5=06dd9a8e73fe6a98ab5e27067d1ff2e3</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2Fs00259-003-1178-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-003-1178-1%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25A9h%25C3%25A9%26aufirst%3DM.%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DGotthardt%26aufirst%3DM.%26aulast%3DAngerstein%26aufirst%3DC.%26aulast%3DBehr%26aufirst%3DT.%2BM.%26atitle%3DImproved%2520kinetic%2520stability%2520of%2520DTPA-dGlu%2520as%2520compared%2520with%2520conventional%2520monofunctional%2520DTPA%2520in%2520chelating%2520indium%2520and%2520yttrium%253A%2520preclinical%2520and%2520initial%2520clinical%2520evaluation%2520of%2520radiometal%2520labelled%2520minigastrin%2520derivatives%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2003%26volume%3D30%26spage%3D1140%26epage%3D1146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">von Guggenberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behr, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saurer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seppi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decristoforo, C.</span><span> </span><span class="NLM_article-title"><sup>99m</sup>Tc-labelling and in vitro and in vivo evaluation of HYNIC- and (<i>N</i><sub>α</sub>-His)acetic acid-modified [<span class="smallcaps smallerCapital">d</span>-Glu1]-minigastrin</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">864</span><span class="NLM_x">–</span> <span class="NLM_lpage">871</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc0300807" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm900400w&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlt1yht7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2004&pages=864-871&author=E.+von+Guggenbergauthor=M.+Beheauthor=T.+M.+Behrauthor=M.+Saurerauthor=T.+Seppiauthor=C.+Decristoforo&title=99mTc-labelling+and+in+vitro+and+in+vivo+evaluation+of+HYNIC-+and+%28N%CE%B1-His%29acetic+acid-modified+%5Bd-Glu1%5D-minigastrin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">99mTc-Labeling and in Vitro and in Vivo Evaluation of HYNIC- and (Nα-His)Acetic Acid-Modified [D-Glu1]-Minigastrin</span></div><div class="casAuthors">Von Guggenberg, E.; Behe, M.; Behr, T. M.; Saurer, M.; Seppi, T.; Decristoforo, C.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">864-871</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Gastrin/CCK-2 receptors are overexpressed in a no. of tumors such as medullary thyroid cancer (MTC) and small cell lung cancer (SCLC).  Recently [D-Glu1]-minigastrin (MG) has been radiolabeled with 131I, 111In, and 90Y and evaluated in patients.  This study describes the labeling and evaluation of MG with technetium-99m using two different labeling approaches: HYNIC as bifunctional coupling agent and (Nα-His)Ac as tridentate ligand for 99mTc(CO3) labeling.  Labeling was performed at high specific activities using Tricine and EDDA as coligands for HYNIC-MG and [99mTc(OH2)3(CO)3]+ for (Nα-His)Ac-MG.  Stability expts. were carried out by reversed phase HPLC anal. in PBS, serum, histidine, and cysteine solns., as well as rat liver and kidney homogenates.  Receptor binding and internalization expts. were performed using CCK-2 receptor pos. AR42J rat pancreatic tumor cells.  Biodistribution expts. were carried out in nude mice carrying AR42J tumors by injection of 99mTc-labeled peptide with or without coinjection of 50 μg of minigastrin I human (MGh).  HYNIC-MG and (Nα-His)Ac-MG could be radiolabeled at high specific activities (>1 Ci/μmol).  For HYNIC-MG, high labeling yields (>95%) were achieved using Tricine and EDDA as coligands.  Stability expts. of all 99mTc-labeled conjugates revealed a high stability of the label in PBS and serum as well as toward challenge with histidine and cysteine.  Incubation in kidney homogenates resulted in a rapid degrdn. of all conjugates with <10% intact peptide after 60 min at 37 °C, with no considerable differences between the radiolabeled conjugates; a somewhat lower degrdn. rate was seen in liver homogenates.  Protein binding varied considerably with lowest levels for 99mTc-EDDA/HYNIC-MG.  Competition expts. of unlabeled conjugates on AR42J membranes vs. [125I-Tyr12]-gastrin I showed high CCK-2 receptor affinity for all conjugates under study.  Internalization behavior was very rapid for all radiolabeled conjugates in the order of 99mTc-(Nα-His)Ac-MG > 99mTc-EDDA/HYNIC-MG > 99mTc-Tricine/HYNIC-MG.  In tumor-bearing nude mice the highest tumor-uptake was obsd. with 99mTc-EDDA/HYNIC-MG (8.1%ID/g) followed by 99mTc-Tricine/HYNIC-MG (2.2%ID/g) and 99mTc-(Nα-His)Ac-MG (1.2%ID/g) which correlated with kidney uptake (101.0%ID/g, 53.8%ID/g, 1.8%ID/g resp.).  In this series of compds. 99mTc-EDDA/HYNIC-MG with its very high tumor/organ ratios except for kidneys seems to be the most promising agent to target CCK-2 receptors.  Despite promising properties concerning receptor binding, internalization, and in vitro stability, 99mTc-(Nα-His)Ac-MG showed low tumor uptake in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra9vjVOxJBO7Vg90H21EOLACvtfcHk0lhdPhEy6v_kkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlt1yht7k%253D&md5=f9999e3db7f499385adce8ef1d934521</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fbc0300807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc0300807%26sid%3Dliteratum%253Aachs%26aulast%3Dvon%2BGuggenberg%26aufirst%3DE.%26aulast%3DBehe%26aufirst%3DM.%26aulast%3DBehr%26aufirst%3DT.%2BM.%26aulast%3DSaurer%26aufirst%3DM.%26aulast%3DSeppi%26aufirst%3DT.%26aulast%3DDecristoforo%26aufirst%3DC.%26atitle%3D99mTc-labelling%2520and%2520in%2520vitro%2520and%2520in%2520vivo%2520evaluation%2520of%2520HYNIC-%2520and%2520%2528N%25CE%25B1-His%2529acetic%2520acid-modified%2520%255Bd-Glu1%255D-minigastrin%26jtitle%3DBioconjugate%2520Chem.%26date%3D2004%26volume%3D15%26spage%3D864%26epage%3D871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">von Guggenberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietrich, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skvortsova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Virgolini, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decristoforo, C.</span><span> </span><span class="NLM_article-title"><sup>99m</sup>Tc-labelled HYNIC-minigastrin with reduced kidney uptake for targeting of CCK-2 receptor-positive tumours</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1209</span><span class="NLM_x">–</span> <span class="NLM_lpage">1218</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm900400w&amp;key=10.1007%2Fs00259-006-0348-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm900400w&amp;key=17308920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm900400w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsFaku7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2007&pages=1209-1218&author=E.+von+Guggenbergauthor=H.+Dietrichauthor=I.+Skvortsovaauthor=M.+Gabrielauthor=I.+J.+Virgoliniauthor=C.+Decristoforo&title=99mTc-labelled+HYNIC-minigastrin+with+reduced+kidney+uptake+for+targeting+of+CCK-2+receptor-positive+tumours"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">99mTc-labelled HYNIC-minigastrin with reduced kidney uptake for targeting of CCK-2 receptor-positive tumors</span></div><div class="casAuthors">von Guggenberg, E.; Dietrich, H.; Skvortsova, I.; Gabriel, M.; Virgolini, I. J.; Decristoforo, C.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1209-1218</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Different attempts have been made to develop a suitable radioligand for targeting CCK-2 receptors in vivo, for staging of medullary thyroid carcinoma (MTC) and other receptor-expressing tumors.  After initial successful clin. studies with [DTPA0,DGlu1]minigastrin (DTPA-MG0) radiolabeled with 111In and 90Y, our group developed a 99mTc-labeled radioligand, based on HYNIC-MG0.  A major drawback obsd. with these derivs. is their high uptake by the kidneys.  In this study we describe the preclin. evaluation of the optimized shortened peptide analog, [HYNIC0,DGlu1,desGlu2-6]minigastrin (HYNIC-MG11).  Methods: 99mTc labeling of HYNIC-MG11 was performed using tricine and EDDA as coligands.  Stability expts. were carried out by reversed phase HPLC anal. in PBS, PBS/cysteine and plasma as well as rat liver and kidney homogenates.  Receptor binding and cell uptake expts. were performed using AR4-2J rat pancreatic tumor cells.  Animal biodistribution was studied in AR4-2J tumor-bearing nude mice.  Results: Radiolabelling was performed at high specific activities and radiochem. purity was >90%.  99mTc-EDDA-HYNIC-MG11 showed high affinity for the CCK-2 receptor and cell internalization comparable to that of 99mTc-EDDA-HYNIC-MG0.  Despite high stability in soln., a low metabolic stability in rat tissue homogenates was found.  In a nude mouse tumor model, very low unspecific retention in most organs, rapid renal excretion with reduced renal retention and high tumor uptake were obsd.  Conclusion: 99mTc-EDDA-HYNIC-MG11 shows advantages over 99mTc-EDDA-HYNIC-MG0 in terms of lower kidney retention with unchanged uptake in tumors and CCK-2 receptor-pos. tissue.  However, the lower metabolic stability and impurities formed in the labeling process still leave room for further improvement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNIpTMls4blLVg90H21EOLACvtfcHk0lhdPhEy6v_kkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsFaku7k%253D&md5=b66c2b74d13fcb180af9eb5db73212d6</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs00259-006-0348-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-006-0348-3%26sid%3Dliteratum%253Aachs%26aulast%3Dvon%2BGuggenberg%26aufirst%3DE.%26aulast%3DDietrich%26aufirst%3DH.%26aulast%3DSkvortsova%26aufirst%3DI.%26aulast%3DGabriel%26aufirst%3DM.%26aulast%3DVirgolini%26aufirst%3DI.%2BJ.%26aulast%3DDecristoforo%26aufirst%3DC.%26atitle%3D99mTc-labelled%2520HYNIC-minigastrin%2520with%2520reduced%2520kidney%2520uptake%2520for%2520targeting%2520of%2520CCK-2%2520receptor-positive%2520tumours%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2007%26volume%3D34%26spage%3D1209%26epage%3D1218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Nock, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maina, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Béhé, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolopoulou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotthardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behr, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mäcke, H. R.</span><span> </span><span class="NLM_article-title">CCK-2/gastrin receptor-targeted tumor imaging with <sup>99m</sup>Tc-labeled minigastrin analogs</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1727</span><span class="NLM_x">–</span> <span class="NLM_lpage">1736</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm900400w&amp;key=16204724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm900400w&amp;key=1%3ACAS%3A528%3ADC%252BD28XitVGlt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=1727-1736&author=B.+A.+Nockauthor=T.+Mainaauthor=M.+B%C3%A9h%C3%A9author=A.+Nikolopoulouauthor=M.+Gotthardtauthor=J.+S.+Schmittauthor=T.+M.+Behrauthor=H.+R.+M%C3%A4cke&title=CCK-2%2Fgastrin+receptor-targeted+tumor+imaging+with+99mTc-labeled+minigastrin+analogs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">CCK-2/gastrin receptor-targeted tumor imaging with 99mTc-labeled minigastrin analogs</span></div><div class="casAuthors">Nock, Berthold A.; Maina, Theodosia; Behe, Martin; Nikolopoulou, Anastasia; Gotthardt, Martin; Schmitt, Jorg S.; Behr, Thomas M.; Macke, Helmut R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1727-1736</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine</span>)
        </div><div class="casAbstract">The aim of this study was to evaluate 3 new 99mTc-labeled minigastrin analogs modified with open chain tetraamines at the N-terminus for their suitability in the CCK-2/gastrin-R-targeted imaging of tumors (CCK-2/gastrin-R = cholecystokinin subtype 2/gastrin receptor).  Methods: The [(D)Glu1]minigastrin sequence was assembled on the solid support and the resp. tetraamine precursors coupled at the N-terminus.  Purified peptide conjugates were labeled with 99mTc under alk. conditions.  Satn. binding expts. were performed for (radio)metalated peptides [99mTc/99gTc]Demogastrin 1-3 in rat acinar pancreatic AR4-2J cell membranes.  Internalization was studied in AR4-2J cells at 37°C.  Radiopeptide stability was tested in murine plasma, urine, and kidney homogenates.  Tissue distribution of the peptides was compared in healthy mice and athymic mice bearing AR4-2J tumors.  Results: Peptide conjugates were obtained in 10%-30% overall yields by solid-phase techniques.  Radiolabeling afforded >98% pure [99mTc] Demogastrin 1-3 species in specific activities of ∼37 GBq/μmol.  Radiopeptides retained a high affinity for the CCK-2/gastrin-R in vitro (50% inhibitory concn. values of ∼1 nmol/L) and internalized rapidly in CCK-2/gastrin-R-pos. cells.  After injection in mice they displayed rapid, high, and specific localization in the CCK-2/gastrin-R-expressing tissues (stomach and AR4-2J tumor) and were excreted from the body via the kidneys in the form of hydrophilic metabolites.  Conclusion: The promising characteristics of [99mTc]Demogastrin 1-3 both in vitro and in animal models illustrate their suitability for CCK-2/gastrin-R-targeted tumor imaging.  These qualities could be confirmed for [99mTc]Demogastrin 2, which provided excellent delineation of tumor deposits in a first patient with metastatic medullary thyroid cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrITI8FstUYkrVg90H21EOLACvtfcHk0li3cpuJmvp4Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitVGlt7g%253D&md5=ad16b01168279fc5334ee61d01c9e4ff</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNock%26aufirst%3DB.%2BA.%26aulast%3DMaina%26aufirst%3DT.%26aulast%3DB%25C3%25A9h%25C3%25A9%26aufirst%3DM.%26aulast%3DNikolopoulou%26aufirst%3DA.%26aulast%3DGotthardt%26aufirst%3DM.%26aulast%3DSchmitt%26aufirst%3DJ.%2BS.%26aulast%3DBehr%26aufirst%3DT.%2BM.%26aulast%3DM%25C3%25A4cke%26aufirst%3DH.%2BR.%26atitle%3DCCK-2%252Fgastrin%2520receptor-targeted%2520tumor%2520imaging%2520with%252099mTc-labeled%2520minigastrin%2520analogs%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2005%26volume%3D46%26spage%3D1727%26epage%3D1736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Béhé, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behr, T. M.</span><span> </span><span class="NLM_article-title">Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies</span> <span class="citation_source-journal">Biopolymers.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">418</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2002&pages=399-418&author=M.+B%C3%A9h%C3%A9author=T.+M.+Behr&title=Cholecystokinin-B+%28CCK-B%29%2Fgastrin+receptor+targeting+peptides+for+staging+and+therapy+of+medullary+thyroid+cancer+and+other+CCK-B+receptor+expressing+malignancies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25A9h%25C3%25A9%26aufirst%3DM.%26aulast%3DBehr%26aufirst%3DT.%2BM.%26atitle%3DCholecystokinin-B%2520%2528CCK-B%2529%252Fgastrin%2520receptor%2520targeting%2520peptides%2520for%2520staging%2520and%2520therapy%2520of%2520medullary%2520thyroid%2520cancer%2520and%2520other%2520CCK-B%2520receptor%2520expressing%2520malignancies%26jtitle%3DBiopolymers.%26date%3D2002%26volume%3D66%26spage%3D399%26epage%3D418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Béhé, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kluge, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gotthardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behr, T. M.</span><span> </span><span class="NLM_article-title">Use of polyglutamic acids to reduce uptake of radiometal-labeled minigastrin in the kidneys</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1012</span><span class="NLM_x">–</span> <span class="NLM_lpage">1015</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm900400w&amp;key=15937313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm900400w&amp;key=1%3ACAS%3A528%3ADC%252BD28XitFSqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=1012-1015&author=M.+B%C3%A9h%C3%A9author=G.+Klugeauthor=W.+Beckerauthor=M.+Gotthardtauthor=T.+M.+Behr&title=Use+of+polyglutamic+acids+to+reduce+uptake+of+radiometal-labeled+minigastrin+in+the+kidneys"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Use of polyglutamic acids to reduce uptake of radiometal-labeled minigastrin in the kidneys</span></div><div class="casAuthors">Behe, Martin; Kluge, Gerald; Becker, Wolfgang; Gotthardt, Martin; Behr, Thomas M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1012-1015</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine</span>)
        </div><div class="casAbstract">Uptake of radiolabeled peptides in the kidneys may obscure abdominal tumors in radiopeptide scintigraphy.  This problem is much more pronounced in peptide receptor radionuclide therapy (i.e., radiopeptide therapy), possibly leading to renal damage or even failure.  Cationic peptide uptake in the kidneys can be reduced by the application of cationic amino acids, such as lysine or arginine.  The aim of this study was to develop a suitable method to reduce anionic peptide uptake in the kidneys.  111In-Diethylenetriaminepentaacetic acid DGlu1-minigastrin (111In-DTPA-DGlu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2) was chosen as a model compd. with a sequence of 6 neg. charged glutamic acids in a chain and an addnl. aspartic acid.  Methods: TT (human medullary carcinoma cells)-bearing nu/nu mice of the Institute of Cancer Research genotype received i.p. injections of different chain lengths and wts. of glutamic acids, aspartic acids, and derivs. of glutamic acids.  Uptake in tumors and organs was detd. and compared with the values for untreated control mice.  Results: Accretion of 111In-DTPA-DGlu1-minigastrin in the kidneys could be reduced by up to 90%.  The uptake values for all other organs and the tumors were not affected.  These results were obtained with a chain of 5 or more glutamic acids, whereas uptake in kidneys was affected not at all or only slightly with poly-D-glutamic or polyaspartic acids and with Glux (x = 1-4).  Conclusion: These studies indicated a specific blocking of uptake by Glu5 sequences in the kidneys.  Application of polyglutamic acids is a new, successful method of reducing uptake of neg. charged peptides in the kidneys during radiopeptide therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpICp_yYR6rc7Vg90H21EOLACvtfcHk0li3cpuJmvp4Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XitFSqtrk%253D&md5=923b95333f02413a45c67474d3e65ffa</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25A9h%25C3%25A9%26aufirst%3DM.%26aulast%3DKluge%26aufirst%3DG.%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DGotthardt%26aufirst%3DM.%26aulast%3DBehr%26aufirst%3DT.%2BM.%26atitle%3DUse%2520of%2520polyglutamic%2520acids%2520to%2520reduce%2520uptake%2520of%2520radiometal-labeled%2520minigastrin%2520in%2520the%2520kidneys%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2005%26volume%3D46%26spage%3D1012%26epage%3D1015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Gotthardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Eerd-Vismale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyen, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolleman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maecke, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Béhé, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boerman, O.</span><span> </span><span class="NLM_article-title">Indication for different mechanisms of kidney uptake of radiolabeled peptides</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">596</span><span class="NLM_x">–</span> <span class="NLM_lpage">601</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm900400w&amp;key=10.2967%2Fjnumed.106.036020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm900400w&amp;key=17401097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm900400w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVert7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=596-601&author=M.+Gotthardtauthor=J.+van+Eerd-Vismaleauthor=W.+J.+Oyenauthor=M.+de+Jongauthor=H.+Zhangauthor=E.+Rollemanauthor=H.+R.+Maeckeauthor=M.+B%C3%A9h%C3%A9author=O.+Boerman&title=Indication+for+different+mechanisms+of+kidney+uptake+of+radiolabeled+peptides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Indication for different mechanisms of kidney uptake of radiolabeled peptides</span></div><div class="casAuthors">Gotthardt, Martin; van Eerd-Vismale, Julliette; Oyen, Wim J. G.; de Jong, Marion; Zhang, Hanwen; Rolleman, Edgar; Maecke, Helmut R.; Behe, Martin; Boerman, Otto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">596-601</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine</span>)
        </div><div class="casAbstract">Nephrotoxicity due to renal reabsorption of radiolabeled peptides limits the tumor dose in peptide receptor radiotherapy (PRRT).  Therefore, we evaluated the ability of several agents to inhibit the renal accumulation of different radiopeptides.  Male Wistar rats (4 per group) were injected i.v. with 1 MBq of 111In-labeled octreotide (OCT), minigastrin (MG), bombesin (BOM), or exendin (EX), together with a potential inhibitor of renal uptake (lysine [Lys], poly-glutamic acid [PGA], and Gelofusine [GF], a gelatin-based plasma expander) or phosphate-buffered saline as a control.  Organ uptake at 20 h after injection was detd. as the percentage of injected activity per g (%IA/g).  Lys, PGA, and GF were also combined to det. whether an additive effect could be obtained.  The localization of the peptides in the kidneys was investigated by autoradiog. using a phosphor imager.  OCT accumulation in the kidney was inhibited by Lys and GF (40.7%-45.1%), whereas PGA was ineffective.  On the other hand, renal uptake of BOM, MG, and EX was inhibited by PGA and GF (15.4%-85.4%), whereas Lys was ineffective.  The combination of GF and Lys showed additive effects in inhibiting OCT uptake, whereas PGA and GF had additive effects for the inhibition of EX uptake.  The amt. of kidney uptake correlated with the no. of charged amino acids.  All radiopeptides were localized in the renal cortex, as indicated by autoradiog.  Inhibition of renal accumulation of the radiopeptides tested could be achieved by either Lys or PGA but not by both at the same time, suggesting 2 different uptake mechanisms.  The differences in renal accumulation of radiopeptides may be related to the no. of charges of a mol.  GF is the only compd. that inhibited renal accumulation of all radiopeptides tested.  Addnl. expts. are needed to further elucidate these findings and to optimize inhibition of renal accumulation of radiopeptides to reduce the kidney dose in PRRT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprCvnHwzbCg7Vg90H21EOLACvtfcHk0li3cpuJmvp4Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVert7nF&md5=4f777a18c1aa7a8e838b788615063cbd</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.106.036020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.106.036020%26sid%3Dliteratum%253Aachs%26aulast%3DGotthardt%26aufirst%3DM.%26aulast%3Dvan%2BEerd-Vismale%26aufirst%3DJ.%26aulast%3DOyen%26aufirst%3DW.%2BJ.%26aulast%3Dde%2BJong%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DRolleman%26aufirst%3DE.%26aulast%3DMaecke%26aufirst%3DH.%2BR.%26aulast%3DB%25C3%25A9h%25C3%25A9%26aufirst%3DM.%26aulast%3DBoerman%26aufirst%3DO.%26atitle%3DIndication%2520for%2520different%2520mechanisms%2520of%2520kidney%2520uptake%2520of%2520radiolabeled%2520peptides%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2007%26volume%3D48%26spage%3D596%26epage%3D601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Melis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krenning, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Visser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolleman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, M.</span><span> </span><span class="NLM_article-title">Renal uptake and retention of radiolabeled somatostatin, bombesin, neurotensin, minigastrin, and CCK analogs: species and gender differences</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">633</span><span class="NLM_x">–</span> <span class="NLM_lpage">641</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm900400w&amp;key=10.1016%2Fj.nucmedbio.2007.05.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm900400w&amp;key=17707803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm900400w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpt1eit70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2007&pages=633-641&author=M.+Melisauthor=E.+P.+Krenningauthor=B.+F.+Bernardauthor=M.+de+Visserauthor=E.+Rollemanauthor=M.+de+Jong&title=Renal+uptake+and+retention+of+radiolabeled+somatostatin%2C+bombesin%2C+neurotensin%2C+minigastrin%2C+and+CCK+analogs%3A+species+and+gender+differences"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Renal uptake and retention of radiolabeled somatostatin, bombesin, neurotensin, minigastrin and CCK analogues: Species and gender differences</span></div><div class="casAuthors">Melis, Marleen; Krenning, Eric P.; Bernard, Bert F.; de Visser, Monique; Rolleman, Edgar; de Jong, Marion</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">633-641</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Introduction: During therapy with radiolabeled peptides, the kidney is most often the crit. organ.  Newly developed peptides are evaluated preclinically in different animal models before their application in humans.  In this study, the renal retention of several radiolabeled peptides was compared in male and female rats and mice.  Methods: After i.v. injection of radiolabeled peptides [somatostatin, cholecystokinin (CCK), minigastrin, bombesin and neurotensin analogs], renal uptake was detd. in both male and female Lewis rats and C57Bl mice.  In addn., ex vivo autoradiog. of renal sections was performed to localize accumulated radioactivity.  Results: An equal distribution pattern of renal radioactivity was found for all peptides: high accumulation in the cortex, lower accumulation in the outer medulla and no radioactivity in the inner medulla of the kidneys.  In both male rats and mice, an increasing renal uptake was found: [111In-DTPA]CCK8 < [111In-DTPA-Pro1,Tyr4]bombesin ≈ [111In-DTPA]neurotensin < [111In-DTPA]octreotide « [111In-DTPA]MG0.  Renal uptake of [111In-DTPA]octreotide in rats showed no gender difference, and renal radioactivity was about const. over time.  In mice, however, renal uptake in females was significantly higher than that in males and decreased rapidly over time in both genders.  Moreover, renal radioactivity in female mice injected with [111In-DTPA]octreotide showed a different localization pattern.  Conclusions: Regarding the renal uptake of different radiolabeled peptides, both species showed the same ranking order.  Similar to findings in patients, rats showed comparable and const. renal retention of radioactivity in both genders, in contrast to mice.  Therefore, rats appear to be the more favorable species for the study of the renal retention of radioactivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRjBZg5zuTV7Vg90H21EOLACvtfcHk0li5Gnd2H_xFuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpt1eit70%253D&md5=102f673938df1694e159b3b55c6723f4</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2007.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2007.05.002%26sid%3Dliteratum%253Aachs%26aulast%3DMelis%26aufirst%3DM.%26aulast%3DKrenning%26aufirst%3DE.%2BP.%26aulast%3DBernard%26aufirst%3DB.%2BF.%26aulast%3Dde%2BVisser%26aufirst%3DM.%26aulast%3DRolleman%26aufirst%3DE.%26aulast%3Dde%2BJong%26aufirst%3DM.%26atitle%3DRenal%2520uptake%2520and%2520retention%2520of%2520radiolabeled%2520somatostatin%252C%2520bombesin%252C%2520neurotensin%252C%2520minigastrin%252C%2520and%2520CCK%2520analogs%253A%2520species%2520and%2520gender%2520differences%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2007%26volume%3D34%26spage%3D633%26epage%3D641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Béhé, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reubi, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maecke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breeman, W. A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krenning, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behr, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, M.</span><span> </span><span class="NLM_article-title">Optimisation of In-111 labelled minigastrin related to the kidney uptake</span> <span class="citation_source-journal">Nucl. Med. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">S5</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2005&pages=S5&author=M.+B%C3%A9h%C3%A9author=J.+C.+Reubiauthor=B.+Nockauthor=J.+S.+Schmittauthor=H.+Maeckeauthor=W.+A.+P.+Breemanauthor=E.+Krenningauthor=T.+M.+Behrauthor=M.+de+Jong&title=Optimisation+of+In-111+labelled+minigastrin+related+to+the+kidney+uptake"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25A9h%25C3%25A9%26aufirst%3DM.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DNock%26aufirst%3DB.%26aulast%3DSchmitt%26aufirst%3DJ.%2BS.%26aulast%3DMaecke%26aufirst%3DH.%26aulast%3DBreeman%26aufirst%3DW.%2BA.%2BP.%26aulast%3DKrenning%26aufirst%3DE.%26aulast%3DBehr%26aufirst%3DT.%2BM.%26aulast%3Dde%2BJong%26aufirst%3DM.%26atitle%3DOptimisation%2520of%2520In-111%2520labelled%2520minigastrin%2520related%2520to%2520the%2520kidney%2520uptake%26jtitle%3DNucl.%2520Med.%2520Rev.%26date%3D2005%26volume%3D8%26spage%3DS5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">von Guggenberg, E.; Saurer, M.; Behe, M.; Virgolini, I.; Decristoforo, C.</span><span> </span><span class="NLM_article-title"><sup>99m</sup>Tc-HYNIC-Minigastrin with high tumour uptake and low kidney accumulation: in vitro and in vivo evaluation</span>. In  <span class="citation_source-book">Technetium, Rhenium and Other Materials in Chemistry and Nuclear Medicine</span>, <span class="NLM_edition">7th</span> ed.; <span class="NLM_publisher-name">SGEditoriali</span>: <span class="NLM_publisher-loc">Padova, Italy</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">333</span>− <span class="NLM_lpage">334</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=333-334&author=E.+von+Guggenberg&author=M.+Saurer&author=M.+Behe&author=I.+Virgolini&author=C.+Decristoforo&title=Technetium%2C+Rhenium+and+Other+Materials+in+Chemistry+and+Nuclear+Medicine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3Dvon%2BGuggenberg%26aufirst%3DE.%26atitle%3D99mTc-HYNIC-Minigastrin%2520with%2520high%2520tumour%2520uptake%2520and%2520low%2520kidney%2520accumulation%253A%2520in%2520vitro%2520and%2520in%2520vivo%2520evaluation%26btitle%3DTechnetium%252C%2520Rhenium%2520and%2520Other%2520Materials%2520in%2520Chemistry%2520and%2520Nuclear%2520Medicine%26pub%3DSGEditoriali%26date%3D2006%26spage%3D333%26epage%3D334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Nikolopoulou, A.; Nock, B. A.; Petrou, C.; Ketani, E.; Cordopatis, P.; Maina, T.</span><span> </span><span class="NLM_article-title">In vivo targeting of CCK-2/Gastrin-R and reduction of renal accumulation with truncated [99mTc]Demogastrin 4−6</span>. In  <span class="citation_source-book">Technetium, Rhenium and Other Materials in Chemistry and Nuclear Medicine</span>, <span class="NLM_edition">7th</span> ed.; <span class="NLM_publisher-name">SGEditoriali</span>: <span class="NLM_publisher-loc">Padova, Italy</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">325</span>− <span class="NLM_lpage">326</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=325-326&author=A.+Nikolopoulou&author=B.+A.+Nock&author=C.+Petrou&author=E.+Ketani&author=P.+Cordopatis&author=T.+Maina&title=Technetium%2C+Rhenium+and+Other+Materials+in+Chemistry+and+Nuclear+Medicine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DNikolopoulou%26aufirst%3DA.%26atitle%3DIn%2520vivo%2520targeting%2520of%2520CCK-2%252FGastrin-R%2520and%2520reduction%2520of%2520renal%2520accumulation%2520with%2520truncated%2520%255B99mTc%255DDemogastrin%25204%25E2%2588%25926%26btitle%3DTechnetium%252C%2520Rhenium%2520and%2520Other%2520Materials%2520in%2520Chemistry%2520and%2520Nuclear%2520Medicine%26pub%3DSGEditoriali%26date%3D2006%26spage%3D325%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Kosowicz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikol̷ajczak, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czepczyński, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziemnicka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gryczyńska, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowiński, J.</span><span> </span><span class="NLM_article-title">Two peptide receptor ligands <sup>99m</sup>Tc-EDDA/HYNIC-Tyr<sub>3</sub>-octreotide and <sup>99m</sup>Tc-EDDA/HYNIC-<span class="smallcaps smallerCapital">d</span>Glu-octagastrin for scintigraphy of medullary thyroid carcinoma</span> <span class="citation_source-journal">Cancer Biother. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">613</span><span class="NLM_x">–</span> <span class="NLM_lpage">628</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm900400w&amp;key=10.1089%2Fcbr.2006.368" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm900400w&amp;key=17979564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm900400w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1GrsLvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2007&pages=613-628&author=J.+Kosowiczauthor=R.+Mikol%CC%B7ajczakauthor=R.+Czepczy%C5%84skiauthor=K.+Ziemnickaauthor=M.+Gryczy%C5%84skaauthor=J.+Sowi%C5%84ski&title=Two+peptide+receptor+ligands+99mTc-EDDA%2FHYNIC-Tyr3-octreotide+and+99mTc-EDDA%2FHYNIC-dGlu-octagastrin+for+scintigraphy+of+medullary+thyroid+carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Two Peptide Receptor Ligands 99mTc-EDDA/HYNIC-Tyr3-Octreotide and 99mTc-EDDA/HYNIC-DGlu-Octagastrin for Scintigraphy of Medullary Thyroid Carcinoma</span></div><div class="casAuthors">Kosowicz, Jerzy; Mikolajczak, Renata; Czepczynski, Rafal; Ziemnicka, Katarzyna; Gryczynska, Maria; Sowinski, Jerzy</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biotherapy & Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">613-628</span>CODEN:
                <span class="NLM_cas:coden">CBRAFJ</span>;
        ISSN:<span class="NLM_cas:issn">1084-9785</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Somatostatin and gastrin receptors are overexpressed in medullary thyroid carcinoma (MTC) cells; hence, both of them are potential targets for peptide receptor scintigraphy and radiotherapy.  Therefore, the aim of our study was to assess the clin. value of two technetium-99m-labeled peptides, a new gastrin analog, the EDDA/HYNIC-DGlu-octagastrin and a somatostatin analog, EDDA/HYNIC-Tyr3-octreotide (EDDA/HYNIC-TOC) for scintigraphy in patients with MTC to detect recurrences and metastases and select patients for peptide receptor radiotherapy.  Material and Methods: Thirty (30) patients, 20 females and 10 males, 22-83 years of age (mean, 52.7) with the diagnosis of MTC in different stages of the disease (preoperative, postsurgery, remission, recurrence, or metastatic disease) were included in this study.  Before surgery, in all patients serum calcitonin concns. were elevated.  The diagnosis of MTC was confirmed in all cases by histopathol. of the removed tumor and immunohistochem. staining giving pos. reactions for calcitonin and chromogranin A.  Imaging studies using 99mTc-EDDA/HYNIC-TOC and a new minigastrin analog, 99mTc-EDDA/HYNIC-DGlu-octagastrin, were performed in each patient and the results compared with each other and with other imaging methods.  Scans of the whole body, head, neck, and chest were performed 2 and 4 h after injections of the tracer, 500-600 MBq in each case, using a double-head Varicam (Elscint, Israel) gamma camera.  Results: 99mTc-EDDA/HYNIC-TOC detected somatostatin receptor-pos. lesions in 20 patients with MTC, whereas 99mTc-EDDA/HYNIC-DGlu-octagastrin displayed gastrin receptors in 11 patients.  In 9 cases, the scans were pos. in both methods, although in 2 cases different pathol. foci were visualized.  In 12 cases, only 99mTc-EDDA/HYNIC-TOC scintigraphy was pos., whereas in 3 other cases only 99mTc-EDDA/HYNIC-DGlu-octagastrin revealed pathol. lesions.  Conclusions: Scintigraphy using 99mTc-HYNIC-TOC permits the visualization of somatostatin receptor-pos. MTC in the majority of cases.  The new gastrin analog, 99mTc-HYNIC-DGlu-octagastrin, is well tolerated, shows no renal retention, and in some cases of MTC, provides addnl. information on the expression of gastrin receptors.  However, inferior quality of octagastrin scans indicates the need for further improvement of this radiopeptide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0sHZVa3SHsrVg90H21EOLACvtfcHk0lhcLP22ye9knA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1GrsLvI&md5=8e1c2766ce53bf0500c97f1c868d1ada</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1089%2Fcbr.2006.368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fcbr.2006.368%26sid%3Dliteratum%253Aachs%26aulast%3DKosowicz%26aufirst%3DJ.%26aulast%3DMikol%25CC%25B7ajczak%26aufirst%3DR.%26aulast%3DCzepczy%25C5%2584ski%26aufirst%3DR.%26aulast%3DZiemnicka%26aufirst%3DK.%26aulast%3DGryczy%25C5%2584ska%26aufirst%3DM.%26aulast%3DSowi%25C5%2584ski%26aufirst%3DJ.%26atitle%3DTwo%2520peptide%2520receptor%2520ligands%252099mTc-EDDA%252FHYNIC-Tyr3-octreotide%2520and%252099mTc-EDDA%252FHYNIC-dGlu-octagastrin%2520for%2520scintigraphy%2520of%2520medullary%2520thyroid%2520carcinoma%26jtitle%3DCancer%2520Biother.%2520Radiopharm.%26date%3D2007%26volume%3D22%26spage%3D613%26epage%3D628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Good, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waser, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller-Brand, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Béhé, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reubi, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maecke, H. R.</span><span> </span><span class="NLM_article-title">Macrocyclic chelator-coupled gastrin-based radiopharmaceuticals for targeting of gastrin receptor-expressing tumours</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1868</span><span class="NLM_x">–</span> <span class="NLM_lpage">1877</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm900400w&amp;key=10.1007%2Fs00259-008-0803-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm900400w&amp;key=18509636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm900400w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCjtbzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2008&pages=1868-1877&author=S.+Goodauthor=M.+A.+Walterauthor=B.+Waserauthor=X.+Wangauthor=J.+M%C3%BCller-Brandauthor=M.+P.+B%C3%A9h%C3%A9author=J.+C.+Reubiauthor=H.+R.+Maecke&title=Macrocyclic+chelator-coupled+gastrin-based+radiopharmaceuticals+for+targeting+of+gastrin+receptor-expressing+tumours"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocyclic chelator-coupled gastrin-based radiopharmaceuticals for targeting of gastrin receptor-expressing tumours</span></div><div class="casAuthors">Good, Stephan; Walter, Martin A.; Waser, Beatrice; Wang, Xuejuan; Muller-Brand, Jan; Behe, Martin P.; Reubi, Jean-Claude; Maecke, Helmut R.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1868-1877</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Diethylenetriamine-pentaacetic acid (DTPA)-coupled minigastrins are unsuitable for therapeutic application with the available β-emitting radiometals due to low complex stability.  Low tumor-to-kidney ratio of the known radiopharmaceuticals is further limiting their potency.  Macrocyclic chelators were used for coupling to increase complex stability, the peptide sequence modified to enhance radiolytic stability, and tumor-to-kidney ratio and metabolic stability studied using 111In-labeled derivs.  Gastrin derivs. with decreasing nos. of glutamic acids were synthesized using 111In as surrogate for therapeutic radiometals for in vitro and in vivo studies.  Gastrin receptor affinities of the natIn-metalated compds. were detd. by receptor autoradiog. using 125I-CCK as radioligand.  Internalization was evaluated in AR4-2J cells.  Enzymic stability was detd. by incubating the 111In-labeled peptides in human serum.  Biodistribution was performed in AR4-2J-bearing Lewis rats.  IC50 values of the natIn-metalated gastrin derivs. vary between 1.2 and 4.8 nmol/L for all methionine-contg. derivs.  Replacement of methionine by norleucine, isoleucine, methionine-sulfoxide, or methionine-sulfone resulted in significant decrease of receptor affinity (IC50 between 9.9 and 1195 nmol/L).  All cholecystokinin receptor affinities were >100 nmol/L.  All 111In-labeled radiopeptides showed receptor-specific internalization.  Serum mean-life times varied between 2.0 and 72.6 h, pos. correlating with the no. of Glu residues.  All 111In-labeled macrocyclic chelator conjugates showed higher tumor-to-kidney ratios after 24 h (0.37-0.99) compared to 111In-DTPA-minigastrin 0 (0.05).  Tumor wash out between 4 and 24 h was low.  Imaging studies confirmed receptor-specific blocking of the tumor uptake.  Thus, reducing the no. of glutamates increased tumor-to-kidney ratio but resulted in lower metabolic stability.  The properties of the macrocyclic chelator-bearing derivs. make them potentially suitable for clin. purposes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTFCtj4wIeGLVg90H21EOLACvtfcHk0lhcLP22ye9knA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCjtbzE&md5=32bd7ff02f3bedfe4bc038575b949da7</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2Fs00259-008-0803-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-008-0803-4%26sid%3Dliteratum%253Aachs%26aulast%3DGood%26aufirst%3DS.%26aulast%3DWalter%26aufirst%3DM.%2BA.%26aulast%3DWaser%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DM%25C3%25BCller-Brand%26aufirst%3DJ.%26aulast%3DB%25C3%25A9h%25C3%25A9%26aufirst%3DM.%2BP.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DMaecke%26aufirst%3DH.%2BR.%26atitle%3DMacrocyclic%2520chelator-coupled%2520gastrin-based%2520radiopharmaceuticals%2520for%2520targeting%2520of%2520gastrin%2520receptor-expressing%2520tumours%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2008%26volume%3D35%26spage%3D1868%26epage%3D1877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Breeman, W. A. P.; de Blois, E.; van Gameren, A.; Melis, M.; Fröberg, A.; de Jong, M.; Mäcke, H.; Krenning, E. P.</span><span> </span><span class="NLM_article-title">Aspects of CCK-2 Receptor-Targeting with <sup>111</sup>In-DOTA-MG</span>. In  <span class="citation_source-book">Technetium, Rhenium and Other Materials in Chemistry and Nuclear Medicine</span>, <span class="NLM_edition">7th</span> ed.; <span class="NLM_publisher-name">SGEditoriali</span>: <span class="NLM_publisher-loc">Padova, Italy</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">231</span>− <span class="NLM_lpage">232</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=231-232&author=W.+A.+P.+Breeman&author=E.+de+Blois&author=A.+van+Gameren&author=M.+Melis&author=A.+Fr%C3%B6berg&author=M.+de+Jong&author=H.+M%C3%A4cke&author=E.+P.+Krenning&title=Technetium%2C+Rhenium+and+Other+Materials+in+Chemistry+and+Nuclear+Medicine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBreeman%26aufirst%3DW.%2BA.%2BP.%26atitle%3DAspects%2520of%2520CCK-2%2520Receptor-Targeting%2520with%2520111In-DOTA-MG%26btitle%3DTechnetium%252C%2520Rhenium%2520and%2520Other%2520Materials%2520in%2520Chemistry%2520and%2520Nuclear%2520Medicine%26pub%3DSGEditoriali%26date%3D2006%26spage%3D231%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Maina, T.; Nikolopoulou, A.; Ketani, E.; Petrou, C.; Cordopatis, P.; Nock, B. A.</span><span> </span><span class="NLM_article-title">Oxidation−Nle<sup>11</sup>/Mox<sup>11</sup> replacement of Met<sup>11</sup> in [99mTc]Demogastrin 2: Effects on CCK-2/Gastrin-R-Interaction</span>. In  <span class="citation_source-book">Technetium, Rhenium and Other Materials in Chemistry and Nuclear Medicine</span>, <span class="NLM_edition">7th</span> ed.; <span class="NLM_publisher-name">SGEditoriali</span>: <span class="NLM_publisher-loc">Padova, Italy</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">, </span>: pp  <span class="NLM_fpage">323</span>− <span class="NLM_lpage">324</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=323-324&author=T.+Maina&author=A.+Nikolopoulou&author=E.+Ketani&author=C.+Petrou&author=P.+Cordopatis&author=B.+A.+Nock&title=Technetium%2C+Rhenium+and+Other+Materials+in+Chemistry+and+Nuclear+Medicine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMaina%26aufirst%3DT.%26atitle%3DOxidation%25E2%2588%2592Nle11%252FMox11%2520replacement%2520of%2520Met11%2520in%2520%255B99mTc%255DDemogastrin%25202%253A%2520Effects%2520on%2520CCK-2%252FGastrin-R-Interaction%26btitle%3DTechnetium%252C%2520Rhenium%2520and%2520Other%2520Materials%2520in%2520Chemistry%2520and%2520Nuclear%2520Medicine%26pub%3DSGEditoriali%26date%3D2006%26spage%3D323%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Mather, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenzie, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sosabowski, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellison, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, S. A.</span><span> </span><span class="NLM_article-title">Selection of radiolabeled gastrin analogs for peptide receptor-targeted radionuclide therapy</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">615</span><span class="NLM_x">–</span> <span class="NLM_lpage">622</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=615-622&author=S.+J.+Matherauthor=A.+J.+McKenzieauthor=J.+K.+Sosabowskiauthor=T.+M.+Morrisauthor=D.+Ellisonauthor=S.+A.+Watson&title=Selection+of+radiolabeled+gastrin+analogs+for+peptide+receptor-targeted+radionuclide+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMather%26aufirst%3DS.%2BJ.%26aulast%3DMcKenzie%26aufirst%3DA.%2BJ.%26aulast%3DSosabowski%26aufirst%3DJ.%2BK.%26aulast%3DMorris%26aufirst%3DT.%2BM.%26aulast%3DEllison%26aufirst%3DD.%26aulast%3DWatson%26aufirst%3DS.%2BA.%26atitle%3DSelection%2520of%2520radiolabeled%2520gastrin%2520analogs%2520for%2520peptide%2520receptor-targeted%2520radionuclide%2520therapy%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2007%26volume%3D48%26spage%3D615%26epage%3D622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Stone, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giragossian, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mierke, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, G. E.</span><span> </span><span class="NLM_article-title">Further evidence for a C-terminal structural motif in CCK2 receptor active peptide hormones</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">2211</span><span class="NLM_x">–</span> <span class="NLM_lpage">2222</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=2211-2222&author=S.+R.+Stoneauthor=C.+Giragossianauthor=D.+F.+Mierkeauthor=G.+E.+Jackson&title=Further+evidence+for+a+C-terminal+structural+motif+in+CCK2+receptor+active+peptide+hormones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStone%26aufirst%3DS.%2BR.%26aulast%3DGiragossian%26aufirst%3DC.%26aulast%3DMierke%26aufirst%3DD.%2BF.%26aulast%3DJackson%26aufirst%3DG.%2BE.%26atitle%3DFurther%2520evidence%2520for%2520a%2520C-terminal%2520structural%2520motif%2520in%2520CCK2%2520receptor%2520active%2520peptide%2520hormones%26jtitle%3DPeptides%26date%3D2007%26volume%3D28%26spage%3D2211%26epage%3D2222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Charpentier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelaprat, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durieux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reibaud, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchard, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roques, B. P.</span><span> </span><span class="NLM_article-title">Cyclic cholecystokinin analogs with high selectivity for central receptors</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">1968</span><span class="NLM_x">–</span> <span class="NLM_lpage">1972</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1988&pages=1968-1972&author=B.+Charpentierauthor=D.+Pelapratauthor=C.+Durieuxauthor=A.+Dorauthor=M.+Reibaudauthor=J.+C.+Blanchardauthor=B.+P.+Roques&title=Cyclic+cholecystokinin+analogs+with+high+selectivity+for+central+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCharpentier%26aufirst%3DB.%26aulast%3DPelaprat%26aufirst%3DD.%26aulast%3DDurieux%26aufirst%3DC.%26aulast%3DDor%26aufirst%3DA.%26aulast%3DReibaud%26aufirst%3DM.%26aulast%3DBlanchard%26aufirst%3DJ.%2BC.%26aulast%3DRoques%26aufirst%3DB.%2BP.%26atitle%3DCyclic%2520cholecystokinin%2520analogs%2520with%2520high%2520selectivity%2520for%2520central%2520receptors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1988%26volume%3D85%26spage%3D1968%26epage%3D1972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Haubner, R.</span><span> </span><span class="NLM_article-title">Alphavbeta3-integrin imaging: a new approach to characterise angiogenesis?</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">S54</span><span class="NLM_x">–</span> <span class="NLM_lpage">S63</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2006&pages=S54-S63&author=R.+Haubner&title=Alphavbeta3-integrin+imaging%3A+a+new+approach+to+characterise+angiogenesis%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHaubner%26aufirst%3DR.%26atitle%3DAlphavbeta3-integrin%2520imaging%253A%2520a%2520new%2520approach%2520to%2520characterise%2520angiogenesis%253F%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2006%26volume%3D33%26spage%3DS54%26epage%3DS63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">de Visser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verwijnen, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, M.</span><span> </span><span class="NLM_article-title">Update: improvement strategies for peptide receptor scintigraphy and radionuclide therapy</span> <span class="citation_source-journal">Cancer Biother. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">157</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm900400w&amp;key=10.1089%2Fcbr.2007.0435" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm900400w&amp;key=18454684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm900400w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlsV2mt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2008&pages=137-157&author=M.+de+Visserauthor=S.+M.+Verwijnenauthor=M.+de+Jong&title=Update%3A+improvement+strategies+for+peptide+receptor+scintigraphy+and+radionuclide+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Update: Improvement Strategies for Peptide Receptor Scintigraphy and Radionuclide Therapy</span></div><div class="casAuthors">de Visser, Monique; Verwijnen, Suzanne M.; de Jong, Marion</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biotherapy & Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">137-157</span>CODEN:
                <span class="NLM_cas:coden">CBRAFJ</span>;
        ISSN:<span class="NLM_cas:issn">1084-9785</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Somatostatin receptor-targeting peptides are widely used for the imaging and therapy of neuroendocrine tumors.  Peptide-receptor radionuclide therapy (PRRT) in neuroendocrine tumor patients with radiolabeled somatostatin analogs has resulted in symptomatic improvement, prolonged survival, and enhanced quality of life.  The side-effects of PRRT are few and mostly mild, certainly when using kidney protective agents.  If a more widespread use of PRRT is possible, such therapy might become the therapy of first choice in patients with metastasized or inoperable neuroendocrine gastroenteropancreatic tumors.  Yet, much profit can be gained from improving the receptor-targeting strategies available and developing new strategies.  This review presents an overview of several options to optimize receptor-targeted imaging and radionuclide therapy.  These include the optimization of peptide analogs, increasing the no. of receptors on the tumor site, and combining PRRT with other treatment strategies.  The development of new peptide analogs with increased receptor-binding affinity and improved stability might lead to a higher accumulation of radioactivity inside tumor cells.  Analogs of somatostatin have been widely studied.  However, much profit can be gained in improving peptide analogs targeting other tumor-related receptors, including gastrin-releasing peptide (GRP) receptors, neurotensin (NT) receptors, cholecystokinin (CCK) receptors, and glucagon-like peptide-1 (GLP-1) receptors.  Several peptide analogs targeting these receptors are well on their way to clin. utilization.  The literature shows that it is possible to increase the receptor d. on tumor cells by using different methods, which results in higher binding and internalization rates and thus a higher contrast during peptide-receptor scintigraphy.  In PRRT treatment, this would enable the administration of higher therapeutic doses to tumors, which might lead to a higher cure rate in patients.  Combinations of radionuclide therapy with other treatment modalities, such as chemotherapy or pretreatment with radiosensitizers, might increase the impact of the treatment.  Further, the administration of higher dosages of radioactivity to the patient, enabled by combinations of PRRT with strategies reducing the radiation dose to healthy organs, will improve the outcome of tumor treatment.  Also, targeting one or several tumor-specific receptors by using combinations of therapeutic agents, as well as by reducing nontarget uptake of radioactivity, will enlarge the therapeutic window of PRRT.  Clin. studies will provide more insight in the effects of combining treatment strategies in cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhR64l5HA65bVg90H21EOLACvtfcHk0lj7v6c_9Fz5zA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlsV2mt78%253D&md5=9edb9300c263f764e945cb9f1dbee0c7</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1089%2Fcbr.2007.0435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fcbr.2007.0435%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BVisser%26aufirst%3DM.%26aulast%3DVerwijnen%26aufirst%3DS.%2BM.%26aulast%3Dde%2BJong%26aufirst%3DM.%26atitle%3DUpdate%253A%2520improvement%2520strategies%2520for%2520peptide%2520receptor%2520scintigraphy%2520and%2520radionuclide%2520therapy%26jtitle%3DCancer%2520Biother.%2520Radiopharm.%26date%3D2008%26volume%3D23%26spage%3D137%26epage%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Trejtnar, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laznicek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laznickova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopecky, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Béhé, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maecke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maina, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nock, B.</span><span> </span><span class="NLM_article-title">Biodistribution and elimination characteristics of two <sup>111</sup>In-labeled CCK-2/gastrin receptor-specific peptides in rats</span> <span class="citation_source-journal">Anticancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">907</span><span class="NLM_x">–</span> <span class="NLM_lpage">912</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm900400w&amp;key=17465219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm900400w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltVKmt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=907-912&author=F.+Trejtnarauthor=M.+Laznicekauthor=A.+Laznickovaauthor=M.+Kopeckyauthor=M.+Petrikauthor=M.+B%C3%A9h%C3%A9author=J.+Schmidtauthor=H.+Maeckeauthor=T.+Mainaauthor=B.+Nock&title=Biodistribution+and+elimination+characteristics+of+two+111In-labeled+CCK-2%2Fgastrin+receptor-specific+peptides+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Biodistribution and elimination characteristics of two 111In-labeled CCK-2/gastrin receptor-specific peptides in rats</span></div><div class="casAuthors">Trejtnar, Franktisek; Laznicek, Milan; Laznickova, Alice; Kopecky, Martin; Petrik, Milos; Behe, Martin; Schmidt, Jorg; Maecke, Helmut; Maina, Theodosia; Nock, Berthold</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">907-912</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Background: Due to their high CCK-2/gastrin receptor selectivity, high affinity, and rapid background clearance, radiolabeled minigastrins (MG) are emerging as promising new tools in the diagnosis and therapy of CCK-2/gastrin receptor-pos. tumors.  In this study, the pharmacokinetic profile, particularly the excretion mode, of two 111In-labeled minigastrins was compared in rats.  The first tracer, 111In-MG-0 is based on (D)Glu1-MG, while the second, 111In-MG-11, is its des-(Glu)5-deriv., expected to be less retained in renal tissue.  Materials and Methods: The fate of 111In-MG-0 and 111In-MG-11 in the body of rats was investigated during biodistribution and bioelimination expts., while the resp. elimination parameters were detd. in perfused rat liver and kidney models.  Results: During biodistribution both compds. were rapidly cleared from the blood and most non-target organs whereas activity levels in the bowel and stomach declined slowly.  The overall contribution of hepatobiliary excretion of 111In-MG-0 and 111In-MG-11 was relatively small.  In the perfused rat liver their elimination into the bile was negligible.  In contrast, renal excretion was the major excretion pathway for both analogs, mainly via glomerular filtration.  However, kidney levels were substantially higher and retention was more prolonged in the case of 111In-MG-0 as compared to 111In-MG-11.  Conclusion: The presence of the (Glu)5-chain in 111In-MG-0 appears to be implicated in the prolonged radioactivity retention in the kidney of rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUmwWI7DqYarVg90H21EOLACvtfcHk0lj7v6c_9Fz5zA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltVKmt7c%253D&md5=f9a7065d2f074358ed795f14e79365e0</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTrejtnar%26aufirst%3DF.%26aulast%3DLaznicek%26aufirst%3DM.%26aulast%3DLaznickova%26aufirst%3DA.%26aulast%3DKopecky%26aufirst%3DM.%26aulast%3DPetrik%26aufirst%3DM.%26aulast%3DB%25C3%25A9h%25C3%25A9%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DJ.%26aulast%3DMaecke%26aufirst%3DH.%26aulast%3DMaina%26aufirst%3DT.%26aulast%3DNock%26aufirst%3DB.%26atitle%3DBiodistribution%2520and%2520elimination%2520characteristics%2520of%2520two%2520111In-labeled%2520CCK-2%252Fgastrin%2520receptor-specific%2520peptides%2520in%2520rats%26jtitle%3DAnticancer%2520Res.%26date%3D2007%26volume%3D27%26spage%3D907%26epage%3D912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Sosabowski, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dekker, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beresford, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagan, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenzie, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mather, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, S. A.</span><span> </span><span class="NLM_article-title">Formulation development and manufacturing of a gastrin/CCK-2 receptor targeting peptide as an intermediate drug product for a clinical imaging study</span> <span class="citation_source-journal">Eur. J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">211</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm900400w&amp;key=10.1016%2Fj.ejps.2007.02.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm900400w&amp;key=17387005" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm900400w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkvFyqu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2007&pages=102-211&author=J.+K.+Sosabowskiauthor=M.+Leeauthor=B.+A.+Dekkerauthor=B.+P.+Simmonsauthor=S.+Singhauthor=H.+Beresfordauthor=S.+A.+Haganauthor=A.+J.+McKenzieauthor=S.+J.+Matherauthor=S.+A.+Watson&title=Formulation+development+and+manufacturing+of+a+gastrin%2FCCK-2+receptor+targeting+peptide+as+an+intermediate+drug+product+for+a+clinical+imaging+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Formulation development and manufacturing of a gastrin/CCK-2 receptor targeting peptide as an intermediate drug product for a clinical imaging study</span></div><div class="casAuthors">Sosabowski, Jane K.; Lee, Myrto; Dekker, Bronwen A.; Simmons, Ben P.; Singh, Surjeet; Beresford, Hayden; Hagan, Susan A.; McKenzie, Andrew J.; Mather, Stephen J.; Watson, Susan A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">102-111</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A DOTA-gastrin analog (APH070) which, when labeled with 111In, has high affinity for the gastrin/CCK-2 receptor (3 nM) and low tumor to kidney ratio in animal models, has been formulated and manufd. for a clin. study.  Oxidn. of the peptide methionine residue greatly reduces receptor affinity, therefore development work focused on producing a stable intermediate drug product (iDP) while ensuring that the formulation, container, closure and manufg. process did not inhibit the extremely sensitive radiolabeling reaction (itself a source of oxidn.).  Stress testing revealed that APH070 was stable at 2-8° at pH 6-9.  Addn. of an antioxidant (monothioglycerol) to the peptide formulation reduced stability when compared to buffer alone.  Use of FluroTec (4023/50) stoppers (rather than FluroTec Plus (4110/40)) increased both the stability and radiolabeling efficiency of APH070.  Long term stability (6 mo) of the final formulation (1 mg/mL APH070 in 0.01 M pH 7.2 phosphate buffer) stored at 5° in type I glass vials with FluroTec (4023/50) stoppers was 98.6±0.2% and 98.4±0.1% for upright and inverted samples, resp.  Clin. scale radiolabeling of the final formulation routinely achieves the specification of >85% 111In-APH070 (unoxidized) stable for up to 2 h after diln. with 0.9% w/v saline soln.  Specific uptake of the radiopharmaceutical in CCK-2R-expressing AR42J tumors in nude mice has been demonstrated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFwp3OJd00hrVg90H21EOLACvtfcHk0lico1EwrCvsyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkvFyqu74%253D&md5=ad9ccf0a418295e805808edbf56c8589</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2007.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2007.02.007%26sid%3Dliteratum%253Aachs%26aulast%3DSosabowski%26aufirst%3DJ.%2BK.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DDekker%26aufirst%3DB.%2BA.%26aulast%3DSimmons%26aufirst%3DB.%2BP.%26aulast%3DSingh%26aufirst%3DS.%26aulast%3DBeresford%26aufirst%3DH.%26aulast%3DHagan%26aufirst%3DS.%2BA.%26aulast%3DMcKenzie%26aufirst%3DA.%2BJ.%26aulast%3DMather%26aufirst%3DS.%2BJ.%26aulast%3DWatson%26aufirst%3DS.%2BA.%26atitle%3DFormulation%2520development%2520and%2520manufacturing%2520of%2520a%2520gastrin%252FCCK-2%2520receptor%2520targeting%2520peptide%2520as%2520an%2520intermediate%2520drug%2520product%2520for%2520a%2520clinical%2520imaging%2520study%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2007%26volume%3D31%26spage%3D102%26epage%3D211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Werle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernkop-Schnürch, A.</span><span> </span><span class="NLM_article-title">Strategies to improve plasma half life time of peptide and protein drugs</span> <span class="citation_source-journal">Amino Acids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">351</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm900400w&amp;key=10.1007%2Fs00726-005-0289-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm900400w&amp;key=16622600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm900400w&amp;key=1%3ACAS%3A528%3ADC%252BD28Xls1egsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2006&pages=351-367&author=M.+Werleauthor=A.+Bernkop-Schn%C3%BCrch&title=Strategies+to+improve+plasma+half+life+time+of+peptide+and+protein+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies to improve plasma half life time of peptide and protein drugs</span></div><div class="casAuthors">Werle, M.; Bernkop-Schnuerch, A.</div><div class="citationInfo"><span class="NLM_cas:title">Amino Acids</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">351-367</span>CODEN:
                <span class="NLM_cas:coden">AACIE6</span>;
        ISSN:<span class="NLM_cas:issn">0939-4451</span>.
    
            (<span class="NLM_cas:orgname">Springer Wien</span>)
        </div><div class="casAbstract">A review.  Due to the obvious advantages of long-acting peptide and protein drugs, strategies to prolong blood plasma half life time of such compds. are highly on demand.  Short plasma half life times are commonly due to fast renal clearance as well as to enzymic degrdn. occurring during systemic circulation.  Modifications of the peptide/protein can lead to prolonged plasma half life times.  By shortening the overall amino acid amt. of somatostatin and replacing L-analog amino acids with D-amino acids, plasma half life time of the derivate octreotide was 1.5 h in comparison to only few minutes of somatostatin.  A PEG2,40K conjugate of INF-α-2b exhibited a 330-fold prolonged plasma half life time compared to the native protein.  It was the aim of this review to provide an overview of possible strategies to prolong plasma half life time such as modification of N- and C-terminus or PEGylation as well as methods to evaluate the effectiveness of drug modifications.  Furthermore, fundamental data about most important proteolytic enzymes of human blood, liver, and kidney as well as their cleavage specificity and inhibitors for them are provided to predict enzymic cleavage of peptide and protein drugs during systemic circulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovVKc2VODC97Vg90H21EOLACvtfcHk0lico1EwrCvsyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xls1egsrw%253D&md5=2e286c53028f38cfe33deef26bb160d0</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1007%2Fs00726-005-0289-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00726-005-0289-3%26sid%3Dliteratum%253Aachs%26aulast%3DWerle%26aufirst%3DM.%26aulast%3DBernkop-Schn%25C3%25BCrch%26aufirst%3DA.%26atitle%3DStrategies%2520to%2520improve%2520plasma%2520half%2520life%2520time%2520of%2520peptide%2520and%2520protein%2520drugs%26jtitle%3DAmino%2520Acids%26date%3D2006%26volume%3D30%26spage%3D351%26epage%3D367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">De Luca, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Capua, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saviano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Della Moglie, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aloj, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarallo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedone, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morelli, G.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of cyclic and branched peptide analogs as ligands for cholecystokinin type 1 receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">5845</span><span class="NLM_x">–</span> <span class="NLM_lpage">3853</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=5845-3853&author=S.+De+Lucaauthor=A.+De+Capuaauthor=M.+Savianoauthor=R.+Della+Moglieauthor=L.+Alojauthor=L.+Taralloauthor=C.+Pedoneauthor=G.+Morelli&title=Synthesis+and+biological+evaluation+of+cyclic+and+branched+peptide+analogs+as+ligands+for+cholecystokinin+type+1+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BLuca%26aufirst%3DS.%26aulast%3DDe%2BCapua%26aufirst%3DA.%26aulast%3DSaviano%26aufirst%3DM.%26aulast%3DDella%2BMoglie%26aufirst%3DR.%26aulast%3DAloj%26aufirst%3DL.%26aulast%3DTarallo%26aufirst%3DL.%26aulast%3DPedone%26aufirst%3DC.%26aulast%3DMorelli%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520cyclic%2520and%2520branched%2520peptide%2520analogs%2520as%2520ligands%2520for%2520cholecystokinin%2520type%25201%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D5845%26epage%3D3853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Fröberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nock, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maina, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Herder, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Wilt, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Lugt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Blois, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdijsseldonck, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mäcke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krenning, E.</span><span> </span><span class="NLM_article-title"><sup>99m</sup>Tc-Demogastrin 2 for CCK 2-receptor scintigraphy in medullary thyroid carcinoma</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">S109</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2006&pages=S109&author=A.+Fr%C3%B6bergauthor=B.+Nockauthor=T.+Mainaauthor=M.+de+Jongauthor=W.+de+Herderauthor=H.+de+Wiltauthor=A.+van+der+Lugtauthor=E.+de+Bloisauthor=M.+Verdijsseldonckauthor=H.+M%C3%A4ckeauthor=E.+Krenning&title=99mTc-Demogastrin+2+for+CCK+2-receptor+scintigraphy+in+medullary+thyroid+carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFr%25C3%25B6berg%26aufirst%3DA.%26aulast%3DNock%26aufirst%3DB.%26aulast%3DMaina%26aufirst%3DT.%26aulast%3Dde%2BJong%26aufirst%3DM.%26aulast%3Dde%2BHerder%26aufirst%3DW.%26aulast%3Dde%2BWilt%26aufirst%3DH.%26aulast%3Dvan%2Bder%2BLugt%26aufirst%3DA.%26aulast%3Dde%2BBlois%26aufirst%3DE.%26aulast%3DVerdijsseldonck%26aufirst%3DM.%26aulast%3DM%25C3%25A4cke%26aufirst%3DH.%26aulast%3DKrenning%26aufirst%3DE.%26atitle%3D99mTc-Demogastrin%25202%2520for%2520CCK%25202-receptor%2520scintigraphy%2520in%2520medullary%2520thyroid%2520carcinoma%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2006%26volume%3D33%26spage%3DS109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Sosabowski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matzow, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mather, S.</span><span> </span><span class="NLM_article-title">Targeting of CCK2 receptor expressing tumours using an <sup>111</sup>In-labelled minigastrin dimer</span> <span class="citation_source-journal">Q. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">S13</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=S13&author=J.+Sosabowskiauthor=T.+Matzowauthor=J.+Fosterauthor=S.+Mather&title=Targeting+of+CCK2+receptor+expressing+tumours+using+an+111In-labelled+minigastrin+dimer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSosabowski%26aufirst%3DJ.%26aulast%3DMatzow%26aufirst%3DT.%26aulast%3DFoster%26aufirst%3DJ.%26aulast%3DMather%26aufirst%3DS.%26atitle%3DTargeting%2520of%2520CCK2%2520receptor%2520expressing%2520tumours%2520using%2520an%2520111In-labelled%2520minigastrin%2520dimer%26jtitle%3DQ.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2008%26volume%3D52%26spage%3DS13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">von Guggenberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melendez Alafort, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mather, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moncayo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decristoforo, C.</span><span> </span><span class="NLM_article-title">Preparation via coligand exchange and characterization of [<sup>99m</sup>Tc-EDDA-HYNIC-D-Phe<sup>1</sup>;Tyr<sup>3</sup>]Octreotide (<sup>99m</sup>Tc-EDDA/HYNIC-TOC)</span> <span class="citation_source-journal">J. Lab. Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">318</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm900400w&amp;key=10.1002%2Fjlcr.672" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm900400w&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjt1Wmsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=307-318&author=E.+von+Guggenbergauthor=B.+Sargauthor=H.+Lindnerauthor=L.+Melendez+Alafortauthor=S.+J.+Matherauthor=R.+Moncayoauthor=C.+Decristoforo&title=Preparation+via+coligand+exchange+and+characterization+of+%5B99mTc-EDDA-HYNIC-D-Phe1%3BTyr3%5DOctreotide+%2899mTc-EDDA%2FHYNIC-TOC%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation via coligand exchange and characterization of [99mTc-EDDA-HYNIC-D-Phe1,Tyr3]octreotide (99mTc-EDDA/HYNIC-TOC)</span></div><div class="casAuthors">von Guggenberg, Elisabeth; Sarg, Bettina; Lindner, Herbert; Alafort, Laura Melendez; Mather, Stephen J.; Moncayo, Roy; Decristoforo, Clemens</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds & Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">307-318</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">[99mTc-EDDA-HYNIC-D-Phe1,Tyr3]octreotide (99mTc-EDDA/HYNIC-TOC) is a promising new agent with the potential to replace [111In-DTPA-D-Phe1]-octreotide in somatostatin receptor scintigraphy.  This hydrazinonicotinic acid derivatized somatostatin complex contains ethylenediamine-N,N'-diacetic acid (EDDA) as a coligand resulting in a high in vitro and in vivo stability.  Since direct 99mTc-labeling of HYNIC-TOC with EDDA results in low labeling yields, the authors describe the prepn. of 99mTc-EDDA/HYNIC-TOC via coligand exchange from Tricine for EDDA.  Exchange of coligands is achieved at elevated temp. and under optimized conditions of pH, EDDA concn. and stannous ion.  High labeling yields (mean 95.9%) were achieved at high specific activities (> 37 GBq/μmol).  Characterization via HPLC, receptor binding and LC-MS of the resulting complex is described.  The formulation developed enables rapid and simple labeling of 99mTc-EDDA/HYNIC-TOC in a manner suitable for a clin. setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlLpzV54vF8LVg90H21EOLACvtfcHk0lgBjxRxcRZ0Jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjt1Wmsrk%253D&md5=22ff744e46c93a28cb25088c73aab20a</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.672&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.672%26sid%3Dliteratum%253Aachs%26aulast%3Dvon%2BGuggenberg%26aufirst%3DE.%26aulast%3DSarg%26aufirst%3DB.%26aulast%3DLindner%26aufirst%3DH.%26aulast%3DMelendez%2BAlafort%26aufirst%3DL.%26aulast%3DMather%26aufirst%3DS.%2BJ.%26aulast%3DMoncayo%26aufirst%3DR.%26aulast%3DDecristoforo%26aufirst%3DC.%26atitle%3DPreparation%2520via%2520coligand%2520exchange%2520and%2520characterization%2520of%2520%255B99mTc-EDDA-HYNIC-D-Phe1%253BTyr3%255DOctreotide%2520%252899mTc-EDDA%252FHYNIC-TOC%2529%26jtitle%3DJ.%2520Lab.%2520Compd.%2520Radiopharm.%26date%3D2003%26volume%3D46%26spage%3D307%26epage%3D318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Svoboda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dupuche, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bui, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christophe, J.</span><span> </span><span class="NLM_article-title">Internalization−sequestration and degradation of cholecystokinin (CCK) in tumoral rat pancreatic AR 4-2 J cells</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">1055</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">216</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1055&publication_year=1990&pages=207-216&author=M.+Svobodaauthor=M.+H.+Dupucheauthor=M.+Lambertauthor=D.+Buiauthor=J.+Christophe&title=Internalization%E2%88%92sequestration+and+degradation+of+cholecystokinin+%28CCK%29+in+tumoral+rat+pancreatic+AR+4-2+J+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSvoboda%26aufirst%3DM.%26aulast%3DDupuche%26aufirst%3DM.%2BH.%26aulast%3DLambert%26aufirst%3DM.%26aulast%3DBui%26aufirst%3DD.%26aulast%3DChristophe%26aufirst%3DJ.%26atitle%3DInternalization%25E2%2588%2592sequestration%2520and%2520degradation%2520of%2520cholecystokinin%2520%2528CCK%2529%2520in%2520tumoral%2520rat%2520pancreatic%2520AR%25204-2%2520J%2520cells%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1990%26volume%3D1055%26spage%3D207%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm900400w&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm900400w%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2009.52.issue-15%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm900400w" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799671d7dff24c7","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
